<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_neg 1500329484171 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/XBench.gif' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S'>WHITFIELD_CELL_CYCLE_G1_S</a></td><td><a href='WHITFIELD_CELL_CYCLE_G1_S.html'>Details ...</a></td><td>112</td><td>-0.47</td><td>-1.87</td><td>0.000</td><td>0.919</td><td>0.652</td><td>2324</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/LI_PROSTATE_CANCER_EPIGENETIC'>LI_PROSTATE_CANCER_EPIGENETIC</a></td><td><a href='LI_PROSTATE_CANCER_EPIGENETIC.html'>Details ...</a></td><td>17</td><td>-0.68</td><td>-1.84</td><td>0.004</td><td>0.673</td><td>0.803</td><td>1521</td><td>tags=47%, list=13%, signal=54%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_EZH2_TARGETS'>KAMMINGA_EZH2_TARGETS</a></td><td><a href='KAMMINGA_EZH2_TARGETS.html'>Details ...</a></td><td>39</td><td>-0.55</td><td>-1.82</td><td>0.002</td><td>0.546</td><td>0.850</td><td>1621</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PID_FAS_PATHWAY'>PID_FAS_PATHWAY</a></td><td><a href='PID_FAS_PATHWAY.html'>Details ...</a></td><td>35</td><td>-0.57</td><td>-1.82</td><td>0.000</td><td>0.410</td><td>0.851</td><td>2290</td><td>tags=46%, list=20%, signal=57%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53'>WU_APOPTOSIS_BY_CDKN1A_VIA_TP53</a></td><td><a href='WU_APOPTOSIS_BY_CDKN1A_VIA_TP53.html'>Details ...</a></td><td>50</td><td>-0.52</td><td>-1.80</td><td>0.000</td><td>0.421</td><td>0.917</td><td>1702</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/PID_INSULIN_PATHWAY'>PID_INSULIN_PATHWAY</a></td><td><a href='PID_INSULIN_PATHWAY.html'>Details ...</a></td><td>37</td><td>-0.55</td><td>-1.77</td><td>0.004</td><td>0.476</td><td>0.971</td><td>2797</td><td>tags=54%, list=24%, signal=71%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MACAEVA_PBMC_RESPONSE_TO_IR'>MACAEVA_PBMC_RESPONSE_TO_IR</a></td><td><a href='MACAEVA_PBMC_RESPONSE_TO_IR.html'>Details ...</a></td><td>83</td><td>-0.47</td><td>-1.77</td><td>0.000</td><td>0.409</td><td>0.971</td><td>2620</td><td>tags=41%, list=23%, signal=53%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GABRIELY_MIR21_TARGETS'>GABRIELY_MIR21_TARGETS</a></td><td><a href='GABRIELY_MIR21_TARGETS.html'>Details ...</a></td><td>232</td><td>-0.41</td><td>-1.76</td><td>0.000</td><td>0.384</td><td>0.978</td><td>2639</td><td>tags=38%, list=23%, signal=48%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NOD1_2_SIGNALING_PATHWAY'>REACTOME_NOD1_2_SIGNALING_PATHWAY</a></td><td><a href='REACTOME_NOD1_2_SIGNALING_PATHWAY.html'>Details ...</a></td><td>29</td><td>-0.56</td><td>-1.75</td><td>0.007</td><td>0.412</td><td>0.988</td><td>2131</td><td>tags=45%, list=18%, signal=55%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR30_TARGETS_UP'>IKEDA_MIR30_TARGETS_UP</a></td><td><a href='IKEDA_MIR30_TARGETS_UP.html'>Details ...</a></td><td>94</td><td>-0.46</td><td>-1.74</td><td>0.000</td><td>0.423</td><td>0.993</td><td>1987</td><td>tags=35%, list=17%, signal=42%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA1_UP'>BOYLAN_MULTIPLE_MYELOMA_PCA1_UP</a></td><td><a href='BOYLAN_MULTIPLE_MYELOMA_PCA1_UP.html'>Details ...</a></td><td>55</td><td>-0.49</td><td>-1.73</td><td>0.003</td><td>0.417</td><td>0.994</td><td>1231</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PLASMA_CELL_UP'>MORI_PLASMA_CELL_UP</a></td><td><a href='MORI_PLASMA_CELL_UP.html'>Details ...</a></td><td>47</td><td>-0.51</td><td>-1.70</td><td>0.004</td><td>0.507</td><td>1.000</td><td>2443</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CDC42RAC_PATHWAY'>BIOCARTA_CDC42RAC_PATHWAY</a></td><td><a href='BIOCARTA_CDC42RAC_PATHWAY.html'>Details ...</a></td><td>15</td><td>-0.66</td><td>-1.70</td><td>0.007</td><td>0.492</td><td>1.000</td><td>1744</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_ESTRADIOL_UP'>FRASOR_RESPONSE_TO_ESTRADIOL_UP</a></td><td><a href='FRASOR_RESPONSE_TO_ESTRADIOL_UP.html'>Details ...</a></td><td>22</td><td>-0.58</td><td>-1.69</td><td>0.007</td><td>0.482</td><td>1.000</td><td>491</td><td>tags=23%, list=4%, signal=24%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP'>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP</a></td><td><a href='CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP.html'>Details ...</a></td><td>69</td><td>-0.46</td><td>-1.68</td><td>0.002</td><td>0.494</td><td>1.000</td><td>2152</td><td>tags=35%, list=19%, signal=42%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D6'>GENTILE_UV_RESPONSE_CLUSTER_D6</a></td><td><a href='GENTILE_UV_RESPONSE_CLUSTER_D6.html'>Details ...</a></td><td>32</td><td>-0.52</td><td>-1.67</td><td>0.011</td><td>0.553</td><td>1.000</td><td>793</td><td>tags=25%, list=7%, signal=27%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12'>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12</a></td><td><a href='SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12.html'>Details ...</a></td><td>173</td><td>-0.40</td><td>-1.66</td><td>0.000</td><td>0.531</td><td>1.000</td><td>1894</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_DN'>ZHAN_MULTIPLE_MYELOMA_PR_DN</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_PR_DN.html'>Details ...</a></td><td>34</td><td>-0.52</td><td>-1.66</td><td>0.002</td><td>0.502</td><td>1.000</td><td>2348</td><td>tags=47%, list=20%, signal=59%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AKT_PATHWAY'>BIOCARTA_AKT_PATHWAY</a></td><td><a href='BIOCARTA_AKT_PATHWAY.html'>Details ...</a></td><td>20</td><td>-0.58</td><td>-1.65</td><td>0.008</td><td>0.543</td><td>1.000</td><td>957</td><td>tags=25%, list=8%, signal=27%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_DN'>XU_CREBBP_TARGETS_DN</a></td><td><a href='XU_CREBBP_TARGETS_DN.html'>Details ...</a></td><td>33</td><td>-0.52</td><td>-1.64</td><td>0.008</td><td>0.547</td><td>1.000</td><td>2161</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>21</td><td>BIOCARTA_IL1R_PATHWAY</td><td></td><td>26</td><td>-0.54</td><td>-1.64</td><td>0.017</td><td>0.525</td><td>1.000</td><td>1887</td><td>tags=38%, list=16%, signal=46%</td></tr><tr><td class='lessen'>22</td><td>GALE_APL_WITH_FLT3_MUTATED_UP</td><td></td><td>50</td><td>-0.47</td><td>-1.64</td><td>0.009</td><td>0.530</td><td>1.000</td><td>1686</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>23</td><td>GRABARCZYK_BCL11B_TARGETS_DN</td><td></td><td>37</td><td>-0.50</td><td>-1.64</td><td>0.009</td><td>0.510</td><td>1.000</td><td>2446</td><td>tags=46%, list=21%, signal=58%</td></tr><tr><td class='lessen'>24</td><td>REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION</td><td></td><td>18</td><td>-0.59</td><td>-1.62</td><td>0.020</td><td>0.550</td><td>1.000</td><td>1894</td><td>tags=44%, list=16%, signal=53%</td></tr><tr><td class='lessen'>25</td><td>PID_IGF1_PATHWAY</td><td></td><td>26</td><td>-0.54</td><td>-1.62</td><td>0.015</td><td>0.558</td><td>1.000</td><td>2202</td><td>tags=50%, list=19%, signal=62%</td></tr><tr><td class='lessen'>26</td><td>VALK_AML_WITH_CEBPA</td><td></td><td>23</td><td>-0.55</td><td>-1.61</td><td>0.019</td><td>0.557</td><td>1.000</td><td>2438</td><td>tags=39%, list=21%, signal=49%</td></tr><tr><td class='lessen'>27</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN</td><td></td><td>47</td><td>-0.47</td><td>-1.61</td><td>0.005</td><td>0.547</td><td>1.000</td><td>1245</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>28</td><td>ZHENG_FOXP3_TARGETS_UP</td><td></td><td>20</td><td>-0.57</td><td>-1.60</td><td>0.016</td><td>0.577</td><td>1.000</td><td>1525</td><td>tags=35%, list=13%, signal=40%</td></tr><tr><td class='lessen'>29</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>202</td><td>-0.37</td><td>-1.60</td><td>0.002</td><td>0.570</td><td>1.000</td><td>2038</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>30</td><td>REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS</td><td></td><td>42</td><td>-0.48</td><td>-1.60</td><td>0.011</td><td>0.551</td><td>1.000</td><td>1887</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>31</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>28</td><td>-0.53</td><td>-1.60</td><td>0.013</td><td>0.534</td><td>1.000</td><td>2229</td><td>tags=36%, list=19%, signal=44%</td></tr><tr><td class='lessen'>32</td><td>PID_ATM_PATHWAY</td><td></td><td>34</td><td>-0.50</td><td>-1.59</td><td>0.015</td><td>0.542</td><td>1.000</td><td>2397</td><td>tags=47%, list=21%, signal=59%</td></tr><tr><td class='lessen'>33</td><td>WHITFIELD_CELL_CYCLE_G2</td><td></td><td>155</td><td>-0.38</td><td>-1.59</td><td>0.000</td><td>0.542</td><td>1.000</td><td>2619</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>34</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>262</td><td>-0.36</td><td>-1.59</td><td>0.000</td><td>0.530</td><td>1.000</td><td>2436</td><td>tags=31%, list=21%, signal=38%</td></tr><tr><td class='lessen'>35</td><td>PID_LIS1_PATHWAY</td><td></td><td>23</td><td>-0.54</td><td>-1.59</td><td>0.024</td><td>0.531</td><td>1.000</td><td>2263</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>36</td><td>VANHARANTA_UTERINE_FIBROID_UP</td><td></td><td>23</td><td>-0.55</td><td>-1.58</td><td>0.016</td><td>0.532</td><td>1.000</td><td>2749</td><td>tags=57%, list=24%, signal=74%</td></tr><tr><td class='lessen'>37</td><td>PECE_MAMMARY_STEM_CELL_DN</td><td></td><td>107</td><td>-0.41</td><td>-1.58</td><td>0.002</td><td>0.520</td><td>1.000</td><td>2437</td><td>tags=34%, list=21%, signal=42%</td></tr><tr><td class='lessen'>38</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td><td></td><td>40</td><td>-0.47</td><td>-1.57</td><td>0.025</td><td>0.544</td><td>1.000</td><td>2307</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>39</td><td>CHIBA_RESPONSE_TO_TSA_DN</td><td></td><td>18</td><td>-0.56</td><td>-1.57</td><td>0.022</td><td>0.531</td><td>1.000</td><td>1502</td><td>tags=39%, list=13%, signal=45%</td></tr><tr><td class='lessen'>40</td><td>PID_RAS_PATHWAY</td><td></td><td>20</td><td>-0.56</td><td>-1.57</td><td>0.028</td><td>0.520</td><td>1.000</td><td>1170</td><td>tags=35%, list=10%, signal=39%</td></tr><tr><td class='lessen'>41</td><td>HEIDENBLAD_AMPLICON_8Q24_UP</td><td></td><td>31</td><td>-0.50</td><td>-1.57</td><td>0.015</td><td>0.539</td><td>1.000</td><td>663</td><td>tags=19%, list=6%, signal=20%</td></tr><tr><td class='lessen'>42</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>54</td><td>-0.44</td><td>-1.56</td><td>0.010</td><td>0.543</td><td>1.000</td><td>1456</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>43</td><td>LINSLEY_MIR16_TARGETS</td><td></td><td>167</td><td>-0.37</td><td>-1.56</td><td>0.000</td><td>0.536</td><td>1.000</td><td>2668</td><td>tags=36%, list=23%, signal=46%</td></tr><tr><td class='lessen'>44</td><td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td><td></td><td>65</td><td>-0.43</td><td>-1.56</td><td>0.005</td><td>0.535</td><td>1.000</td><td>601</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>45</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN</td><td></td><td>16</td><td>-0.58</td><td>-1.56</td><td>0.028</td><td>0.534</td><td>1.000</td><td>3001</td><td>tags=56%, list=26%, signal=76%</td></tr><tr><td class='lessen'>46</td><td>KAMMINGA_SENESCENCE</td><td></td><td>27</td><td>-0.52</td><td>-1.55</td><td>0.017</td><td>0.539</td><td>1.000</td><td>3088</td><td>tags=44%, list=27%, signal=60%</td></tr><tr><td class='lessen'>47</td><td>MCBRYAN_PUBERTAL_BREAST_5_6WK_DN</td><td></td><td>107</td><td>-0.39</td><td>-1.55</td><td>0.008</td><td>0.543</td><td>1.000</td><td>2559</td><td>tags=37%, list=22%, signal=48%</td></tr><tr><td class='lessen'>48</td><td>SHEPARD_BMYB_TARGETS</td><td></td><td>50</td><td>-0.44</td><td>-1.54</td><td>0.018</td><td>0.573</td><td>1.000</td><td>723</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>49</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>158</td><td>-0.37</td><td>-1.54</td><td>0.000</td><td>0.569</td><td>1.000</td><td>2593</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>50</td><td>GRATIAS_RETINOBLASTOMA_16Q24</td><td></td><td>15</td><td>-0.59</td><td>-1.54</td><td>0.040</td><td>0.561</td><td>1.000</td><td>2803</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>51</td><td>HEIDENBLAD_AMPLICON_12P11_12_DN</td><td></td><td>20</td><td>-0.54</td><td>-1.54</td><td>0.023</td><td>0.559</td><td>1.000</td><td>1641</td><td>tags=35%, list=14%, signal=41%</td></tr><tr><td class='lessen'>52</td><td>CROONQUIST_NRAS_SIGNALING_DN</td><td></td><td>67</td><td>-0.41</td><td>-1.53</td><td>0.009</td><td>0.556</td><td>1.000</td><td>1739</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>53</td><td>PID_P53_REGULATION_PATHWAY</td><td></td><td>53</td><td>-0.44</td><td>-1.53</td><td>0.009</td><td>0.562</td><td>1.000</td><td>2174</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>54</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP</td><td></td><td>41</td><td>-0.46</td><td>-1.53</td><td>0.020</td><td>0.552</td><td>1.000</td><td>1289</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>55</td><td>COATES_MACROPHAGE_M1_VS_M2_UP</td><td></td><td>55</td><td>-0.42</td><td>-1.53</td><td>0.015</td><td>0.557</td><td>1.000</td><td>2120</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>56</td><td>RUAN_RESPONSE_TO_TROGLITAZONE_UP</td><td></td><td>16</td><td>-0.58</td><td>-1.53</td><td>0.048</td><td>0.547</td><td>1.000</td><td>1293</td><td>tags=31%, list=11%, signal=35%</td></tr><tr><td class='lessen'>57</td><td>KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS</td><td></td><td>117</td><td>-0.39</td><td>-1.52</td><td>0.005</td><td>0.547</td><td>1.000</td><td>1500</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>58</td><td>GENTLES_LEUKEMIC_STEM_CELL_UP</td><td></td><td>19</td><td>-0.55</td><td>-1.52</td><td>0.048</td><td>0.550</td><td>1.000</td><td>1231</td><td>tags=32%, list=11%, signal=35%</td></tr><tr><td class='lessen'>59</td><td>ABRAMSON_INTERACT_WITH_AIRE</td><td></td><td>43</td><td>-0.46</td><td>-1.52</td><td>0.024</td><td>0.548</td><td>1.000</td><td>1712</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>60</td><td>SANSOM_APC_TARGETS_DN</td><td></td><td>237</td><td>-0.35</td><td>-1.52</td><td>0.002</td><td>0.554</td><td>1.000</td><td>2090</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>61</td><td>BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP</td><td></td><td>22</td><td>-0.53</td><td>-1.52</td><td>0.046</td><td>0.546</td><td>1.000</td><td>3796</td><td>tags=64%, list=33%, signal=94%</td></tr><tr><td class='lessen'>62</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP</td><td></td><td>54</td><td>-0.43</td><td>-1.52</td><td>0.022</td><td>0.540</td><td>1.000</td><td>3036</td><td>tags=41%, list=26%, signal=55%</td></tr><tr><td class='lessen'>63</td><td>BIOCARTA_HDAC_PATHWAY</td><td></td><td>21</td><td>-0.53</td><td>-1.52</td><td>0.030</td><td>0.533</td><td>1.000</td><td>1841</td><td>tags=43%, list=16%, signal=51%</td></tr><tr><td class='lessen'>64</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_UP</td><td></td><td>145</td><td>-0.37</td><td>-1.51</td><td>0.007</td><td>0.542</td><td>1.000</td><td>1890</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>65</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>66</td><td>-0.42</td><td>-1.51</td><td>0.016</td><td>0.540</td><td>1.000</td><td>2722</td><td>tags=45%, list=24%, signal=59%</td></tr><tr><td class='lessen'>66</td><td>OLSSON_E2F3_TARGETS_UP</td><td></td><td>17</td><td>-0.55</td><td>-1.51</td><td>0.037</td><td>0.543</td><td>1.000</td><td>1007</td><td>tags=29%, list=9%, signal=32%</td></tr><tr><td class='lessen'>67</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP</td><td></td><td>17</td><td>-0.55</td><td>-1.51</td><td>0.047</td><td>0.542</td><td>1.000</td><td>2799</td><td>tags=59%, list=24%, signal=77%</td></tr><tr><td class='lessen'>68</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN</td><td></td><td>43</td><td>-0.44</td><td>-1.50</td><td>0.020</td><td>0.555</td><td>1.000</td><td>2396</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>69</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>111</td><td>-0.38</td><td>-1.50</td><td>0.002</td><td>0.547</td><td>1.000</td><td>2579</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>70</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>317</td><td>-0.33</td><td>-1.50</td><td>0.002</td><td>0.543</td><td>1.000</td><td>1999</td><td>tags=26%, list=17%, signal=30%</td></tr><tr><td class='lessen'>71</td><td>LE_NEURONAL_DIFFERENTIATION_DN</td><td></td><td>17</td><td>-0.55</td><td>-1.49</td><td>0.049</td><td>0.567</td><td>1.000</td><td>3097</td><td>tags=47%, list=27%, signal=64%</td></tr><tr><td class='lessen'>72</td><td>TAVOR_CEBPA_TARGETS_UP</td><td></td><td>37</td><td>-0.46</td><td>-1.49</td><td>0.022</td><td>0.567</td><td>1.000</td><td>1783</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>73</td><td>SMIRNOV_RESPONSE_TO_IR_6HR_UP</td><td></td><td>148</td><td>-0.36</td><td>-1.49</td><td>0.005</td><td>0.581</td><td>1.000</td><td>1837</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>74</td><td>REACTOME_DOWNSTREAM_TCR_SIGNALING</td><td></td><td>27</td><td>-0.49</td><td>-1.48</td><td>0.044</td><td>0.583</td><td>1.000</td><td>957</td><td>tags=26%, list=8%, signal=28%</td></tr><tr><td class='lessen'>75</td><td>AIYAR_COBRA1_TARGETS_DN</td><td></td><td>21</td><td>-0.53</td><td>-1.48</td><td>0.035</td><td>0.578</td><td>1.000</td><td>2337</td><td>tags=48%, list=20%, signal=60%</td></tr><tr><td class='lessen'>76</td><td>XU_GH1_EXOGENOUS_TARGETS_DN</td><td></td><td>66</td><td>-0.40</td><td>-1.48</td><td>0.014</td><td>0.581</td><td>1.000</td><td>2395</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>77</td><td>PID_IL23_PATHWAY</td><td></td><td>26</td><td>-0.49</td><td>-1.48</td><td>0.045</td><td>0.580</td><td>1.000</td><td>1799</td><td>tags=35%, list=16%, signal=41%</td></tr><tr><td class='lessen'>78</td><td>ZHANG_TLX_TARGETS_36HR_DN</td><td></td><td>166</td><td>-0.35</td><td>-1.47</td><td>0.000</td><td>0.595</td><td>1.000</td><td>1440</td><td>tags=20%, list=12%, signal=22%</td></tr><tr><td class='lessen'>79</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>120</td><td>-0.37</td><td>-1.47</td><td>0.010</td><td>0.599</td><td>1.000</td><td>857</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>80</td><td>SIG_CHEMOTAXIS</td><td></td><td>34</td><td>-0.46</td><td>-1.47</td><td>0.043</td><td>0.604</td><td>1.000</td><td>1286</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>81</td><td>REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION</td><td></td><td>172</td><td>-0.35</td><td>-1.47</td><td>0.005</td><td>0.598</td><td>1.000</td><td>1503</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>82</td><td>PID_NFKAPPAB_CANONICAL_PATHWAY</td><td></td><td>22</td><td>-0.52</td><td>-1.46</td><td>0.044</td><td>0.607</td><td>1.000</td><td>269</td><td>tags=23%, list=2%, signal=23%</td></tr><tr><td class='lessen'>83</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_DN</td><td></td><td>48</td><td>-0.42</td><td>-1.46</td><td>0.025</td><td>0.613</td><td>1.000</td><td>1259</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>84</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP</td><td></td><td>23</td><td>-0.50</td><td>-1.46</td><td>0.060</td><td>0.606</td><td>1.000</td><td>1755</td><td>tags=30%, list=15%, signal=36%</td></tr><tr><td class='lessen'>85</td><td>ST_TUMOR_NECROSIS_FACTOR_PATHWAY</td><td></td><td>28</td><td>-0.49</td><td>-1.46</td><td>0.037</td><td>0.600</td><td>1.000</td><td>1298</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>86</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_UP</td><td></td><td>50</td><td>-0.43</td><td>-1.46</td><td>0.030</td><td>0.595</td><td>1.000</td><td>1289</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>87</td><td>THUM_SYSTOLIC_HEART_FAILURE_DN</td><td></td><td>155</td><td>-0.35</td><td>-1.45</td><td>0.007</td><td>0.622</td><td>1.000</td><td>2242</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>88</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td><td></td><td>109</td><td>-0.36</td><td>-1.45</td><td>0.007</td><td>0.652</td><td>1.000</td><td>2619</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>89</td><td>CHANGOLKAR_H2AFY_TARGETS_DN</td><td></td><td>22</td><td>-0.50</td><td>-1.44</td><td>0.085</td><td>0.651</td><td>1.000</td><td>1656</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>90</td><td>SHIN_B_CELL_LYMPHOMA_CLUSTER_2</td><td></td><td>26</td><td>-0.48</td><td>-1.44</td><td>0.057</td><td>0.653</td><td>1.000</td><td>2216</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>91</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP</td><td></td><td>27</td><td>-0.47</td><td>-1.44</td><td>0.054</td><td>0.646</td><td>1.000</td><td>2226</td><td>tags=44%, list=19%, signal=55%</td></tr><tr><td class='lessen'>92</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_5</td><td></td><td>108</td><td>-0.37</td><td>-1.44</td><td>0.012</td><td>0.654</td><td>1.000</td><td>2255</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>93</td><td>VANASSE_BCL2_TARGETS_UP</td><td></td><td>25</td><td>-0.49</td><td>-1.44</td><td>0.069</td><td>0.650</td><td>1.000</td><td>1694</td><td>tags=36%, list=15%, signal=42%</td></tr><tr><td class='lessen'>94</td><td>REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM</td><td></td><td>49</td><td>-0.41</td><td>-1.44</td><td>0.035</td><td>0.657</td><td>1.000</td><td>1195</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>95</td><td>KLEIN_TARGETS_OF_BCR_ABL1_FUSION</td><td></td><td>34</td><td>-0.46</td><td>-1.43</td><td>0.058</td><td>0.654</td><td>1.000</td><td>1594</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>96</td><td>ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER</td><td></td><td>126</td><td>-0.36</td><td>-1.43</td><td>0.027</td><td>0.650</td><td>1.000</td><td>2968</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>97</td><td>RAMALHO_STEMNESS_UP</td><td></td><td>181</td><td>-0.34</td><td>-1.43</td><td>0.003</td><td>0.645</td><td>1.000</td><td>2025</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>98</td><td>GREENBAUM_E2A_TARGETS_UP</td><td></td><td>31</td><td>-0.46</td><td>-1.43</td><td>0.036</td><td>0.639</td><td>1.000</td><td>878</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>99</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN</td><td></td><td>46</td><td>-0.43</td><td>-1.43</td><td>0.027</td><td>0.635</td><td>1.000</td><td>3162</td><td>tags=46%, list=27%, signal=63%</td></tr><tr><td class='lessen'>100</td><td>PID_IL6_7_PATHWAY</td><td></td><td>42</td><td>-0.43</td><td>-1.43</td><td>0.049</td><td>0.635</td><td>1.000</td><td>1999</td><td>tags=38%, list=17%, signal=46%</td></tr><tr><td class='lessen'>101</td><td>REICHERT_MITOSIS_LIN9_TARGETS</td><td></td><td>26</td><td>-0.48</td><td>-1.43</td><td>0.068</td><td>0.640</td><td>1.000</td><td>3036</td><td>tags=50%, list=26%, signal=68%</td></tr><tr><td class='lessen'>102</td><td>LEE_LIVER_CANCER_MYC_DN</td><td></td><td>27</td><td>-0.47</td><td>-1.43</td><td>0.063</td><td>0.651</td><td>1.000</td><td>2255</td><td>tags=37%, list=19%, signal=46%</td></tr><tr><td class='lessen'>103</td><td>ROZANOV_MMP14_TARGETS_DN</td><td></td><td>20</td><td>-0.51</td><td>-1.42</td><td>0.073</td><td>0.651</td><td>1.000</td><td>1455</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>104</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>41</td><td>-0.42</td><td>-1.42</td><td>0.043</td><td>0.645</td><td>1.000</td><td>2359</td><td>tags=34%, list=20%, signal=43%</td></tr><tr><td class='lessen'>105</td><td>GRADE_COLON_AND_RECTAL_CANCER_DN</td><td></td><td>56</td><td>-0.40</td><td>-1.42</td><td>0.040</td><td>0.646</td><td>1.000</td><td>2031</td><td>tags=36%, list=18%, signal=43%</td></tr><tr><td class='lessen'>106</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td><td></td><td>30</td><td>-0.46</td><td>-1.42</td><td>0.056</td><td>0.642</td><td>1.000</td><td>2939</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>107</td><td>REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING</td><td></td><td>30</td><td>-0.46</td><td>-1.42</td><td>0.046</td><td>0.637</td><td>1.000</td><td>1720</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>108</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>230</td><td>-0.33</td><td>-1.42</td><td>0.007</td><td>0.642</td><td>1.000</td><td>2070</td><td>tags=27%, list=18%, signal=32%</td></tr><tr><td class='lessen'>109</td><td>WANG_CLIM2_TARGETS_UP</td><td></td><td>167</td><td>-0.34</td><td>-1.42</td><td>0.010</td><td>0.642</td><td>1.000</td><td>2358</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>110</td><td>PID_ECADHERIN_NASCENT_AJ_PATHWAY</td><td></td><td>36</td><td>-0.44</td><td>-1.42</td><td>0.054</td><td>0.638</td><td>1.000</td><td>2049</td><td>tags=36%, list=18%, signal=44%</td></tr><tr><td class='lessen'>111</td><td>KEGG_CALCIUM_SIGNALING_PATHWAY</td><td></td><td>69</td><td>-0.39</td><td>-1.41</td><td>0.023</td><td>0.651</td><td>1.000</td><td>2122</td><td>tags=41%, list=18%, signal=49%</td></tr><tr><td class='lessen'>112</td><td>YIH_RESPONSE_TO_ARSENITE_C2</td><td></td><td>15</td><td>-0.53</td><td>-1.41</td><td>0.072</td><td>0.649</td><td>1.000</td><td>1892</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>113</td><td>KASLER_HDAC7_TARGETS_1_UP</td><td></td><td>155</td><td>-0.34</td><td>-1.41</td><td>0.018</td><td>0.645</td><td>1.000</td><td>2022</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>114</td><td>PID_TNF_PATHWAY</td><td></td><td>45</td><td>-0.41</td><td>-1.41</td><td>0.064</td><td>0.646</td><td>1.000</td><td>1871</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>115</td><td>KENNY_CTNNB1_TARGETS_DN</td><td></td><td>40</td><td>-0.43</td><td>-1.41</td><td>0.063</td><td>0.644</td><td>1.000</td><td>1454</td><td>tags=30%, list=13%, signal=34%</td></tr><tr><td class='lessen'>116</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>351</td><td>-0.31</td><td>-1.41</td><td>0.002</td><td>0.642</td><td>1.000</td><td>2601</td><td>tags=30%, list=22%, signal=37%</td></tr><tr><td class='lessen'>117</td><td>BRACHAT_RESPONSE_TO_CISPLATIN</td><td></td><td>18</td><td>-0.52</td><td>-1.41</td><td>0.081</td><td>0.637</td><td>1.000</td><td>1874</td><td>tags=44%, list=16%, signal=53%</td></tr><tr><td class='lessen'>118</td><td>NAKAMURA_METASTASIS_MODEL_DN</td><td></td><td>23</td><td>-0.48</td><td>-1.41</td><td>0.065</td><td>0.634</td><td>1.000</td><td>1872</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>119</td><td>JAZAG_TGFB1_SIGNALING_UP</td><td></td><td>66</td><td>-0.39</td><td>-1.41</td><td>0.028</td><td>0.639</td><td>1.000</td><td>2086</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>120</td><td>REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING</td><td></td><td>27</td><td>-0.46</td><td>-1.41</td><td>0.067</td><td>0.637</td><td>1.000</td><td>1720</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>121</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP</td><td></td><td>20</td><td>-0.50</td><td>-1.41</td><td>0.079</td><td>0.633</td><td>1.000</td><td>1238</td><td>tags=40%, list=11%, signal=45%</td></tr><tr><td class='lessen'>122</td><td>WONG_ENDMETRIUM_CANCER_DN</td><td></td><td>19</td><td>-0.52</td><td>-1.40</td><td>0.069</td><td>0.630</td><td>1.000</td><td>1215</td><td>tags=26%, list=10%, signal=29%</td></tr><tr><td class='lessen'>123</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>30</td><td>-0.46</td><td>-1.40</td><td>0.063</td><td>0.637</td><td>1.000</td><td>3021</td><td>tags=40%, list=26%, signal=54%</td></tr><tr><td class='lessen'>124</td><td>REACTOME_IL_3_5_AND_GM_CSF_SIGNALING</td><td></td><td>37</td><td>-0.43</td><td>-1.40</td><td>0.052</td><td>0.633</td><td>1.000</td><td>2360</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>125</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN</td><td></td><td>33</td><td>-0.44</td><td>-1.40</td><td>0.070</td><td>0.634</td><td>1.000</td><td>1476</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>126</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>77</td><td>-0.38</td><td>-1.40</td><td>0.030</td><td>0.633</td><td>1.000</td><td>2663</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>127</td><td>REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B</td><td></td><td>16</td><td>-0.52</td><td>-1.40</td><td>0.079</td><td>0.630</td><td>1.000</td><td>3637</td><td>tags=63%, list=31%, signal=91%</td></tr><tr><td class='lessen'>128</td><td>HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>38</td><td>-0.43</td><td>-1.40</td><td>0.047</td><td>0.634</td><td>1.000</td><td>498</td><td>tags=16%, list=4%, signal=16%</td></tr><tr><td class='lessen'>129</td><td>GYORFFY_DOXORUBICIN_RESISTANCE</td><td></td><td>23</td><td>-0.47</td><td>-1.40</td><td>0.080</td><td>0.633</td><td>1.000</td><td>2747</td><td>tags=39%, list=24%, signal=51%</td></tr><tr><td class='lessen'>130</td><td>REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING</td><td></td><td>16</td><td>-0.53</td><td>-1.39</td><td>0.094</td><td>0.638</td><td>1.000</td><td>2376</td><td>tags=50%, list=21%, signal=63%</td></tr><tr><td class='lessen'>131</td><td>FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN</td><td></td><td>43</td><td>-0.41</td><td>-1.39</td><td>0.055</td><td>0.640</td><td>1.000</td><td>2204</td><td>tags=30%, list=19%, signal=37%</td></tr><tr><td class='lessen'>132</td><td>HOEBEKE_LYMPHOID_STEM_CELL_UP</td><td></td><td>69</td><td>-0.38</td><td>-1.39</td><td>0.045</td><td>0.642</td><td>1.000</td><td>2615</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>133</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</td><td></td><td>16</td><td>-0.53</td><td>-1.39</td><td>0.098</td><td>0.642</td><td>1.000</td><td>1367</td><td>tags=38%, list=12%, signal=42%</td></tr><tr><td class='lessen'>134</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_DN</td><td></td><td>131</td><td>-0.34</td><td>-1.39</td><td>0.027</td><td>0.643</td><td>1.000</td><td>2122</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>135</td><td>BROWNE_HCMV_INFECTION_16HR_UP</td><td></td><td>173</td><td>-0.33</td><td>-1.39</td><td>0.016</td><td>0.642</td><td>1.000</td><td>1749</td><td>tags=23%, list=15%, signal=26%</td></tr><tr><td class='lessen'>136</td><td>PID_KIT_PATHWAY</td><td></td><td>46</td><td>-0.41</td><td>-1.39</td><td>0.060</td><td>0.644</td><td>1.000</td><td>1281</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>137</td><td>KEGG_APOPTOSIS</td><td></td><td>74</td><td>-0.37</td><td>-1.39</td><td>0.041</td><td>0.643</td><td>1.000</td><td>1755</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>138</td><td>IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN</td><td></td><td>51</td><td>-0.40</td><td>-1.38</td><td>0.048</td><td>0.641</td><td>1.000</td><td>1715</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>139</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>120</td><td>-0.35</td><td>-1.38</td><td>0.019</td><td>0.640</td><td>1.000</td><td>2318</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>140</td><td>GROSS_ELK3_TARGETS_UP</td><td></td><td>21</td><td>-0.48</td><td>-1.38</td><td>0.092</td><td>0.647</td><td>1.000</td><td>1727</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>141</td><td>BROWNE_HCMV_INFECTION_14HR_DN</td><td></td><td>206</td><td>-0.32</td><td>-1.38</td><td>0.015</td><td>0.644</td><td>1.000</td><td>2715</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>142</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP</td><td></td><td>44</td><td>-0.41</td><td>-1.38</td><td>0.072</td><td>0.640</td><td>1.000</td><td>1824</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>143</td><td>BIOCARTA_CASPASE_PATHWAY</td><td></td><td>23</td><td>-0.48</td><td>-1.38</td><td>0.097</td><td>0.638</td><td>1.000</td><td>2657</td><td>tags=39%, list=23%, signal=51%</td></tr><tr><td class='lessen'>144</td><td>REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS</td><td></td><td>19</td><td>-0.50</td><td>-1.38</td><td>0.103</td><td>0.633</td><td>1.000</td><td>2376</td><td>tags=47%, list=21%, signal=60%</td></tr><tr><td class='lessen'>145</td><td>REACTOME_G2_M_CHECKPOINTS</td><td></td><td>38</td><td>-0.42</td><td>-1.38</td><td>0.065</td><td>0.636</td><td>1.000</td><td>1974</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>146</td><td>PID_MYC_PATHWAY</td><td></td><td>24</td><td>-0.48</td><td>-1.37</td><td>0.092</td><td>0.646</td><td>1.000</td><td>446</td><td>tags=25%, list=4%, signal=26%</td></tr><tr><td class='lessen'>147</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>407</td><td>-0.30</td><td>-1.37</td><td>0.002</td><td>0.648</td><td>1.000</td><td>2145</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>148</td><td>BIOCARTA_DEATH_PATHWAY</td><td></td><td>32</td><td>-0.44</td><td>-1.37</td><td>0.078</td><td>0.651</td><td>1.000</td><td>1692</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>149</td><td>REACTOME_GENERIC_TRANSCRIPTION_PATHWAY</td><td></td><td>239</td><td>-0.32</td><td>-1.37</td><td>0.006</td><td>0.648</td><td>1.000</td><td>2154</td><td>tags=27%, list=19%, signal=32%</td></tr><tr><td class='lessen'>150</td><td>MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN</td><td></td><td>16</td><td>-0.52</td><td>-1.37</td><td>0.106</td><td>0.644</td><td>1.000</td><td>1987</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>151</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_DN</td><td></td><td>67</td><td>-0.37</td><td>-1.37</td><td>0.052</td><td>0.649</td><td>1.000</td><td>2446</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>152</td><td>REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX</td><td></td><td>28</td><td>-0.45</td><td>-1.37</td><td>0.080</td><td>0.649</td><td>1.000</td><td>1842</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>153</td><td>CROONQUIST_IL6_DEPRIVATION_DN</td><td></td><td>88</td><td>-0.36</td><td>-1.37</td><td>0.039</td><td>0.645</td><td>1.000</td><td>1783</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>154</td><td>PID_IL27_PATHWAY</td><td></td><td>21</td><td>-0.49</td><td>-1.37</td><td>0.098</td><td>0.649</td><td>1.000</td><td>2181</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>155</td><td>MATZUK_SPERMATID_DIFFERENTIATION</td><td></td><td>20</td><td>-0.49</td><td>-1.37</td><td>0.082</td><td>0.645</td><td>1.000</td><td>2912</td><td>tags=45%, list=25%, signal=60%</td></tr><tr><td class='lessen'>156</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>268</td><td>-0.31</td><td>-1.37</td><td>0.002</td><td>0.642</td><td>1.000</td><td>1528</td><td>tags=22%, list=13%, signal=24%</td></tr><tr><td class='lessen'>157</td><td>PID_RHOA_REG_PATHWAY</td><td></td><td>29</td><td>-0.44</td><td>-1.36</td><td>0.089</td><td>0.647</td><td>1.000</td><td>3449</td><td>tags=52%, list=30%, signal=73%</td></tr><tr><td class='lessen'>158</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP</td><td></td><td>106</td><td>-0.35</td><td>-1.36</td><td>0.037</td><td>0.661</td><td>1.000</td><td>2285</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>159</td><td>HOQUE_METHYLATED_IN_CANCER</td><td></td><td>31</td><td>-0.44</td><td>-1.36</td><td>0.099</td><td>0.663</td><td>1.000</td><td>1693</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>160</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN</td><td></td><td>383</td><td>-0.30</td><td>-1.36</td><td>0.003</td><td>0.664</td><td>1.000</td><td>2443</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>161</td><td>BIOCARTA_NDKDYNAMIN_PATHWAY</td><td></td><td>16</td><td>-0.50</td><td>-1.36</td><td>0.103</td><td>0.665</td><td>1.000</td><td>1665</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>162</td><td>NOUSHMEHR_GBM_SILENCED_BY_METHYLATION</td><td></td><td>23</td><td>-0.47</td><td>-1.35</td><td>0.107</td><td>0.664</td><td>1.000</td><td>875</td><td>tags=17%, list=8%, signal=19%</td></tr><tr><td class='lessen'>163</td><td>PID_SHP2_PATHWAY</td><td></td><td>35</td><td>-0.42</td><td>-1.35</td><td>0.092</td><td>0.661</td><td>1.000</td><td>1644</td><td>tags=31%, list=14%, signal=37%</td></tr><tr><td class='lessen'>164</td><td>ROVERSI_GLIOMA_LOH_REGIONS</td><td></td><td>19</td><td>-0.48</td><td>-1.35</td><td>0.104</td><td>0.665</td><td>1.000</td><td>1227</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>165</td><td>YANG_BREAST_CANCER_ESR1_BULK_UP</td><td></td><td>20</td><td>-0.48</td><td>-1.35</td><td>0.099</td><td>0.663</td><td>1.000</td><td>2309</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>166</td><td>GAL_LEUKEMIC_STEM_CELL_UP</td><td></td><td>83</td><td>-0.35</td><td>-1.35</td><td>0.043</td><td>0.660</td><td>1.000</td><td>2814</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>167</td><td>EGUCHI_CELL_CYCLE_RB1_TARGETS</td><td></td><td>23</td><td>-0.47</td><td>-1.35</td><td>0.100</td><td>0.659</td><td>1.000</td><td>1629</td><td>tags=35%, list=14%, signal=40%</td></tr><tr><td class='lessen'>168</td><td>ROSS_AML_WITH_PML_RARA_FUSION</td><td></td><td>42</td><td>-0.41</td><td>-1.35</td><td>0.080</td><td>0.658</td><td>1.000</td><td>2339</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>169</td><td>ZHANG_TLX_TARGETS_60HR_DN</td><td></td><td>244</td><td>-0.31</td><td>-1.35</td><td>0.008</td><td>0.661</td><td>1.000</td><td>2061</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>170</td><td>BROWNE_HCMV_INFECTION_10HR_UP</td><td></td><td>75</td><td>-0.37</td><td>-1.35</td><td>0.056</td><td>0.660</td><td>1.000</td><td>1054</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>171</td><td>REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE</td><td></td><td>28</td><td>-0.45</td><td>-1.35</td><td>0.100</td><td>0.664</td><td>1.000</td><td>478</td><td>tags=18%, list=4%, signal=19%</td></tr><tr><td class='lessen'>172</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP</td><td></td><td>29</td><td>-0.43</td><td>-1.35</td><td>0.097</td><td>0.661</td><td>1.000</td><td>2354</td><td>tags=45%, list=20%, signal=56%</td></tr><tr><td class='lessen'>173</td><td>PID_NFAT_3PATHWAY</td><td></td><td>45</td><td>-0.40</td><td>-1.35</td><td>0.073</td><td>0.658</td><td>1.000</td><td>2202</td><td>tags=42%, list=19%, signal=52%</td></tr><tr><td class='lessen'>174</td><td>YAGI_AML_SURVIVAL</td><td></td><td>99</td><td>-0.34</td><td>-1.34</td><td>0.047</td><td>0.668</td><td>1.000</td><td>2172</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>175</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN</td><td></td><td>19</td><td>-0.48</td><td>-1.34</td><td>0.124</td><td>0.669</td><td>1.000</td><td>1401</td><td>tags=26%, list=12%, signal=30%</td></tr><tr><td class='lessen'>176</td><td>RASHI_NFKB1_TARGETS</td><td></td><td>15</td><td>-0.50</td><td>-1.34</td><td>0.126</td><td>0.673</td><td>1.000</td><td>997</td><td>tags=20%, list=9%, signal=22%</td></tr><tr><td class='lessen'>177</td><td>BIOCARTA_ATRBRCA_PATHWAY</td><td></td><td>17</td><td>-0.49</td><td>-1.34</td><td>0.118</td><td>0.676</td><td>1.000</td><td>1008</td><td>tags=35%, list=9%, signal=39%</td></tr><tr><td class='lessen'>178</td><td>PID_TCR_CALCIUM_PATHWAY</td><td></td><td>18</td><td>-0.49</td><td>-1.34</td><td>0.131</td><td>0.673</td><td>1.000</td><td>1733</td><td>tags=44%, list=15%, signal=52%</td></tr><tr><td class='lessen'>179</td><td>ZHANG_TLX_TARGETS_DN</td><td></td><td>81</td><td>-0.36</td><td>-1.34</td><td>0.060</td><td>0.670</td><td>1.000</td><td>3251</td><td>tags=40%, list=28%, signal=55%</td></tr><tr><td class='lessen'>180</td><td>ZHAN_MULTIPLE_MYELOMA_HP_DN</td><td></td><td>40</td><td>-0.41</td><td>-1.34</td><td>0.103</td><td>0.674</td><td>1.000</td><td>1603</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>181</td><td>BIOCARTA_ACTINY_PATHWAY</td><td></td><td>15</td><td>-0.50</td><td>-1.34</td><td>0.145</td><td>0.672</td><td>1.000</td><td>2049</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>182</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP</td><td></td><td>62</td><td>-0.37</td><td>-1.33</td><td>0.054</td><td>0.674</td><td>1.000</td><td>1310</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>183</td><td>KEGG_STARCH_AND_SUCROSE_METABOLISM</td><td></td><td>24</td><td>-0.45</td><td>-1.33</td><td>0.119</td><td>0.671</td><td>1.000</td><td>1985</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>184</td><td>SUNG_METASTASIS_STROMA_DN</td><td></td><td>38</td><td>-0.41</td><td>-1.33</td><td>0.096</td><td>0.676</td><td>1.000</td><td>2367</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>185</td><td>FERRARI_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>15</td><td>-0.52</td><td>-1.33</td><td>0.135</td><td>0.675</td><td>1.000</td><td>2442</td><td>tags=47%, list=21%, signal=59%</td></tr><tr><td class='lessen'>186</td><td>REACTOME_IL_RECEPTOR_SHC_SIGNALING</td><td></td><td>21</td><td>-0.46</td><td>-1.33</td><td>0.118</td><td>0.674</td><td>1.000</td><td>1644</td><td>tags=33%, list=14%, signal=39%</td></tr><tr><td class='lessen'>187</td><td>WILLIAMS_ESR2_TARGETS_UP</td><td></td><td>19</td><td>-0.49</td><td>-1.33</td><td>0.113</td><td>0.671</td><td>1.000</td><td>891</td><td>tags=21%, list=8%, signal=23%</td></tr><tr><td class='lessen'>188</td><td>REACTOME_PACKAGING_OF_TELOMERE_ENDS</td><td></td><td>38</td><td>-0.40</td><td>-1.33</td><td>0.093</td><td>0.670</td><td>1.000</td><td>1966</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>189</td><td>PID_BCR_5PATHWAY</td><td></td><td>64</td><td>-0.37</td><td>-1.33</td><td>0.085</td><td>0.671</td><td>1.000</td><td>1887</td><td>tags=33%, list=16%, signal=39%</td></tr><tr><td class='lessen'>190</td><td>PID_IL1_PATHWAY</td><td></td><td>32</td><td>-0.42</td><td>-1.33</td><td>0.103</td><td>0.668</td><td>1.000</td><td>629</td><td>tags=22%, list=5%, signal=23%</td></tr><tr><td class='lessen'>191</td><td>AZARE_STAT3_TARGETS</td><td></td><td>17</td><td>-0.49</td><td>-1.33</td><td>0.134</td><td>0.669</td><td>1.000</td><td>3391</td><td>tags=47%, list=29%, signal=66%</td></tr><tr><td class='lessen'>192</td><td>BIOCARTA_G2_PATHWAY</td><td></td><td>22</td><td>-0.46</td><td>-1.33</td><td>0.114</td><td>0.666</td><td>1.000</td><td>2497</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>193</td><td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td><td></td><td>19</td><td>-0.48</td><td>-1.33</td><td>0.118</td><td>0.671</td><td>1.000</td><td>608</td><td>tags=16%, list=5%, signal=17%</td></tr><tr><td class='lessen'>194</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>338</td><td>-0.29</td><td>-1.33</td><td>0.013</td><td>0.667</td><td>1.000</td><td>2302</td><td>tags=28%, list=20%, signal=33%</td></tr><tr><td class='lessen'>195</td><td>REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS</td><td></td><td>15</td><td>-0.51</td><td>-1.32</td><td>0.139</td><td>0.670</td><td>1.000</td><td>2173</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>196</td><td>REACTOME_REGULATION_OF_SIGNALING_BY_CBL</td><td></td><td>18</td><td>-0.49</td><td>-1.32</td><td>0.139</td><td>0.673</td><td>1.000</td><td>2360</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>197</td><td>RATTENBACHER_BOUND_BY_CELF1</td><td></td><td>268</td><td>-0.30</td><td>-1.32</td><td>0.019</td><td>0.675</td><td>1.000</td><td>2798</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>198</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>457</td><td>-0.29</td><td>-1.32</td><td>0.006</td><td>0.671</td><td>1.000</td><td>2619</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>199</td><td>BIOCARTA_MEF2D_PATHWAY</td><td></td><td>16</td><td>-0.50</td><td>-1.32</td><td>0.141</td><td>0.668</td><td>1.000</td><td>3647</td><td>tags=56%, list=31%, signal=82%</td></tr><tr><td class='lessen'>200</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN</td><td></td><td>22</td><td>-0.46</td><td>-1.32</td><td>0.117</td><td>0.668</td><td>1.000</td><td>2208</td><td>tags=36%, list=19%, signal=45%</td></tr><tr><td class='lessen'>201</td><td>ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY</td><td></td><td>32</td><td>-0.42</td><td>-1.32</td><td>0.120</td><td>0.665</td><td>1.000</td><td>1262</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>202</td><td>BYSTROEM_CORRELATED_WITH_IL5_DN</td><td></td><td>60</td><td>-0.37</td><td>-1.32</td><td>0.084</td><td>0.662</td><td>1.000</td><td>2246</td><td>tags=38%, list=19%, signal=47%</td></tr><tr><td class='lessen'>203</td><td>REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX</td><td></td><td>19</td><td>-0.48</td><td>-1.32</td><td>0.128</td><td>0.661</td><td>1.000</td><td>1887</td><td>tags=37%, list=16%, signal=44%</td></tr><tr><td class='lessen'>204</td><td>BROWNE_HCMV_INFECTION_6HR_DN</td><td></td><td>116</td><td>-0.33</td><td>-1.32</td><td>0.043</td><td>0.659</td><td>1.000</td><td>2149</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>205</td><td>STAEGE_EWING_FAMILY_TUMOR</td><td></td><td>15</td><td>-0.49</td><td>-1.32</td><td>0.123</td><td>0.665</td><td>1.000</td><td>1504</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>206</td><td>SCHRAETS_MLL_TARGETS_DN</td><td></td><td>16</td><td>-0.49</td><td>-1.32</td><td>0.137</td><td>0.665</td><td>1.000</td><td>3526</td><td>tags=56%, list=30%, signal=81%</td></tr><tr><td class='lessen'>207</td><td>ZHAN_MULTIPLE_MYELOMA_PR_UP</td><td></td><td>41</td><td>-0.39</td><td>-1.32</td><td>0.081</td><td>0.671</td><td>1.000</td><td>1174</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>208</td><td>KEGG_DRUG_METABOLISM_OTHER_ENZYMES</td><td></td><td>23</td><td>-0.45</td><td>-1.31</td><td>0.131</td><td>0.670</td><td>1.000</td><td>1269</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>209</td><td>MORI_PRE_BI_LYMPHOCYTE_UP</td><td></td><td>66</td><td>-0.36</td><td>-1.31</td><td>0.067</td><td>0.667</td><td>1.000</td><td>1739</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>210</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP</td><td></td><td>32</td><td>-0.42</td><td>-1.31</td><td>0.109</td><td>0.666</td><td>1.000</td><td>2253</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>211</td><td>REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT</td><td></td><td>30</td><td>-0.42</td><td>-1.31</td><td>0.110</td><td>0.665</td><td>1.000</td><td>1195</td><td>tags=23%, list=10%, signal=26%</td></tr><tr><td class='lessen'>212</td><td>REACTOME_PI3K_AKT_ACTIVATION</td><td></td><td>29</td><td>-0.43</td><td>-1.31</td><td>0.116</td><td>0.671</td><td>1.000</td><td>1979</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>213</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP</td><td></td><td>42</td><td>-0.40</td><td>-1.31</td><td>0.083</td><td>0.668</td><td>1.000</td><td>1318</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>214</td><td>PETROVA_PROX1_TARGETS_UP</td><td></td><td>18</td><td>-0.48</td><td>-1.31</td><td>0.135</td><td>0.665</td><td>1.000</td><td>3777</td><td>tags=56%, list=33%, signal=82%</td></tr><tr><td class='lessen'>215</td><td>REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_</td><td></td><td>38</td><td>-0.40</td><td>-1.31</td><td>0.106</td><td>0.665</td><td>1.000</td><td>1195</td><td>tags=21%, list=10%, signal=23%</td></tr><tr><td class='lessen'>216</td><td>STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP</td><td></td><td>34</td><td>-0.42</td><td>-1.31</td><td>0.118</td><td>0.674</td><td>1.000</td><td>1434</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>217</td><td>VALK_AML_CLUSTER_12</td><td></td><td>17</td><td>-0.50</td><td>-1.31</td><td>0.124</td><td>0.671</td><td>1.000</td><td>988</td><td>tags=18%, list=9%, signal=19%</td></tr><tr><td class='lessen'>218</td><td>PID_IL3_PATHWAY</td><td></td><td>20</td><td>-0.46</td><td>-1.31</td><td>0.128</td><td>0.669</td><td>1.000</td><td>1644</td><td>tags=35%, list=14%, signal=41%</td></tr><tr><td class='lessen'>219</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN</td><td></td><td>260</td><td>-0.30</td><td>-1.31</td><td>0.022</td><td>0.668</td><td>1.000</td><td>2392</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>220</td><td>BHAT_ESR1_TARGETS_VIA_AKT1_DN</td><td></td><td>55</td><td>-0.37</td><td>-1.31</td><td>0.103</td><td>0.667</td><td>1.000</td><td>1691</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>221</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td><td></td><td>47</td><td>-0.38</td><td>-1.31</td><td>0.098</td><td>0.668</td><td>1.000</td><td>2069</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>222</td><td>REACTOME_GLYCOSAMINOGLYCAN_METABOLISM</td><td></td><td>56</td><td>-0.37</td><td>-1.30</td><td>0.079</td><td>0.668</td><td>1.000</td><td>1819</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>223</td><td>PARK_HSC_MARKERS</td><td></td><td>39</td><td>-0.40</td><td>-1.30</td><td>0.107</td><td>0.667</td><td>1.000</td><td>1805</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>224</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>224</td><td>-0.30</td><td>-1.30</td><td>0.019</td><td>0.674</td><td>1.000</td><td>2080</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>225</td><td>REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION</td><td></td><td>72</td><td>-0.35</td><td>-1.30</td><td>0.083</td><td>0.674</td><td>1.000</td><td>2968</td><td>tags=42%, list=26%, signal=56%</td></tr><tr><td class='lessen'>226</td><td>WENDT_COHESIN_TARGETS_UP</td><td></td><td>32</td><td>-0.42</td><td>-1.30</td><td>0.109</td><td>0.675</td><td>1.000</td><td>2295</td><td>tags=34%, list=20%, signal=43%</td></tr><tr><td class='lessen'>227</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP</td><td></td><td>83</td><td>-0.34</td><td>-1.30</td><td>0.085</td><td>0.673</td><td>1.000</td><td>2731</td><td>tags=37%, list=24%, signal=49%</td></tr><tr><td class='lessen'>228</td><td>SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP</td><td></td><td>15</td><td>-0.50</td><td>-1.30</td><td>0.155</td><td>0.671</td><td>1.000</td><td>1153</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>229</td><td>ZHAN_MULTIPLE_MYELOMA_CD2_UP</td><td></td><td>32</td><td>-0.42</td><td>-1.30</td><td>0.135</td><td>0.672</td><td>1.000</td><td>1136</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>230</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>342</td><td>-0.29</td><td>-1.30</td><td>0.008</td><td>0.670</td><td>1.000</td><td>2344</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>231</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>58</td><td>-0.37</td><td>-1.30</td><td>0.102</td><td>0.668</td><td>1.000</td><td>2215</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>232</td><td>PYEON_HPV_POSITIVE_TUMORS_UP</td><td></td><td>72</td><td>-0.35</td><td>-1.30</td><td>0.084</td><td>0.666</td><td>1.000</td><td>4127</td><td>tags=53%, list=36%, signal=81%</td></tr><tr><td class='lessen'>233</td><td>VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP</td><td></td><td>46</td><td>-0.38</td><td>-1.30</td><td>0.111</td><td>0.664</td><td>1.000</td><td>593</td><td>tags=13%, list=5%, signal=14%</td></tr><tr><td class='lessen'>234</td><td>CUI_GLUCOSE_DEPRIVATION</td><td></td><td>47</td><td>-0.38</td><td>-1.30</td><td>0.103</td><td>0.662</td><td>1.000</td><td>684</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>235</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>63</td><td>-0.36</td><td>-1.30</td><td>0.076</td><td>0.659</td><td>1.000</td><td>1820</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>236</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP</td><td></td><td>19</td><td>-0.47</td><td>-1.30</td><td>0.127</td><td>0.660</td><td>1.000</td><td>175</td><td>tags=16%, list=2%, signal=16%</td></tr><tr><td class='lessen'>237</td><td>MCCLUNG_COCAIN_REWARD_4WK</td><td></td><td>44</td><td>-0.39</td><td>-1.30</td><td>0.095</td><td>0.658</td><td>1.000</td><td>1887</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>238</td><td>NAGY_TFTC_COMPONENTS_HUMAN</td><td></td><td>16</td><td>-0.49</td><td>-1.30</td><td>0.160</td><td>0.658</td><td>1.000</td><td>3799</td><td>tags=75%, list=33%, signal=111%</td></tr><tr><td class='lessen'>239</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>390</td><td>-0.29</td><td>-1.30</td><td>0.011</td><td>0.656</td><td>1.000</td><td>2402</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>240</td><td>REACTOME_MEIOTIC_RECOMBINATION</td><td></td><td>67</td><td>-0.36</td><td>-1.30</td><td>0.098</td><td>0.653</td><td>1.000</td><td>3112</td><td>tags=39%, list=27%, signal=53%</td></tr><tr><td class='lessen'>241</td><td>SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS</td><td></td><td>27</td><td>-0.43</td><td>-1.30</td><td>0.141</td><td>0.653</td><td>1.000</td><td>753</td><td>tags=26%, list=7%, signal=28%</td></tr><tr><td class='lessen'>242</td><td>REACTOME_GAB1_SIGNALOSOME</td><td></td><td>30</td><td>-0.42</td><td>-1.29</td><td>0.128</td><td>0.652</td><td>1.000</td><td>1720</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>243</td><td>REACTOME_MITOTIC_G2_G2_M_PHASES</td><td></td><td>71</td><td>-0.35</td><td>-1.29</td><td>0.080</td><td>0.651</td><td>1.000</td><td>2202</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>244</td><td>BROWNE_HCMV_INFECTION_20HR_UP</td><td></td><td>177</td><td>-0.30</td><td>-1.29</td><td>0.037</td><td>0.649</td><td>1.000</td><td>1749</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>245</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_DN</td><td></td><td>166</td><td>-0.31</td><td>-1.29</td><td>0.049</td><td>0.650</td><td>1.000</td><td>2198</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>246</td><td>MULLIGHAN_NPM1_SIGNATURE_3_UP</td><td></td><td>236</td><td>-0.30</td><td>-1.29</td><td>0.022</td><td>0.648</td><td>1.000</td><td>3208</td><td>tags=37%, list=28%, signal=50%</td></tr><tr><td class='lessen'>247</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP</td><td></td><td>63</td><td>-0.35</td><td>-1.29</td><td>0.080</td><td>0.649</td><td>1.000</td><td>1560</td><td>tags=22%, list=13%, signal=26%</td></tr><tr><td class='lessen'>248</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN</td><td></td><td>75</td><td>-0.34</td><td>-1.29</td><td>0.069</td><td>0.646</td><td>1.000</td><td>2833</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>249</td><td>PID_IL2_STAT5_PATHWAY</td><td></td><td>25</td><td>-0.44</td><td>-1.29</td><td>0.136</td><td>0.644</td><td>1.000</td><td>1525</td><td>tags=32%, list=13%, signal=37%</td></tr><tr><td class='lessen'>250</td><td>REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY</td><td></td><td>25</td><td>-0.43</td><td>-1.29</td><td>0.138</td><td>0.647</td><td>1.000</td><td>937</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>251</td><td>SHEPARD_BMYB_MORPHOLINO_DN</td><td></td><td>128</td><td>-0.32</td><td>-1.29</td><td>0.051</td><td>0.646</td><td>1.000</td><td>2324</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>252</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td><td></td><td>45</td><td>-0.38</td><td>-1.29</td><td>0.126</td><td>0.644</td><td>1.000</td><td>2433</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>253</td><td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td><td></td><td>29</td><td>-0.43</td><td>-1.29</td><td>0.136</td><td>0.645</td><td>1.000</td><td>803</td><td>tags=24%, list=7%, signal=26%</td></tr><tr><td class='lessen'>254</td><td>PID_TOLL_ENDOGENOUS_PATHWAY</td><td></td><td>18</td><td>-0.47</td><td>-1.29</td><td>0.147</td><td>0.643</td><td>1.000</td><td>269</td><td>tags=17%, list=2%, signal=17%</td></tr><tr><td class='lessen'>255</td><td>CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN</td><td></td><td>82</td><td>-0.34</td><td>-1.29</td><td>0.079</td><td>0.645</td><td>1.000</td><td>1758</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>256</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP</td><td></td><td>53</td><td>-0.37</td><td>-1.29</td><td>0.113</td><td>0.648</td><td>1.000</td><td>1692</td><td>tags=38%, list=15%, signal=44%</td></tr><tr><td class='lessen'>257</td><td>BENPORATH_NOS_TARGETS</td><td></td><td>119</td><td>-0.32</td><td>-1.29</td><td>0.067</td><td>0.646</td><td>1.000</td><td>3312</td><td>tags=40%, list=29%, signal=56%</td></tr><tr><td class='lessen'>258</td><td>OHM_METHYLATED_IN_ADULT_CANCERS</td><td></td><td>15</td><td>-0.50</td><td>-1.29</td><td>0.178</td><td>0.645</td><td>1.000</td><td>637</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>259</td><td>CHEN_PDGF_TARGETS</td><td></td><td>15</td><td>-0.48</td><td>-1.29</td><td>0.150</td><td>0.646</td><td>1.000</td><td>2068</td><td>tags=40%, list=18%, signal=49%</td></tr><tr><td class='lessen'>260</td><td>BASSO_CD40_SIGNALING_DN</td><td></td><td>51</td><td>-0.37</td><td>-1.28</td><td>0.112</td><td>0.645</td><td>1.000</td><td>1662</td><td>tags=35%, list=14%, signal=41%</td></tr><tr><td class='lessen'>261</td><td>BIOCARTA_IGF1MTOR_PATHWAY</td><td></td><td>19</td><td>-0.47</td><td>-1.28</td><td>0.169</td><td>0.649</td><td>1.000</td><td>1720</td><td>tags=32%, list=15%, signal=37%</td></tr><tr><td class='lessen'>262</td><td>BIOCARTA_IL12_PATHWAY</td><td></td><td>15</td><td>-0.49</td><td>-1.28</td><td>0.144</td><td>0.648</td><td>1.000</td><td>1841</td><td>tags=40%, list=16%, signal=48%</td></tr><tr><td class='lessen'>263</td><td>MARKEY_RB1_ACUTE_LOF_UP</td><td></td><td>193</td><td>-0.30</td><td>-1.28</td><td>0.042</td><td>0.656</td><td>1.000</td><td>2145</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>264</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>166</td><td>-0.31</td><td>-1.28</td><td>0.050</td><td>0.654</td><td>1.000</td><td>1895</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>265</td><td>REACTOME_PI_3K_CASCADE</td><td></td><td>36</td><td>-0.40</td><td>-1.28</td><td>0.145</td><td>0.657</td><td>1.000</td><td>1720</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>266</td><td>REACTOME_ADAPTIVE_IMMUNE_SYSTEM</td><td></td><td>420</td><td>-0.28</td><td>-1.28</td><td>0.018</td><td>0.656</td><td>1.000</td><td>2309</td><td>tags=26%, list=20%, signal=31%</td></tr><tr><td class='lessen'>267</td><td>BRACHAT_RESPONSE_TO_METHOTREXATE_UP</td><td></td><td>18</td><td>-0.46</td><td>-1.28</td><td>0.157</td><td>0.657</td><td>1.000</td><td>1702</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>268</td><td>KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM</td><td></td><td>56</td><td>-0.36</td><td>-1.28</td><td>0.091</td><td>0.656</td><td>1.000</td><td>2172</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>269</td><td>YU_BAP1_TARGETS</td><td></td><td>27</td><td>-0.43</td><td>-1.28</td><td>0.133</td><td>0.658</td><td>1.000</td><td>63</td><td>tags=11%, list=1%, signal=11%</td></tr><tr><td class='lessen'>270</td><td>PID_NFKAPPAB_ATYPICAL_PATHWAY</td><td></td><td>16</td><td>-0.48</td><td>-1.28</td><td>0.144</td><td>0.656</td><td>1.000</td><td>2232</td><td>tags=44%, list=19%, signal=54%</td></tr><tr><td class='lessen'>271</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>26</td><td>-0.42</td><td>-1.28</td><td>0.138</td><td>0.655</td><td>1.000</td><td>2337</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>272</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN</td><td></td><td>125</td><td>-0.32</td><td>-1.28</td><td>0.068</td><td>0.653</td><td>1.000</td><td>1816</td><td>tags=25%, list=16%, signal=29%</td></tr><tr><td class='lessen'>273</td><td>KANG_DOXORUBICIN_RESISTANCE_UP</td><td></td><td>50</td><td>-0.37</td><td>-1.27</td><td>0.122</td><td>0.652</td><td>1.000</td><td>2814</td><td>tags=34%, list=24%, signal=45%</td></tr><tr><td class='lessen'>274</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP</td><td></td><td>134</td><td>-0.32</td><td>-1.27</td><td>0.062</td><td>0.651</td><td>1.000</td><td>2138</td><td>tags=28%, list=18%, signal=33%</td></tr><tr><td class='lessen'>275</td><td>REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS</td><td></td><td>22</td><td>-0.44</td><td>-1.27</td><td>0.158</td><td>0.649</td><td>1.000</td><td>936</td><td>tags=18%, list=8%, signal=20%</td></tr><tr><td class='lessen'>276</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_DN</td><td></td><td>142</td><td>-0.31</td><td>-1.27</td><td>0.052</td><td>0.651</td><td>1.000</td><td>1645</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>277</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>315</td><td>-0.28</td><td>-1.27</td><td>0.022</td><td>0.652</td><td>1.000</td><td>1651</td><td>tags=21%, list=14%, signal=23%</td></tr><tr><td class='lessen'>278</td><td>BORLAK_LIVER_CANCER_EGF_UP</td><td></td><td>40</td><td>-0.38</td><td>-1.27</td><td>0.128</td><td>0.650</td><td>1.000</td><td>1231</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>279</td><td>DORSAM_HOXA9_TARGETS_UP</td><td></td><td>30</td><td>-0.41</td><td>-1.27</td><td>0.118</td><td>0.649</td><td>1.000</td><td>321</td><td>tags=13%, list=3%, signal=14%</td></tr><tr><td class='lessen'>280</td><td>PID_TAP63_PATHWAY</td><td></td><td>44</td><td>-0.38</td><td>-1.27</td><td>0.128</td><td>0.652</td><td>1.000</td><td>668</td><td>tags=20%, list=6%, signal=22%</td></tr><tr><td class='lessen'>281</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN</td><td></td><td>36</td><td>-0.40</td><td>-1.27</td><td>0.143</td><td>0.656</td><td>1.000</td><td>2073</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>282</td><td>PUJANA_BRCA2_PCC_NETWORK</td><td></td><td>369</td><td>-0.28</td><td>-1.27</td><td>0.024</td><td>0.660</td><td>1.000</td><td>2593</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>283</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP</td><td></td><td>42</td><td>-0.38</td><td>-1.27</td><td>0.129</td><td>0.659</td><td>1.000</td><td>1238</td><td>tags=24%, list=11%, signal=27%</td></tr><tr><td class='lessen'>284</td><td>KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION</td><td></td><td>45</td><td>-0.38</td><td>-1.27</td><td>0.127</td><td>0.658</td><td>1.000</td><td>1744</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>285</td><td>LUI_THYROID_CANCER_PAX8_PPARG_UP</td><td></td><td>31</td><td>-0.41</td><td>-1.27</td><td>0.146</td><td>0.660</td><td>1.000</td><td>2608</td><td>tags=35%, list=23%, signal=46%</td></tr><tr><td class='lessen'>286</td><td>REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING</td><td></td><td>29</td><td>-0.41</td><td>-1.27</td><td>0.136</td><td>0.659</td><td>1.000</td><td>3745</td><td>tags=52%, list=32%, signal=76%</td></tr><tr><td class='lessen'>287</td><td>PID_P75_NTR_PATHWAY</td><td></td><td>55</td><td>-0.36</td><td>-1.27</td><td>0.118</td><td>0.658</td><td>1.000</td><td>339</td><td>tags=15%, list=3%, signal=15%</td></tr><tr><td class='lessen'>288</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_DN</td><td></td><td>116</td><td>-0.32</td><td>-1.26</td><td>0.066</td><td>0.656</td><td>1.000</td><td>723</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>289</td><td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td><td></td><td>26</td><td>-0.42</td><td>-1.26</td><td>0.149</td><td>0.655</td><td>1.000</td><td>1514</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>290</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>58</td><td>-0.36</td><td>-1.26</td><td>0.144</td><td>0.654</td><td>1.000</td><td>1248</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>291</td><td>REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A</td><td></td><td>18</td><td>-0.46</td><td>-1.26</td><td>0.168</td><td>0.652</td><td>1.000</td><td>2173</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>292</td><td>VALK_AML_WITH_FLT3_ITD</td><td></td><td>23</td><td>-0.44</td><td>-1.26</td><td>0.154</td><td>0.650</td><td>1.000</td><td>3299</td><td>tags=39%, list=28%, signal=55%</td></tr><tr><td class='lessen'>293</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T7</td><td></td><td>91</td><td>-0.33</td><td>-1.26</td><td>0.096</td><td>0.649</td><td>1.000</td><td>3409</td><td>tags=40%, list=29%, signal=56%</td></tr><tr><td class='lessen'>294</td><td>VALK_AML_CLUSTER_6</td><td></td><td>27</td><td>-0.42</td><td>-1.26</td><td>0.160</td><td>0.648</td><td>1.000</td><td>1746</td><td>tags=30%, list=15%, signal=35%</td></tr><tr><td class='lessen'>295</td><td>REACTOME_CD28_CO_STIMULATION</td><td></td><td>29</td><td>-0.41</td><td>-1.26</td><td>0.158</td><td>0.650</td><td>1.000</td><td>3303</td><td>tags=48%, list=29%, signal=67%</td></tr><tr><td class='lessen'>296</td><td>VALK_AML_CLUSTER_13</td><td></td><td>16</td><td>-0.48</td><td>-1.26</td><td>0.163</td><td>0.652</td><td>1.000</td><td>1473</td><td>tags=31%, list=13%, signal=36%</td></tr><tr><td class='lessen'>297</td><td>REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION</td><td></td><td>203</td><td>-0.29</td><td>-1.26</td><td>0.052</td><td>0.651</td><td>1.000</td><td>1526</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>298</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP</td><td></td><td>32</td><td>-0.39</td><td>-1.26</td><td>0.130</td><td>0.649</td><td>1.000</td><td>2093</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>299</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_6_UP</td><td></td><td>80</td><td>-0.34</td><td>-1.26</td><td>0.103</td><td>0.653</td><td>1.000</td><td>1250</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>300</td><td>REACTOME_PLATELET_SENSITIZATION_BY_LDL</td><td></td><td>15</td><td>-0.48</td><td>-1.26</td><td>0.170</td><td>0.656</td><td>1.000</td><td>2675</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>301</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_UP</td><td></td><td>152</td><td>-0.30</td><td>-1.26</td><td>0.071</td><td>0.657</td><td>1.000</td><td>2344</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>302</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>341</td><td>-0.28</td><td>-1.26</td><td>0.032</td><td>0.661</td><td>1.000</td><td>3181</td><td>tags=34%, list=27%, signal=45%</td></tr><tr><td class='lessen'>303</td><td>MELLMAN_TUT1_TARGETS_DN</td><td></td><td>34</td><td>-0.39</td><td>-1.25</td><td>0.134</td><td>0.665</td><td>1.000</td><td>526</td><td>tags=21%, list=5%, signal=22%</td></tr><tr><td class='lessen'>304</td><td>REACTOME_TRANSPORT_OF_GLUCOSE_AND_OTHER_SUGARS_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS</td><td></td><td>32</td><td>-0.40</td><td>-1.25</td><td>0.160</td><td>0.669</td><td>1.000</td><td>577</td><td>tags=16%, list=5%, signal=16%</td></tr><tr><td class='lessen'>305</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP</td><td></td><td>236</td><td>-0.29</td><td>-1.25</td><td>0.058</td><td>0.667</td><td>1.000</td><td>2250</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>306</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>100</td><td>-0.32</td><td>-1.25</td><td>0.094</td><td>0.670</td><td>1.000</td><td>1909</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>307</td><td>PID_P73PATHWAY</td><td></td><td>60</td><td>-0.35</td><td>-1.25</td><td>0.124</td><td>0.671</td><td>1.000</td><td>1755</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>308</td><td>KEGG_SMALL_CELL_LUNG_CANCER</td><td></td><td>64</td><td>-0.34</td><td>-1.25</td><td>0.105</td><td>0.669</td><td>1.000</td><td>1690</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>309</td><td>PID_TGFBR_PATHWAY</td><td></td><td>44</td><td>-0.37</td><td>-1.25</td><td>0.140</td><td>0.668</td><td>1.000</td><td>2376</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>310</td><td>HINATA_NFKB_TARGETS_FIBROBLAST_UP</td><td></td><td>58</td><td>-0.35</td><td>-1.25</td><td>0.116</td><td>0.668</td><td>1.000</td><td>2541</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>311</td><td>WARTERS_RESPONSE_TO_IR_SKIN</td><td></td><td>55</td><td>-0.36</td><td>-1.25</td><td>0.133</td><td>0.669</td><td>1.000</td><td>1837</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>312</td><td>BENPORATH_OCT4_TARGETS</td><td></td><td>201</td><td>-0.29</td><td>-1.25</td><td>0.063</td><td>0.667</td><td>1.000</td><td>3326</td><td>tags=39%, list=29%, signal=53%</td></tr><tr><td class='lessen'>313</td><td>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</td><td></td><td>190</td><td>-0.29</td><td>-1.25</td><td>0.056</td><td>0.673</td><td>1.000</td><td>1992</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>314</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td><td></td><td>230</td><td>-0.29</td><td>-1.25</td><td>0.050</td><td>0.671</td><td>1.000</td><td>1477</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>315</td><td>BIOCARTA_MTOR_PATHWAY</td><td></td><td>23</td><td>-0.43</td><td>-1.25</td><td>0.179</td><td>0.669</td><td>1.000</td><td>2326</td><td>tags=48%, list=20%, signal=60%</td></tr><tr><td class='lessen'>316</td><td>GHANDHI_DIRECT_IRRADIATION_UP</td><td></td><td>65</td><td>-0.35</td><td>-1.25</td><td>0.110</td><td>0.670</td><td>1.000</td><td>2177</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>317</td><td>REACTOME_MRNA_3_END_PROCESSING</td><td></td><td>31</td><td>-0.40</td><td>-1.25</td><td>0.179</td><td>0.669</td><td>1.000</td><td>1195</td><td>tags=23%, list=10%, signal=25%</td></tr><tr><td class='lessen'>318</td><td>BONCI_TARGETS_OF_MIR15A_AND_MIR16_1</td><td></td><td>65</td><td>-0.34</td><td>-1.24</td><td>0.127</td><td>0.670</td><td>1.000</td><td>2699</td><td>tags=38%, list=23%, signal=50%</td></tr><tr><td class='lessen'>319</td><td>NEMETH_INFLAMMATORY_RESPONSE_LPS_DN</td><td></td><td>30</td><td>-0.40</td><td>-1.24</td><td>0.151</td><td>0.669</td><td>1.000</td><td>1727</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>320</td><td>GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION</td><td></td><td>28</td><td>-0.41</td><td>-1.24</td><td>0.173</td><td>0.667</td><td>1.000</td><td>2311</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>321</td><td>ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP</td><td></td><td>258</td><td>-0.28</td><td>-1.24</td><td>0.047</td><td>0.671</td><td>1.000</td><td>2277</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>322</td><td>REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY</td><td></td><td>17</td><td>-0.46</td><td>-1.24</td><td>0.213</td><td>0.669</td><td>1.000</td><td>1649</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>323</td><td>PID_ATR_PATHWAY</td><td></td><td>34</td><td>-0.39</td><td>-1.24</td><td>0.135</td><td>0.668</td><td>1.000</td><td>1435</td><td>tags=26%, list=12%, signal=30%</td></tr><tr><td class='lessen'>324</td><td>ROPERO_HDAC2_TARGETS</td><td></td><td>59</td><td>-0.35</td><td>-1.24</td><td>0.144</td><td>0.666</td><td>1.000</td><td>1522</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>325</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_T4</td><td></td><td>70</td><td>-0.34</td><td>-1.24</td><td>0.114</td><td>0.672</td><td>1.000</td><td>1807</td><td>tags=34%, list=16%, signal=40%</td></tr><tr><td class='lessen'>326</td><td>ODONNELL_TFRC_TARGETS_DN</td><td></td><td>98</td><td>-0.32</td><td>-1.24</td><td>0.112</td><td>0.674</td><td>1.000</td><td>1621</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>327</td><td>BOSCO_TH1_CYTOTOXIC_MODULE</td><td></td><td>67</td><td>-0.34</td><td>-1.24</td><td>0.131</td><td>0.674</td><td>1.000</td><td>2657</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>328</td><td>LEE_EARLY_T_LYMPHOCYTE_UP</td><td></td><td>85</td><td>-0.33</td><td>-1.24</td><td>0.118</td><td>0.672</td><td>1.000</td><td>3036</td><td>tags=34%, list=26%, signal=46%</td></tr><tr><td class='lessen'>329</td><td>PID_PLK1_PATHWAY</td><td></td><td>40</td><td>-0.37</td><td>-1.24</td><td>0.150</td><td>0.671</td><td>1.000</td><td>1435</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>330</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>460</td><td>-0.27</td><td>-1.24</td><td>0.013</td><td>0.671</td><td>1.000</td><td>2695</td><td>tags=28%, list=23%, signal=35%</td></tr><tr><td class='lessen'>331</td><td>MIZUSHIMA_AUTOPHAGOSOME_FORMATION</td><td></td><td>17</td><td>-0.46</td><td>-1.24</td><td>0.200</td><td>0.671</td><td>1.000</td><td>3016</td><td>tags=59%, list=26%, signal=79%</td></tr><tr><td class='lessen'>332</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_DN</td><td></td><td>51</td><td>-0.36</td><td>-1.24</td><td>0.129</td><td>0.669</td><td>1.000</td><td>2070</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>333</td><td>KORKOLA_CORRELATED_WITH_POU5F1</td><td></td><td>15</td><td>-0.48</td><td>-1.24</td><td>0.204</td><td>0.674</td><td>1.000</td><td>1206</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>334</td><td>KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>44</td><td>-0.36</td><td>-1.24</td><td>0.170</td><td>0.673</td><td>1.000</td><td>1519</td><td>tags=23%, list=13%, signal=26%</td></tr><tr><td class='lessen'>335</td><td>PID_IL12_STAT4_PATHWAY</td><td></td><td>25</td><td>-0.41</td><td>-1.23</td><td>0.176</td><td>0.674</td><td>1.000</td><td>2442</td><td>tags=48%, list=21%, signal=61%</td></tr><tr><td class='lessen'>336</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP</td><td></td><td>155</td><td>-0.30</td><td>-1.23</td><td>0.067</td><td>0.672</td><td>1.000</td><td>2208</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>337</td><td>SASSON_RESPONSE_TO_FORSKOLIN_UP</td><td></td><td>72</td><td>-0.33</td><td>-1.23</td><td>0.122</td><td>0.672</td><td>1.000</td><td>2701</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>338</td><td>DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN</td><td></td><td>54</td><td>-0.35</td><td>-1.23</td><td>0.124</td><td>0.670</td><td>1.000</td><td>1648</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>339</td><td>REACTOME_IL1_SIGNALING</td><td></td><td>34</td><td>-0.39</td><td>-1.23</td><td>0.166</td><td>0.668</td><td>1.000</td><td>1887</td><td>tags=32%, list=16%, signal=39%</td></tr><tr><td class='lessen'>340</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</td><td></td><td>49</td><td>-0.36</td><td>-1.23</td><td>0.161</td><td>0.668</td><td>1.000</td><td>538</td><td>tags=12%, list=5%, signal=13%</td></tr><tr><td class='lessen'>341</td><td>BARIS_THYROID_CANCER_DN</td><td></td><td>44</td><td>-0.37</td><td>-1.23</td><td>0.156</td><td>0.667</td><td>1.000</td><td>2114</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>342</td><td>LIU_NASOPHARYNGEAL_CARCINOMA</td><td></td><td>56</td><td>-0.35</td><td>-1.23</td><td>0.143</td><td>0.674</td><td>1.000</td><td>2802</td><td>tags=41%, list=24%, signal=54%</td></tr><tr><td class='lessen'>343</td><td>QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR</td><td></td><td>55</td><td>-0.35</td><td>-1.23</td><td>0.143</td><td>0.675</td><td>1.000</td><td>1837</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>344</td><td>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>152</td><td>-0.29</td><td>-1.23</td><td>0.090</td><td>0.675</td><td>1.000</td><td>2420</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>345</td><td>REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE</td><td></td><td>16</td><td>-0.46</td><td>-1.23</td><td>0.205</td><td>0.673</td><td>1.000</td><td>936</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>346</td><td>BIOCARTA_EIF4_PATHWAY</td><td></td><td>23</td><td>-0.42</td><td>-1.23</td><td>0.184</td><td>0.671</td><td>1.000</td><td>2004</td><td>tags=48%, list=17%, signal=58%</td></tr><tr><td class='lessen'>347</td><td>SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL</td><td></td><td>62</td><td>-0.35</td><td>-1.23</td><td>0.143</td><td>0.676</td><td>1.000</td><td>2151</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>348</td><td>PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION</td><td></td><td>24</td><td>-0.42</td><td>-1.23</td><td>0.188</td><td>0.677</td><td>1.000</td><td>1395</td><td>tags=33%, list=12%, signal=38%</td></tr><tr><td class='lessen'>349</td><td>KIM_GERMINAL_CENTER_T_HELPER_UP</td><td></td><td>59</td><td>-0.34</td><td>-1.23</td><td>0.131</td><td>0.677</td><td>1.000</td><td>1727</td><td>tags=25%, list=15%, signal=30%</td></tr><tr><td class='lessen'>350</td><td>NAKAYAMA_FGF2_TARGETS</td><td></td><td>15</td><td>-0.47</td><td>-1.23</td><td>0.208</td><td>0.676</td><td>1.000</td><td>2537</td><td>tags=53%, list=22%, signal=68%</td></tr><tr><td class='lessen'>351</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>260</td><td>-0.28</td><td>-1.23</td><td>0.054</td><td>0.678</td><td>1.000</td><td>2181</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>352</td><td>REACTOME_MRNA_SPLICING_MINOR_PATHWAY</td><td></td><td>38</td><td>-0.38</td><td>-1.22</td><td>0.181</td><td>0.680</td><td>1.000</td><td>620</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>353</td><td>PID_TRKR_PATHWAY</td><td></td><td>46</td><td>-0.36</td><td>-1.22</td><td>0.159</td><td>0.684</td><td>1.000</td><td>1500</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>354</td><td>VALK_AML_CLUSTER_4</td><td></td><td>21</td><td>-0.43</td><td>-1.22</td><td>0.200</td><td>0.682</td><td>1.000</td><td>2175</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>355</td><td>GENTILE_UV_RESPONSE_CLUSTER_D2</td><td></td><td>32</td><td>-0.40</td><td>-1.22</td><td>0.162</td><td>0.680</td><td>1.000</td><td>2872</td><td>tags=44%, list=25%, signal=58%</td></tr><tr><td class='lessen'>356</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_C</td><td></td><td>63</td><td>-0.34</td><td>-1.22</td><td>0.138</td><td>0.679</td><td>1.000</td><td>2065</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>357</td><td>KONG_E2F3_TARGETS</td><td></td><td>88</td><td>-0.32</td><td>-1.22</td><td>0.127</td><td>0.682</td><td>1.000</td><td>1739</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>358</td><td>REACTOME_SIGNALING_BY_ILS</td><td></td><td>93</td><td>-0.32</td><td>-1.22</td><td>0.136</td><td>0.680</td><td>1.000</td><td>1887</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>359</td><td>KEGG_TYPE_II_DIABETES_MELLITUS</td><td></td><td>27</td><td>-0.40</td><td>-1.22</td><td>0.198</td><td>0.685</td><td>1.000</td><td>2172</td><td>tags=41%, list=19%, signal=50%</td></tr><tr><td class='lessen'>360</td><td>CHEN_ETV5_TARGETS_TESTIS</td><td></td><td>15</td><td>-0.47</td><td>-1.22</td><td>0.224</td><td>0.685</td><td>1.000</td><td>179</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>361</td><td>CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY</td><td></td><td>18</td><td>-0.45</td><td>-1.22</td><td>0.205</td><td>0.684</td><td>1.000</td><td>429</td><td>tags=11%, list=4%, signal=12%</td></tr><tr><td class='lessen'>362</td><td>EPPERT_HSC_R</td><td></td><td>84</td><td>-0.32</td><td>-1.22</td><td>0.136</td><td>0.683</td><td>1.000</td><td>1964</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>363</td><td>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</td><td></td><td>126</td><td>-0.30</td><td>-1.22</td><td>0.099</td><td>0.681</td><td>1.000</td><td>2146</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>364</td><td>REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA</td><td></td><td>127</td><td>-0.30</td><td>-1.22</td><td>0.104</td><td>0.683</td><td>1.000</td><td>1195</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>365</td><td>YOSHIOKA_LIVER_CANCER_EARLY_RECURRENCE_DN</td><td></td><td>39</td><td>-0.37</td><td>-1.22</td><td>0.175</td><td>0.686</td><td>1.000</td><td>3269</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>366</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td><td></td><td>184</td><td>-0.29</td><td>-1.22</td><td>0.108</td><td>0.685</td><td>1.000</td><td>2816</td><td>tags=30%, list=24%, signal=40%</td></tr><tr><td class='lessen'>367</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP</td><td></td><td>170</td><td>-0.29</td><td>-1.22</td><td>0.084</td><td>0.685</td><td>1.000</td><td>2316</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>368</td><td>AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53</td><td></td><td>78</td><td>-0.32</td><td>-1.22</td><td>0.117</td><td>0.684</td><td>1.000</td><td>2043</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>369</td><td>KEGG_SELENOAMINO_ACID_METABOLISM</td><td></td><td>22</td><td>-0.43</td><td>-1.21</td><td>0.200</td><td>0.687</td><td>1.000</td><td>1980</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>370</td><td>REACTOME_MYOGENESIS</td><td></td><td>17</td><td>-0.45</td><td>-1.21</td><td>0.216</td><td>0.689</td><td>1.000</td><td>1841</td><td>tags=29%, list=16%, signal=35%</td></tr><tr><td class='lessen'>371</td><td>REACTOME_AMYLOIDS</td><td></td><td>54</td><td>-0.35</td><td>-1.21</td><td>0.166</td><td>0.688</td><td>1.000</td><td>1915</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>372</td><td>REACTOME_SEMAPHORIN_INTERACTIONS</td><td></td><td>51</td><td>-0.35</td><td>-1.21</td><td>0.158</td><td>0.687</td><td>1.000</td><td>605</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>373</td><td>REACTOME_PIP3_ACTIVATES_AKT_SIGNALING</td><td></td><td>23</td><td>-0.42</td><td>-1.21</td><td>0.182</td><td>0.686</td><td>1.000</td><td>1720</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>374</td><td>BILBAN_B_CLL_LPL_UP</td><td></td><td>48</td><td>-0.36</td><td>-1.21</td><td>0.174</td><td>0.685</td><td>1.000</td><td>2088</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>375</td><td>KEGG_LYSOSOME</td><td></td><td>102</td><td>-0.31</td><td>-1.21</td><td>0.147</td><td>0.684</td><td>1.000</td><td>2354</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>376</td><td>REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES</td><td></td><td>51</td><td>-0.35</td><td>-1.21</td><td>0.146</td><td>0.683</td><td>1.000</td><td>2429</td><td>tags=31%, list=21%, signal=40%</td></tr><tr><td class='lessen'>377</td><td>BIOCARTA_PAR1_PATHWAY</td><td></td><td>28</td><td>-0.40</td><td>-1.21</td><td>0.206</td><td>0.684</td><td>1.000</td><td>800</td><td>tags=18%, list=7%, signal=19%</td></tr><tr><td class='lessen'>378</td><td>PID_HIV_NEF_PATHWAY</td><td></td><td>33</td><td>-0.39</td><td>-1.21</td><td>0.199</td><td>0.685</td><td>1.000</td><td>1298</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>379</td><td>JIANG_TIP30_TARGETS_DN</td><td></td><td>21</td><td>-0.43</td><td>-1.21</td><td>0.204</td><td>0.685</td><td>1.000</td><td>969</td><td>tags=24%, list=8%, signal=26%</td></tr><tr><td class='lessen'>380</td><td>WHITFIELD_CELL_CYCLE_G2_M</td><td></td><td>166</td><td>-0.29</td><td>-1.21</td><td>0.087</td><td>0.684</td><td>1.000</td><td>2203</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>381</td><td>COLLIS_PRKDC_SUBSTRATES</td><td></td><td>19</td><td>-0.43</td><td>-1.21</td><td>0.217</td><td>0.683</td><td>1.000</td><td>2616</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>382</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td><td></td><td>160</td><td>-0.29</td><td>-1.21</td><td>0.095</td><td>0.686</td><td>1.000</td><td>1769</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>383</td><td>LE_EGR2_TARGETS_UP</td><td></td><td>94</td><td>-0.31</td><td>-1.21</td><td>0.132</td><td>0.690</td><td>1.000</td><td>2161</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>384</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN</td><td></td><td>15</td><td>-0.47</td><td>-1.21</td><td>0.228</td><td>0.689</td><td>1.000</td><td>1091</td><td>tags=33%, list=9%, signal=37%</td></tr><tr><td class='lessen'>385</td><td>PID_FANCONI_PATHWAY</td><td></td><td>38</td><td>-0.37</td><td>-1.21</td><td>0.189</td><td>0.691</td><td>1.000</td><td>2980</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>386</td><td>MORI_MATURE_B_LYMPHOCYTE_DN</td><td></td><td>66</td><td>-0.33</td><td>-1.21</td><td>0.162</td><td>0.690</td><td>1.000</td><td>2337</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>387</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>242</td><td>-0.27</td><td>-1.20</td><td>0.094</td><td>0.690</td><td>1.000</td><td>2426</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>388</td><td>PID_CXCR4_PATHWAY</td><td></td><td>83</td><td>-0.31</td><td>-1.20</td><td>0.152</td><td>0.692</td><td>1.000</td><td>1746</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>389</td><td>REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT</td><td></td><td>123</td><td>-0.30</td><td>-1.20</td><td>0.136</td><td>0.691</td><td>1.000</td><td>937</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>390</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>472</td><td>-0.26</td><td>-1.20</td><td>0.039</td><td>0.690</td><td>1.000</td><td>1742</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>391</td><td>SAGIV_CD24_TARGETS_DN</td><td></td><td>31</td><td>-0.39</td><td>-1.20</td><td>0.200</td><td>0.689</td><td>1.000</td><td>2138</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>392</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN</td><td></td><td>25</td><td>-0.41</td><td>-1.20</td><td>0.200</td><td>0.688</td><td>1.000</td><td>285</td><td>tags=16%, list=2%, signal=16%</td></tr><tr><td class='lessen'>393</td><td>REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX</td><td></td><td>53</td><td>-0.35</td><td>-1.20</td><td>0.176</td><td>0.692</td><td>1.000</td><td>1664</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>394</td><td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td><td></td><td>56</td><td>-0.34</td><td>-1.20</td><td>0.154</td><td>0.692</td><td>1.000</td><td>2571</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>395</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>32</td><td>-0.38</td><td>-1.20</td><td>0.210</td><td>0.693</td><td>1.000</td><td>1317</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>396</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP</td><td></td><td>17</td><td>-0.44</td><td>-1.20</td><td>0.239</td><td>0.694</td><td>1.000</td><td>329</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>397</td><td>LI_WILMS_TUMOR_ANAPLASTIC_UP</td><td></td><td>16</td><td>-0.45</td><td>-1.20</td><td>0.253</td><td>0.694</td><td>1.000</td><td>2</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>398</td><td>SIMBULAN_PARP1_TARGETS_UP</td><td></td><td>16</td><td>-0.45</td><td>-1.20</td><td>0.244</td><td>0.695</td><td>1.000</td><td>1702</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>399</td><td>BILD_E2F3_ONCOGENIC_SIGNATURE</td><td></td><td>161</td><td>-0.29</td><td>-1.20</td><td>0.113</td><td>0.695</td><td>1.000</td><td>1842</td><td>tags=19%, list=16%, signal=23%</td></tr><tr><td class='lessen'>400</td><td>BYSTROEM_CORRELATED_WITH_IL5_UP</td><td></td><td>42</td><td>-0.36</td><td>-1.20</td><td>0.184</td><td>0.693</td><td>1.000</td><td>2152</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>401</td><td>JAEGER_METASTASIS_UP</td><td></td><td>27</td><td>-0.40</td><td>-1.20</td><td>0.226</td><td>0.692</td><td>1.000</td><td>1558</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>402</td><td>BERNARD_PPAPDC1B_TARGETS_DN</td><td></td><td>35</td><td>-0.37</td><td>-1.20</td><td>0.180</td><td>0.691</td><td>1.000</td><td>1238</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>403</td><td>OLSSON_E2F3_TARGETS_DN</td><td></td><td>32</td><td>-0.38</td><td>-1.20</td><td>0.195</td><td>0.690</td><td>1.000</td><td>2522</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>404</td><td>REACTOME_MEIOSIS</td><td></td><td>87</td><td>-0.31</td><td>-1.20</td><td>0.156</td><td>0.690</td><td>1.000</td><td>3112</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>405</td><td>PID_NEPHRIN_NEPH1_PATHWAY</td><td></td><td>25</td><td>-0.40</td><td>-1.20</td><td>0.222</td><td>0.691</td><td>1.000</td><td>1730</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>406</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP</td><td></td><td>262</td><td>-0.27</td><td>-1.20</td><td>0.090</td><td>0.689</td><td>1.000</td><td>1644</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>407</td><td>GAL_LEUKEMIC_STEM_CELL_DN</td><td></td><td>154</td><td>-0.29</td><td>-1.19</td><td>0.115</td><td>0.697</td><td>1.000</td><td>1558</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>408</td><td>DOANE_BREAST_CANCER_CLASSES_UP</td><td></td><td>40</td><td>-0.36</td><td>-1.19</td><td>0.190</td><td>0.697</td><td>1.000</td><td>2046</td><td>tags=28%, list=18%, signal=33%</td></tr><tr><td class='lessen'>409</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN</td><td></td><td>21</td><td>-0.42</td><td>-1.19</td><td>0.230</td><td>0.695</td><td>1.000</td><td>3036</td><td>tags=52%, list=26%, signal=71%</td></tr><tr><td class='lessen'>410</td><td>MCCABE_HOXC6_TARGETS_CANCER_UP</td><td></td><td>16</td><td>-0.45</td><td>-1.19</td><td>0.241</td><td>0.695</td><td>1.000</td><td>2473</td><td>tags=44%, list=21%, signal=56%</td></tr><tr><td class='lessen'>411</td><td>RAO_BOUND_BY_SALL4_ISOFORM_A</td><td></td><td>90</td><td>-0.31</td><td>-1.19</td><td>0.148</td><td>0.696</td><td>1.000</td><td>2163</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>412</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>233</td><td>-0.28</td><td>-1.19</td><td>0.096</td><td>0.695</td><td>1.000</td><td>1126</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>413</td><td>HADDAD_B_LYMPHOCYTE_PROGENITOR</td><td></td><td>215</td><td>-0.28</td><td>-1.19</td><td>0.097</td><td>0.695</td><td>1.000</td><td>2140</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>414</td><td>RUIZ_TNC_TARGETS_UP</td><td></td><td>102</td><td>-0.30</td><td>-1.19</td><td>0.150</td><td>0.693</td><td>1.000</td><td>2765</td><td>tags=36%, list=24%, signal=47%</td></tr><tr><td class='lessen'>415</td><td>BIOCARTA_ARF_PATHWAY</td><td></td><td>15</td><td>-0.46</td><td>-1.19</td><td>0.236</td><td>0.694</td><td>1.000</td><td>359</td><td>tags=20%, list=3%, signal=21%</td></tr><tr><td class='lessen'>416</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1</td><td></td><td>47</td><td>-0.35</td><td>-1.19</td><td>0.193</td><td>0.698</td><td>1.000</td><td>2064</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>417</td><td>ROME_INSULIN_TARGETS_IN_MUSCLE_DN</td><td></td><td>108</td><td>-0.30</td><td>-1.19</td><td>0.163</td><td>0.698</td><td>1.000</td><td>2571</td><td>tags=31%, list=22%, signal=40%</td></tr><tr><td class='lessen'>418</td><td>IVANOVSKA_MIR106B_TARGETS</td><td></td><td>74</td><td>-0.32</td><td>-1.19</td><td>0.156</td><td>0.699</td><td>1.000</td><td>2608</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>419</td><td>KEGG_AXON_GUIDANCE</td><td></td><td>72</td><td>-0.32</td><td>-1.19</td><td>0.161</td><td>0.701</td><td>1.000</td><td>1909</td><td>tags=29%, list=16%, signal=35%</td></tr><tr><td class='lessen'>420</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP</td><td></td><td>37</td><td>-0.37</td><td>-1.19</td><td>0.205</td><td>0.703</td><td>1.000</td><td>1711</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>421</td><td>ABE_VEGFA_TARGETS_2HR</td><td></td><td>22</td><td>-0.41</td><td>-1.19</td><td>0.237</td><td>0.702</td><td>1.000</td><td>654</td><td>tags=14%, list=6%, signal=14%</td></tr><tr><td class='lessen'>422</td><td>HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>139</td><td>-0.29</td><td>-1.19</td><td>0.120</td><td>0.703</td><td>1.000</td><td>2968</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>423</td><td>PARENT_MTOR_SIGNALING_DN</td><td></td><td>25</td><td>-0.40</td><td>-1.19</td><td>0.222</td><td>0.702</td><td>1.000</td><td>1535</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>424</td><td>MASSARWEH_TAMOXIFEN_RESISTANCE_UP</td><td></td><td>377</td><td>-0.26</td><td>-1.19</td><td>0.074</td><td>0.701</td><td>1.000</td><td>2287</td><td>tags=25%, list=20%, signal=30%</td></tr><tr><td class='lessen'>425</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_UP</td><td></td><td>105</td><td>-0.30</td><td>-1.19</td><td>0.148</td><td>0.700</td><td>1.000</td><td>1990</td><td>tags=29%, list=17%, signal=34%</td></tr><tr><td class='lessen'>426</td><td>PID_ERBB1_INTERNALIZATION_PATHWAY</td><td></td><td>34</td><td>-0.37</td><td>-1.18</td><td>0.203</td><td>0.705</td><td>1.000</td><td>2360</td><td>tags=32%, list=20%, signal=41%</td></tr><tr><td class='lessen'>427</td><td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td><td></td><td>24</td><td>-0.41</td><td>-1.18</td><td>0.216</td><td>0.705</td><td>1.000</td><td>2717</td><td>tags=42%, list=23%, signal=54%</td></tr><tr><td class='lessen'>428</td><td>DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN</td><td></td><td>233</td><td>-0.27</td><td>-1.18</td><td>0.118</td><td>0.708</td><td>1.000</td><td>1851</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>429</td><td>BIOCARTA_ATM_PATHWAY</td><td></td><td>19</td><td>-0.43</td><td>-1.18</td><td>0.239</td><td>0.707</td><td>1.000</td><td>2497</td><td>tags=42%, list=22%, signal=54%</td></tr><tr><td class='lessen'>430</td><td>BIOCARTA_MCM_PATHWAY</td><td></td><td>17</td><td>-0.44</td><td>-1.18</td><td>0.257</td><td>0.709</td><td>1.000</td><td>1629</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>431</td><td>BROWNE_HCMV_INFECTION_30MIN_DN</td><td></td><td>87</td><td>-0.31</td><td>-1.18</td><td>0.173</td><td>0.708</td><td>1.000</td><td>2605</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>432</td><td>ST_ADRENERGIC</td><td></td><td>21</td><td>-0.42</td><td>-1.18</td><td>0.237</td><td>0.710</td><td>1.000</td><td>2103</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>433</td><td>PID_BMP_PATHWAY</td><td></td><td>26</td><td>-0.39</td><td>-1.18</td><td>0.240</td><td>0.712</td><td>1.000</td><td>1846</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>434</td><td>SMID_BREAST_CANCER_BASAL_DN</td><td></td><td>337</td><td>-0.26</td><td>-1.18</td><td>0.081</td><td>0.715</td><td>1.000</td><td>2218</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>435</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>22</td><td>-0.42</td><td>-1.18</td><td>0.236</td><td>0.714</td><td>1.000</td><td>2302</td><td>tags=41%, list=20%, signal=51%</td></tr><tr><td class='lessen'>436</td><td>RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN</td><td></td><td>102</td><td>-0.30</td><td>-1.18</td><td>0.170</td><td>0.715</td><td>1.000</td><td>2438</td><td>tags=28%, list=21%, signal=36%</td></tr><tr><td class='lessen'>437</td><td>KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM</td><td></td><td>23</td><td>-0.41</td><td>-1.18</td><td>0.235</td><td>0.714</td><td>1.000</td><td>1537</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>438</td><td>PID_CMYB_PATHWAY</td><td></td><td>61</td><td>-0.33</td><td>-1.18</td><td>0.200</td><td>0.715</td><td>1.000</td><td>2063</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>439</td><td>WARTERS_IR_RESPONSE_5GY</td><td></td><td>32</td><td>-0.37</td><td>-1.18</td><td>0.248</td><td>0.715</td><td>1.000</td><td>1837</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>440</td><td>PID_PI3KCI_AKT_PATHWAY</td><td></td><td>29</td><td>-0.38</td><td>-1.17</td><td>0.233</td><td>0.716</td><td>1.000</td><td>1720</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>441</td><td>BIOCARTA_41BB_PATHWAY</td><td></td><td>15</td><td>-0.45</td><td>-1.17</td><td>0.244</td><td>0.715</td><td>1.000</td><td>1491</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>442</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP</td><td></td><td>45</td><td>-0.35</td><td>-1.17</td><td>0.212</td><td>0.714</td><td>1.000</td><td>3751</td><td>tags=49%, list=32%, signal=72%</td></tr><tr><td class='lessen'>443</td><td>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN</td><td></td><td>352</td><td>-0.26</td><td>-1.17</td><td>0.091</td><td>0.713</td><td>1.000</td><td>2521</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>444</td><td>SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES</td><td></td><td>33</td><td>-0.37</td><td>-1.17</td><td>0.235</td><td>0.715</td><td>1.000</td><td>2860</td><td>tags=42%, list=25%, signal=56%</td></tr><tr><td class='lessen'>445</td><td>ZWANG_EGF_INTERVAL_UP</td><td></td><td>39</td><td>-0.35</td><td>-1.17</td><td>0.218</td><td>0.719</td><td>1.000</td><td>2344</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>446</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>221</td><td>-0.27</td><td>-1.17</td><td>0.112</td><td>0.719</td><td>1.000</td><td>1080</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>447</td><td>SANSOM_APC_TARGETS</td><td></td><td>133</td><td>-0.29</td><td>-1.17</td><td>0.149</td><td>0.718</td><td>1.000</td><td>1783</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>448</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN</td><td></td><td>33</td><td>-0.37</td><td>-1.17</td><td>0.244</td><td>0.716</td><td>1.000</td><td>2799</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>449</td><td>SHI_SPARC_TARGETS_UP</td><td></td><td>16</td><td>-0.43</td><td>-1.17</td><td>0.260</td><td>0.718</td><td>1.000</td><td>1609</td><td>tags=38%, list=14%, signal=43%</td></tr><tr><td class='lessen'>450</td><td>CHOI_ATL_CHRONIC_VS_ACUTE_DN</td><td></td><td>18</td><td>-0.43</td><td>-1.17</td><td>0.244</td><td>0.717</td><td>1.000</td><td>1573</td><td>tags=22%, list=14%, signal=26%</td></tr><tr><td class='lessen'>451</td><td>KEGG_ABC_TRANSPORTERS</td><td></td><td>21</td><td>-0.42</td><td>-1.17</td><td>0.239</td><td>0.718</td><td>1.000</td><td>1495</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>452</td><td>DELPUECH_FOXO3_TARGETS_DN</td><td></td><td>36</td><td>-0.36</td><td>-1.17</td><td>0.237</td><td>0.718</td><td>1.000</td><td>1175</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>453</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_UP</td><td></td><td>31</td><td>-0.37</td><td>-1.17</td><td>0.243</td><td>0.719</td><td>1.000</td><td>1317</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>454</td><td>BURTON_ADIPOGENESIS_3</td><td></td><td>92</td><td>-0.31</td><td>-1.17</td><td>0.189</td><td>0.719</td><td>1.000</td><td>1629</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>455</td><td>HORIUCHI_WTAP_TARGETS_DN</td><td></td><td>265</td><td>-0.27</td><td>-1.17</td><td>0.118</td><td>0.722</td><td>1.000</td><td>2968</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>456</td><td>REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM</td><td></td><td>15</td><td>-0.44</td><td>-1.17</td><td>0.260</td><td>0.724</td><td>1.000</td><td>714</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>457</td><td>HINATA_NFKB_TARGETS_KERATINOCYTE_UP</td><td></td><td>59</td><td>-0.32</td><td>-1.16</td><td>0.202</td><td>0.726</td><td>1.000</td><td>2575</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>458</td><td>REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES</td><td></td><td>43</td><td>-0.35</td><td>-1.16</td><td>0.234</td><td>0.726</td><td>1.000</td><td>1122</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>459</td><td>REACTOME_AXON_GUIDANCE</td><td></td><td>145</td><td>-0.28</td><td>-1.16</td><td>0.142</td><td>0.725</td><td>1.000</td><td>1909</td><td>tags=23%, list=16%, signal=28%</td></tr><tr><td class='lessen'>460</td><td>REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS</td><td></td><td>32</td><td>-0.37</td><td>-1.16</td><td>0.229</td><td>0.726</td><td>1.000</td><td>1842</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>461</td><td>FARMER_BREAST_CANCER_CLUSTER_5</td><td></td><td>17</td><td>-0.43</td><td>-1.16</td><td>0.245</td><td>0.726</td><td>1.000</td><td>575</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>462</td><td>REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING</td><td></td><td>19</td><td>-0.42</td><td>-1.16</td><td>0.259</td><td>0.725</td><td>1.000</td><td>3167</td><td>tags=53%, list=27%, signal=72%</td></tr><tr><td class='lessen'>463</td><td>KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION</td><td></td><td>34</td><td>-0.37</td><td>-1.16</td><td>0.255</td><td>0.725</td><td>1.000</td><td>2469</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>464</td><td>KEGG_JAK_STAT_SIGNALING_PATHWAY</td><td></td><td>96</td><td>-0.30</td><td>-1.16</td><td>0.178</td><td>0.726</td><td>1.000</td><td>1919</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>465</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING</td><td></td><td>350</td><td>-0.26</td><td>-1.16</td><td>0.101</td><td>0.729</td><td>1.000</td><td>2300</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>466</td><td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td><td></td><td>78</td><td>-0.31</td><td>-1.16</td><td>0.215</td><td>0.729</td><td>1.000</td><td>2096</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>467</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN</td><td></td><td>162</td><td>-0.28</td><td>-1.16</td><td>0.147</td><td>0.731</td><td>1.000</td><td>1869</td><td>tags=22%, list=16%, signal=25%</td></tr><tr><td class='lessen'>468</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td><td></td><td>109</td><td>-0.30</td><td>-1.16</td><td>0.193</td><td>0.730</td><td>1.000</td><td>1588</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>469</td><td>DAIRKEE_TERT_TARGETS_DN</td><td></td><td>77</td><td>-0.31</td><td>-1.16</td><td>0.207</td><td>0.732</td><td>1.000</td><td>2369</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>470</td><td>LEE_LIVER_CANCER_MYC_TGFA_DN</td><td></td><td>29</td><td>-0.37</td><td>-1.16</td><td>0.257</td><td>0.732</td><td>1.000</td><td>2846</td><td>tags=45%, list=25%, signal=59%</td></tr><tr><td class='lessen'>471</td><td>NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP</td><td></td><td>29</td><td>-0.38</td><td>-1.16</td><td>0.271</td><td>0.732</td><td>1.000</td><td>1614</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>472</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>82</td><td>-0.30</td><td>-1.16</td><td>0.201</td><td>0.734</td><td>1.000</td><td>2438</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>473</td><td>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>15</td><td>-0.44</td><td>-1.16</td><td>0.273</td><td>0.735</td><td>1.000</td><td>680</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>474</td><td>PID_TELOMERASE_PATHWAY</td><td></td><td>60</td><td>-0.32</td><td>-1.16</td><td>0.208</td><td>0.735</td><td>1.000</td><td>1131</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>475</td><td>MORI_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>83</td><td>-0.31</td><td>-1.16</td><td>0.190</td><td>0.733</td><td>1.000</td><td>1739</td><td>tags=20%, list=15%, signal=24%</td></tr><tr><td class='lessen'>476</td><td>PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY</td><td></td><td>31</td><td>-0.37</td><td>-1.15</td><td>0.233</td><td>0.734</td><td>1.000</td><td>1383</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>477</td><td>KEGG_RETINOL_METABOLISM</td><td></td><td>16</td><td>-0.43</td><td>-1.15</td><td>0.297</td><td>0.739</td><td>1.000</td><td>1269</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>478</td><td>REACTOME_TCR_SIGNALING</td><td></td><td>42</td><td>-0.35</td><td>-1.15</td><td>0.224</td><td>0.739</td><td>1.000</td><td>957</td><td>tags=17%, list=8%, signal=18%</td></tr><tr><td class='lessen'>479</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_7_UP</td><td></td><td>74</td><td>-0.32</td><td>-1.15</td><td>0.226</td><td>0.739</td><td>1.000</td><td>1250</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>480</td><td>HUANG_GATA2_TARGETS_DN</td><td></td><td>54</td><td>-0.33</td><td>-1.15</td><td>0.244</td><td>0.739</td><td>1.000</td><td>3025</td><td>tags=41%, list=26%, signal=55%</td></tr><tr><td class='lessen'>481</td><td>PID_ANGIOPOIETIN_RECEPTOR_PATHWAY</td><td></td><td>37</td><td>-0.36</td><td>-1.15</td><td>0.245</td><td>0.740</td><td>1.000</td><td>1702</td><td>tags=32%, list=15%, signal=38%</td></tr><tr><td class='lessen'>482</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP</td><td></td><td>248</td><td>-0.26</td><td>-1.15</td><td>0.131</td><td>0.740</td><td>1.000</td><td>1865</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>483</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN</td><td></td><td>100</td><td>-0.29</td><td>-1.15</td><td>0.169</td><td>0.742</td><td>1.000</td><td>3057</td><td>tags=39%, list=26%, signal=53%</td></tr><tr><td class='lessen'>484</td><td>CAIRO_HEPATOBLASTOMA_UP</td><td></td><td>163</td><td>-0.28</td><td>-1.15</td><td>0.163</td><td>0.742</td><td>1.000</td><td>2431</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>485</td><td>PID_IL2_PI3K_PATHWAY</td><td></td><td>31</td><td>-0.37</td><td>-1.15</td><td>0.253</td><td>0.742</td><td>1.000</td><td>1720</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>486</td><td>WU_HBX_TARGETS_2_UP</td><td></td><td>18</td><td>-0.41</td><td>-1.15</td><td>0.278</td><td>0.742</td><td>1.000</td><td>2202</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>487</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN</td><td></td><td>20</td><td>-0.41</td><td>-1.15</td><td>0.289</td><td>0.741</td><td>1.000</td><td>561</td><td>tags=10%, list=5%, signal=10%</td></tr><tr><td class='lessen'>488</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>202</td><td>-0.27</td><td>-1.15</td><td>0.159</td><td>0.740</td><td>1.000</td><td>2661</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>489</td><td>SUNG_METASTASIS_STROMA_UP</td><td></td><td>79</td><td>-0.31</td><td>-1.15</td><td>0.217</td><td>0.741</td><td>1.000</td><td>799</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>490</td><td>KEGG_ENDOCYTOSIS</td><td></td><td>132</td><td>-0.28</td><td>-1.15</td><td>0.188</td><td>0.743</td><td>1.000</td><td>2018</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>491</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>136</td><td>-0.28</td><td>-1.15</td><td>0.177</td><td>0.746</td><td>1.000</td><td>1690</td><td>tags=23%, list=15%, signal=26%</td></tr><tr><td class='lessen'>492</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN</td><td></td><td>137</td><td>-0.28</td><td>-1.15</td><td>0.193</td><td>0.745</td><td>1.000</td><td>3187</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>493</td><td>EPPERT_LSC_R</td><td></td><td>33</td><td>-0.36</td><td>-1.15</td><td>0.272</td><td>0.744</td><td>1.000</td><td>3243</td><td>tags=42%, list=28%, signal=59%</td></tr><tr><td class='lessen'>494</td><td>CHEN_LIVER_METABOLISM_QTL_CIS</td><td></td><td>63</td><td>-0.32</td><td>-1.14</td><td>0.215</td><td>0.744</td><td>1.000</td><td>1544</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>495</td><td>GOLUB_ALL_VS_AML_UP</td><td></td><td>23</td><td>-0.39</td><td>-1.14</td><td>0.285</td><td>0.747</td><td>1.000</td><td>1911</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>496</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN</td><td></td><td>16</td><td>-0.42</td><td>-1.14</td><td>0.281</td><td>0.749</td><td>1.000</td><td>3252</td><td>tags=50%, list=28%, signal=69%</td></tr><tr><td class='lessen'>497</td><td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td><td></td><td>94</td><td>-0.29</td><td>-1.14</td><td>0.201</td><td>0.748</td><td>1.000</td><td>1714</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>498</td><td>DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP</td><td></td><td>35</td><td>-0.36</td><td>-1.14</td><td>0.263</td><td>0.747</td><td>1.000</td><td>1869</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>499</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>256</td><td>-0.26</td><td>-1.14</td><td>0.155</td><td>0.752</td><td>1.000</td><td>1681</td><td>tags=19%, list=15%, signal=21%</td></tr><tr><td class='lessen'>500</td><td>SMID_BREAST_CANCER_NORMAL_LIKE_UP</td><td></td><td>273</td><td>-0.26</td><td>-1.14</td><td>0.142</td><td>0.751</td><td>1.000</td><td>1258</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>501</td><td>KONDO_EZH2_TARGETS</td><td></td><td>120</td><td>-0.29</td><td>-1.14</td><td>0.209</td><td>0.750</td><td>1.000</td><td>1289</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>502</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN</td><td></td><td>39</td><td>-0.35</td><td>-1.14</td><td>0.262</td><td>0.750</td><td>1.000</td><td>1789</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>503</td><td>PID_INTEGRIN_A4B1_PATHWAY</td><td></td><td>24</td><td>-0.38</td><td>-1.14</td><td>0.270</td><td>0.749</td><td>1.000</td><td>2152</td><td>tags=46%, list=19%, signal=56%</td></tr><tr><td class='lessen'>504</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN</td><td></td><td>22</td><td>-0.40</td><td>-1.14</td><td>0.288</td><td>0.753</td><td>1.000</td><td>3285</td><td>tags=55%, list=28%, signal=76%</td></tr><tr><td class='lessen'>505</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_DN</td><td></td><td>216</td><td>-0.26</td><td>-1.14</td><td>0.157</td><td>0.752</td><td>1.000</td><td>2359</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>506</td><td>FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP</td><td></td><td>23</td><td>-0.39</td><td>-1.14</td><td>0.281</td><td>0.751</td><td>1.000</td><td>2638</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>507</td><td>LIU_TARGETS_OF_VMYB_VS_CMYB_DN</td><td></td><td>29</td><td>-0.38</td><td>-1.14</td><td>0.264</td><td>0.754</td><td>1.000</td><td>2210</td><td>tags=31%, list=19%, signal=38%</td></tr><tr><td class='lessen'>508</td><td>BIOCARTA_CALCINEURIN_PATHWAY</td><td></td><td>15</td><td>-0.44</td><td>-1.14</td><td>0.324</td><td>0.754</td><td>1.000</td><td>1702</td><td>tags=40%, list=15%, signal=47%</td></tr><tr><td class='lessen'>509</td><td>HWANG_PROSTATE_CANCER_MARKERS</td><td></td><td>21</td><td>-0.40</td><td>-1.14</td><td>0.280</td><td>0.755</td><td>1.000</td><td>678</td><td>tags=19%, list=6%, signal=20%</td></tr><tr><td class='lessen'>510</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td><td></td><td>111</td><td>-0.28</td><td>-1.13</td><td>0.191</td><td>0.759</td><td>1.000</td><td>1861</td><td>tags=23%, list=16%, signal=28%</td></tr><tr><td class='lessen'>511</td><td>REACTOME_G1_PHASE</td><td></td><td>35</td><td>-0.35</td><td>-1.13</td><td>0.273</td><td>0.757</td><td>1.000</td><td>1702</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>512</td><td>REACTOME_MRNA_PROCESSING</td><td></td><td>144</td><td>-0.28</td><td>-1.13</td><td>0.203</td><td>0.756</td><td>1.000</td><td>1195</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>513</td><td>PID_BARD1_PATHWAY</td><td></td><td>27</td><td>-0.37</td><td>-1.13</td><td>0.260</td><td>0.758</td><td>1.000</td><td>2549</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>514</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>39</td><td>-0.35</td><td>-1.13</td><td>0.258</td><td>0.759</td><td>1.000</td><td>2871</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>515</td><td>YANAGIHARA_ESX1_TARGETS</td><td></td><td>20</td><td>-0.40</td><td>-1.13</td><td>0.290</td><td>0.759</td><td>1.000</td><td>1326</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>516</td><td>URS_ADIPOCYTE_DIFFERENTIATION_UP</td><td></td><td>37</td><td>-0.35</td><td>-1.13</td><td>0.259</td><td>0.758</td><td>1.000</td><td>1762</td><td>tags=27%, list=15%, signal=32%</td></tr><tr><td class='lessen'>517</td><td>OXFORD_RALA_OR_RALB_TARGETS_UP</td><td></td><td>46</td><td>-0.33</td><td>-1.13</td><td>0.254</td><td>0.758</td><td>1.000</td><td>2146</td><td>tags=33%, list=19%, signal=40%</td></tr><tr><td class='lessen'>518</td><td>MORI_IMMATURE_B_LYMPHOCYTE_UP</td><td></td><td>45</td><td>-0.33</td><td>-1.13</td><td>0.241</td><td>0.759</td><td>1.000</td><td>2216</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>519</td><td>KEGG_P53_SIGNALING_PATHWAY</td><td></td><td>58</td><td>-0.32</td><td>-1.13</td><td>0.238</td><td>0.759</td><td>1.000</td><td>2088</td><td>tags=29%, list=18%, signal=36%</td></tr><tr><td class='lessen'>520</td><td>STOSSI_RESPONSE_TO_ESTRADIOL</td><td></td><td>19</td><td>-0.41</td><td>-1.13</td><td>0.319</td><td>0.758</td><td>1.000</td><td>30</td><td>tags=11%, list=0%, signal=11%</td></tr><tr><td class='lessen'>521</td><td>PID_CD40_PATHWAY</td><td></td><td>26</td><td>-0.38</td><td>-1.13</td><td>0.285</td><td>0.764</td><td>1.000</td><td>3879</td><td>tags=54%, list=34%, signal=81%</td></tr><tr><td class='lessen'>522</td><td>PENG_GLUTAMINE_DEPRIVATION_UP</td><td></td><td>31</td><td>-0.37</td><td>-1.13</td><td>0.314</td><td>0.764</td><td>1.000</td><td>3036</td><td>tags=45%, list=26%, signal=61%</td></tr><tr><td class='lessen'>523</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>94</td><td>-0.29</td><td>-1.13</td><td>0.214</td><td>0.766</td><td>1.000</td><td>2509</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>524</td><td>KEGG_CELL_CYCLE</td><td></td><td>110</td><td>-0.28</td><td>-1.13</td><td>0.213</td><td>0.766</td><td>1.000</td><td>2511</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>525</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>399</td><td>-0.25</td><td>-1.13</td><td>0.129</td><td>0.769</td><td>1.000</td><td>2098</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>526</td><td>PID_ARF6_TRAFFICKING_PATHWAY</td><td></td><td>40</td><td>-0.34</td><td>-1.13</td><td>0.284</td><td>0.770</td><td>1.000</td><td>1690</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>527</td><td>NIELSEN_SYNOVIAL_SARCOMA_DN</td><td></td><td>16</td><td>-0.43</td><td>-1.12</td><td>0.311</td><td>0.774</td><td>1.000</td><td>1039</td><td>tags=31%, list=9%, signal=34%</td></tr><tr><td class='lessen'>528</td><td>IGARASHI_ATF4_TARGETS_DN</td><td></td><td>68</td><td>-0.31</td><td>-1.12</td><td>0.252</td><td>0.774</td><td>1.000</td><td>1518</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>529</td><td>EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION</td><td></td><td>25</td><td>-0.38</td><td>-1.12</td><td>0.295</td><td>0.772</td><td>1.000</td><td>2575</td><td>tags=36%, list=22%, signal=46%</td></tr><tr><td class='lessen'>530</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>135</td><td>-0.28</td><td>-1.12</td><td>0.211</td><td>0.772</td><td>1.000</td><td>2635</td><td>tags=31%, list=23%, signal=40%</td></tr><tr><td class='lessen'>531</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR</td><td></td><td>26</td><td>-0.38</td><td>-1.12</td><td>0.287</td><td>0.774</td><td>1.000</td><td>892</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>532</td><td>KEGG_PRIMARY_IMMUNODEFICIENCY</td><td></td><td>24</td><td>-0.38</td><td>-1.12</td><td>0.281</td><td>0.774</td><td>1.000</td><td>645</td><td>tags=13%, list=6%, signal=13%</td></tr><tr><td class='lessen'>533</td><td>PID_WNT_NONCANONICAL_PATHWAY</td><td></td><td>25</td><td>-0.38</td><td>-1.12</td><td>0.282</td><td>0.773</td><td>1.000</td><td>1990</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>534</td><td>CARD_MIR302A_TARGETS</td><td></td><td>58</td><td>-0.31</td><td>-1.12</td><td>0.262</td><td>0.773</td><td>1.000</td><td>1264</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>535</td><td>KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>69</td><td>-0.31</td><td>-1.12</td><td>0.248</td><td>0.772</td><td>1.000</td><td>1516</td><td>tags=23%, list=13%, signal=27%</td></tr><tr><td class='lessen'>536</td><td>YANG_BREAST_CANCER_ESR1_LASER_DN</td><td></td><td>41</td><td>-0.34</td><td>-1.12</td><td>0.283</td><td>0.771</td><td>1.000</td><td>1244</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>537</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td><td></td><td>100</td><td>-0.29</td><td>-1.12</td><td>0.240</td><td>0.771</td><td>1.000</td><td>2397</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>538</td><td>REACTOME_METABOLISM_OF_CARBOHYDRATES</td><td></td><td>153</td><td>-0.27</td><td>-1.12</td><td>0.216</td><td>0.771</td><td>1.000</td><td>2663</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>539</td><td>WANG_LMO4_TARGETS_UP</td><td></td><td>279</td><td>-0.25</td><td>-1.12</td><td>0.186</td><td>0.769</td><td>1.000</td><td>2638</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>540</td><td>KORKOLA_YOLK_SAC_TUMOR</td><td></td><td>19</td><td>-0.41</td><td>-1.12</td><td>0.312</td><td>0.770</td><td>1.000</td><td>1535</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>541</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>42</td><td>-0.34</td><td>-1.12</td><td>0.274</td><td>0.772</td><td>1.000</td><td>742</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>542</td><td>REACTOME_MRNA_SPLICING</td><td></td><td>100</td><td>-0.29</td><td>-1.12</td><td>0.262</td><td>0.773</td><td>1.000</td><td>1195</td><td>tags=14%, list=10%, signal=15%</td></tr><tr><td class='lessen'>543</td><td>REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE</td><td></td><td>94</td><td>-0.29</td><td>-1.12</td><td>0.259</td><td>0.772</td><td>1.000</td><td>1939</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>544</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_B</td><td></td><td>46</td><td>-0.33</td><td>-1.12</td><td>0.289</td><td>0.772</td><td>1.000</td><td>2497</td><td>tags=37%, list=22%, signal=47%</td></tr><tr><td class='lessen'>545</td><td>PID_HDAC_CLASSII_PATHWAY</td><td></td><td>28</td><td>-0.37</td><td>-1.12</td><td>0.311</td><td>0.771</td><td>1.000</td><td>297</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>546</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP</td><td></td><td>80</td><td>-0.30</td><td>-1.12</td><td>0.248</td><td>0.771</td><td>1.000</td><td>1755</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>547</td><td>REACTOME_CELL_CYCLE</td><td></td><td>355</td><td>-0.25</td><td>-1.12</td><td>0.169</td><td>0.769</td><td>1.000</td><td>1974</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>548</td><td>NAKAMURA_ADIPOGENESIS_EARLY_UP</td><td></td><td>36</td><td>-0.35</td><td>-1.12</td><td>0.296</td><td>0.774</td><td>1.000</td><td>54</td><td>tags=11%, list=0%, signal=11%</td></tr><tr><td class='lessen'>549</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>352</td><td>-0.25</td><td>-1.12</td><td>0.170</td><td>0.773</td><td>1.000</td><td>3235</td><td>tags=34%, list=28%, signal=45%</td></tr><tr><td class='lessen'>550</td><td>LIU_SOX4_TARGETS_UP</td><td></td><td>109</td><td>-0.28</td><td>-1.12</td><td>0.239</td><td>0.773</td><td>1.000</td><td>2337</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>551</td><td>REACTOME_RNA_POL_II_TRANSCRIPTION</td><td></td><td>92</td><td>-0.29</td><td>-1.12</td><td>0.247</td><td>0.774</td><td>1.000</td><td>1643</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>552</td><td>VALK_AML_CLUSTER_3</td><td></td><td>23</td><td>-0.38</td><td>-1.11</td><td>0.297</td><td>0.774</td><td>1.000</td><td>2039</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>553</td><td>YU_MYC_TARGETS_DN</td><td></td><td>42</td><td>-0.33</td><td>-1.11</td><td>0.271</td><td>0.779</td><td>1.000</td><td>2354</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>554</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>378</td><td>-0.24</td><td>-1.11</td><td>0.162</td><td>0.780</td><td>1.000</td><td>1755</td><td>tags=19%, list=15%, signal=21%</td></tr><tr><td class='lessen'>555</td><td>REACTOME_MEIOTIC_SYNAPSIS</td><td></td><td>53</td><td>-0.32</td><td>-1.11</td><td>0.270</td><td>0.779</td><td>1.000</td><td>2853</td><td>tags=36%, list=25%, signal=47%</td></tr><tr><td class='lessen'>556</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP</td><td></td><td>41</td><td>-0.34</td><td>-1.11</td><td>0.270</td><td>0.781</td><td>1.000</td><td>1425</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>557</td><td>SWEET_LUNG_CANCER_KRAS_DN</td><td></td><td>232</td><td>-0.25</td><td>-1.11</td><td>0.211</td><td>0.781</td><td>1.000</td><td>2145</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>558</td><td>REACTOME_DIABETES_PATHWAYS</td><td></td><td>97</td><td>-0.29</td><td>-1.11</td><td>0.279</td><td>0.793</td><td>1.000</td><td>2808</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>559</td><td>JIANG_AGING_CEREBRAL_CORTEX_DN</td><td></td><td>43</td><td>-0.33</td><td>-1.11</td><td>0.304</td><td>0.795</td><td>1.000</td><td>2930</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>560</td><td>REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK</td><td></td><td>30</td><td>-0.35</td><td>-1.11</td><td>0.304</td><td>0.796</td><td>1.000</td><td>4112</td><td>tags=47%, list=36%, signal=72%</td></tr><tr><td class='lessen'>561</td><td>ONDER_CDH1_SIGNALING_VIA_CTNNB1</td><td></td><td>45</td><td>-0.33</td><td>-1.11</td><td>0.277</td><td>0.795</td><td>1.000</td><td>1560</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>562</td><td>PID_NECTIN_PATHWAY</td><td></td><td>21</td><td>-0.39</td><td>-1.10</td><td>0.323</td><td>0.799</td><td>1.000</td><td>1383</td><td>tags=29%, list=12%, signal=32%</td></tr><tr><td class='lessen'>563</td><td>KEGG_PATHWAYS_IN_CANCER</td><td></td><td>211</td><td>-0.26</td><td>-1.10</td><td>0.221</td><td>0.797</td><td>1.000</td><td>1755</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>564</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K27ME3</td><td></td><td>17</td><td>-0.40</td><td>-1.10</td><td>0.327</td><td>0.796</td><td>1.000</td><td>312</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>565</td><td>PID_HNF3A_PATHWAY</td><td></td><td>25</td><td>-0.37</td><td>-1.10</td><td>0.339</td><td>0.796</td><td>1.000</td><td>1619</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>566</td><td>TANG_SENESCENCE_TP53_TARGETS_UP</td><td></td><td>16</td><td>-0.42</td><td>-1.10</td><td>0.350</td><td>0.795</td><td>1.000</td><td>1727</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>567</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td><td></td><td>63</td><td>-0.30</td><td>-1.10</td><td>0.287</td><td>0.794</td><td>1.000</td><td>2412</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>568</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>76</td><td>-0.29</td><td>-1.10</td><td>0.275</td><td>0.793</td><td>1.000</td><td>2172</td><td>tags=29%, list=19%, signal=35%</td></tr><tr><td class='lessen'>569</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td><td></td><td>38</td><td>-0.34</td><td>-1.10</td><td>0.303</td><td>0.793</td><td>1.000</td><td>2184</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>570</td><td>REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY</td><td></td><td>52</td><td>-0.32</td><td>-1.10</td><td>0.286</td><td>0.792</td><td>1.000</td><td>3303</td><td>tags=35%, list=29%, signal=48%</td></tr><tr><td class='lessen'>571</td><td>WHITEFORD_PEDIATRIC_CANCER_MARKERS</td><td></td><td>101</td><td>-0.28</td><td>-1.10</td><td>0.266</td><td>0.791</td><td>1.000</td><td>2436</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>572</td><td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td><td></td><td>164</td><td>-0.26</td><td>-1.10</td><td>0.240</td><td>0.791</td><td>1.000</td><td>2829</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>573</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP</td><td></td><td>153</td><td>-0.27</td><td>-1.10</td><td>0.240</td><td>0.791</td><td>1.000</td><td>3187</td><td>tags=31%, list=28%, signal=43%</td></tr><tr><td class='lessen'>574</td><td>SABATES_COLORECTAL_ADENOMA_DN</td><td></td><td>88</td><td>-0.29</td><td>-1.10</td><td>0.269</td><td>0.790</td><td>1.000</td><td>1528</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>575</td><td>KEGG_PROTEIN_EXPORT</td><td></td><td>22</td><td>-0.39</td><td>-1.10</td><td>0.313</td><td>0.796</td><td>1.000</td><td>2136</td><td>tags=32%, list=18%, signal=39%</td></tr><tr><td class='lessen'>576</td><td>PID_HNF3B_PATHWAY</td><td></td><td>22</td><td>-0.38</td><td>-1.10</td><td>0.335</td><td>0.796</td><td>1.000</td><td>1136</td><td>tags=23%, list=10%, signal=25%</td></tr><tr><td class='lessen'>577</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>166</td><td>-0.26</td><td>-1.10</td><td>0.239</td><td>0.796</td><td>1.000</td><td>2316</td><td>tags=28%, list=20%, signal=34%</td></tr><tr><td class='lessen'>578</td><td>ROVERSI_GLIOMA_COPY_NUMBER_DN</td><td></td><td>31</td><td>-0.36</td><td>-1.10</td><td>0.329</td><td>0.796</td><td>1.000</td><td>1183</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>579</td><td>ST_WNT_BETA_CATENIN_PATHWAY</td><td></td><td>18</td><td>-0.40</td><td>-1.10</td><td>0.340</td><td>0.797</td><td>1.000</td><td>2163</td><td>tags=39%, list=19%, signal=48%</td></tr><tr><td class='lessen'>580</td><td>VANTVEER_BREAST_CANCER_BRCA1_UP</td><td></td><td>25</td><td>-0.37</td><td>-1.10</td><td>0.319</td><td>0.797</td><td>1.000</td><td>3094</td><td>tags=40%, list=27%, signal=54%</td></tr><tr><td class='lessen'>581</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>429</td><td>-0.24</td><td>-1.10</td><td>0.169</td><td>0.796</td><td>1.000</td><td>2445</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>582</td><td>SEIDEN_ONCOGENESIS_BY_MET</td><td></td><td>77</td><td>-0.30</td><td>-1.10</td><td>0.288</td><td>0.797</td><td>1.000</td><td>1712</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>583</td><td>KEGG_CHRONIC_MYELOID_LEUKEMIA</td><td></td><td>63</td><td>-0.31</td><td>-1.10</td><td>0.308</td><td>0.796</td><td>1.000</td><td>1702</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>584</td><td>BIOCARTA_EIF_PATHWAY</td><td></td><td>16</td><td>-0.41</td><td>-1.10</td><td>0.366</td><td>0.798</td><td>1.000</td><td>2327</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>585</td><td>BIOCARTA_CTCF_PATHWAY</td><td></td><td>18</td><td>-0.40</td><td>-1.10</td><td>0.336</td><td>0.798</td><td>1.000</td><td>645</td><td>tags=22%, list=6%, signal=23%</td></tr><tr><td class='lessen'>586</td><td>MARKS_HDAC_TARGETS_DN</td><td></td><td>15</td><td>-0.42</td><td>-1.10</td><td>0.359</td><td>0.797</td><td>1.000</td><td>1270</td><td>tags=27%, list=11%, signal=30%</td></tr><tr><td class='lessen'>587</td><td>REACTOME_RECYCLING_PATHWAY_OF_L1</td><td></td><td>21</td><td>-0.39</td><td>-1.10</td><td>0.317</td><td>0.796</td><td>1.000</td><td>2628</td><td>tags=48%, list=23%, signal=61%</td></tr><tr><td class='lessen'>588</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_5_DN</td><td></td><td>21</td><td>-0.39</td><td>-1.10</td><td>0.333</td><td>0.796</td><td>1.000</td><td>3369</td><td>tags=57%, list=29%, signal=80%</td></tr><tr><td class='lessen'>589</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>435</td><td>-0.24</td><td>-1.10</td><td>0.185</td><td>0.798</td><td>1.000</td><td>2723</td><td>tags=28%, list=24%, signal=35%</td></tr><tr><td class='lessen'>590</td><td>BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN</td><td></td><td>16</td><td>-0.41</td><td>-1.09</td><td>0.326</td><td>0.798</td><td>1.000</td><td>3299</td><td>tags=50%, list=28%, signal=70%</td></tr><tr><td class='lessen'>591</td><td>DOUGLAS_BMI1_TARGETS_DN</td><td></td><td>261</td><td>-0.25</td><td>-1.09</td><td>0.218</td><td>0.800</td><td>1.000</td><td>1943</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>592</td><td>HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP</td><td></td><td>41</td><td>-0.34</td><td>-1.09</td><td>0.319</td><td>0.799</td><td>1.000</td><td>3627</td><td>tags=41%, list=31%, signal=60%</td></tr><tr><td class='lessen'>593</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>188</td><td>-0.26</td><td>-1.09</td><td>0.241</td><td>0.805</td><td>1.000</td><td>2137</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>594</td><td>BRUINS_UVC_RESPONSE_MIDDLE</td><td></td><td>73</td><td>-0.30</td><td>-1.09</td><td>0.289</td><td>0.807</td><td>1.000</td><td>2874</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>595</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>333</td><td>-0.24</td><td>-1.09</td><td>0.221</td><td>0.806</td><td>1.000</td><td>2621</td><td>tags=29%, list=23%, signal=36%</td></tr><tr><td class='lessen'>596</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>364</td><td>-0.24</td><td>-1.09</td><td>0.216</td><td>0.808</td><td>1.000</td><td>2176</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>597</td><td>FOSTER_KDM1A_TARGETS_DN</td><td></td><td>154</td><td>-0.26</td><td>-1.09</td><td>0.256</td><td>0.808</td><td>1.000</td><td>2164</td><td>tags=25%, list=19%, signal=30%</td></tr><tr><td class='lessen'>598</td><td>BIOCARTA_G1_PATHWAY</td><td></td><td>23</td><td>-0.38</td><td>-1.09</td><td>0.333</td><td>0.807</td><td>1.000</td><td>1974</td><td>tags=30%, list=17%, signal=37%</td></tr><tr><td class='lessen'>599</td><td>MADAN_DPPA4_TARGETS</td><td></td><td>18</td><td>-0.40</td><td>-1.09</td><td>0.336</td><td>0.807</td><td>1.000</td><td>150</td><td>tags=11%, list=1%, signal=11%</td></tr><tr><td class='lessen'>600</td><td>ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN</td><td></td><td>340</td><td>-0.24</td><td>-1.09</td><td>0.224</td><td>0.806</td><td>1.000</td><td>2160</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>601</td><td>BIOCARTA_BCELLSURVIVAL_PATHWAY</td><td></td><td>16</td><td>-0.41</td><td>-1.09</td><td>0.351</td><td>0.806</td><td>1.000</td><td>1720</td><td>tags=31%, list=15%, signal=37%</td></tr><tr><td class='lessen'>602</td><td>PRAMOONJAGO_SOX4_TARGETS_DN</td><td></td><td>44</td><td>-0.33</td><td>-1.09</td><td>0.318</td><td>0.805</td><td>1.000</td><td>1716</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>603</td><td>AMIT_SERUM_RESPONSE_120_MCF10A</td><td></td><td>55</td><td>-0.31</td><td>-1.09</td><td>0.309</td><td>0.808</td><td>1.000</td><td>2925</td><td>tags=40%, list=25%, signal=53%</td></tr><tr><td class='lessen'>604</td><td>REACTOME_METABOLISM_OF_NON_CODING_RNA</td><td></td><td>44</td><td>-0.33</td><td>-1.09</td><td>0.299</td><td>0.808</td><td>1.000</td><td>1846</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>605</td><td>BROWNE_HCMV_INFECTION_10HR_DN</td><td></td><td>40</td><td>-0.33</td><td>-1.09</td><td>0.324</td><td>0.810</td><td>1.000</td><td>2772</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>606</td><td>NABA_ECM_GLYCOPROTEINS</td><td></td><td>52</td><td>-0.32</td><td>-1.09</td><td>0.327</td><td>0.809</td><td>1.000</td><td>909</td><td>tags=15%, list=8%, signal=17%</td></tr><tr><td class='lessen'>607</td><td>SA_CASPASE_CASCADE</td><td></td><td>18</td><td>-0.40</td><td>-1.09</td><td>0.358</td><td>0.808</td><td>1.000</td><td>522</td><td>tags=17%, list=5%, signal=17%</td></tr><tr><td class='lessen'>608</td><td>REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT</td><td></td><td>19</td><td>-0.39</td><td>-1.08</td><td>0.349</td><td>0.811</td><td>1.000</td><td>18</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>609</td><td>REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS</td><td></td><td>25</td><td>-0.36</td><td>-1.08</td><td>0.340</td><td>0.813</td><td>1.000</td><td>1383</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>610</td><td>REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION</td><td></td><td>85</td><td>-0.28</td><td>-1.08</td><td>0.280</td><td>0.812</td><td>1.000</td><td>2968</td><td>tags=35%, list=26%, signal=47%</td></tr><tr><td class='lessen'>611</td><td>REACTOME_SIGNALING_BY_SCF_KIT</td><td></td><td>65</td><td>-0.30</td><td>-1.08</td><td>0.294</td><td>0.814</td><td>1.000</td><td>1720</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>612</td><td>BIOCARTA_RHO_PATHWAY</td><td></td><td>26</td><td>-0.36</td><td>-1.08</td><td>0.342</td><td>0.813</td><td>1.000</td><td>1754</td><td>tags=19%, list=15%, signal=23%</td></tr><tr><td class='lessen'>613</td><td>REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS</td><td></td><td>55</td><td>-0.31</td><td>-1.08</td><td>0.314</td><td>0.812</td><td>1.000</td><td>2807</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>614</td><td>LU_AGING_BRAIN_DN</td><td></td><td>107</td><td>-0.28</td><td>-1.08</td><td>0.289</td><td>0.812</td><td>1.000</td><td>2653</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>615</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_UP</td><td></td><td>93</td><td>-0.29</td><td>-1.08</td><td>0.311</td><td>0.812</td><td>1.000</td><td>1708</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>616</td><td>CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN</td><td></td><td>27</td><td>-0.36</td><td>-1.08</td><td>0.361</td><td>0.815</td><td>1.000</td><td>2785</td><td>tags=44%, list=24%, signal=58%</td></tr><tr><td class='lessen'>617</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>188</td><td>-0.26</td><td>-1.08</td><td>0.256</td><td>0.815</td><td>1.000</td><td>2638</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>618</td><td>CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP</td><td></td><td>144</td><td>-0.26</td><td>-1.08</td><td>0.281</td><td>0.814</td><td>1.000</td><td>2619</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>619</td><td>FUJII_YBX1_TARGETS_DN</td><td></td><td>173</td><td>-0.26</td><td>-1.08</td><td>0.272</td><td>0.819</td><td>1.000</td><td>3187</td><td>tags=34%, list=28%, signal=46%</td></tr><tr><td class='lessen'>620</td><td>PID_INSULIN_GLUCOSE_PATHWAY</td><td></td><td>19</td><td>-0.38</td><td>-1.08</td><td>0.346</td><td>0.819</td><td>1.000</td><td>1134</td><td>tags=16%, list=10%, signal=17%</td></tr><tr><td class='lessen'>621</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP</td><td></td><td>88</td><td>-0.28</td><td>-1.08</td><td>0.306</td><td>0.818</td><td>1.000</td><td>1648</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>622</td><td>REACTOME_KINESINS</td><td></td><td>16</td><td>-0.40</td><td>-1.08</td><td>0.386</td><td>0.817</td><td>1.000</td><td>2968</td><td>tags=50%, list=26%, signal=67%</td></tr><tr><td class='lessen'>623</td><td>BERNARD_PPAPDC1B_TARGETS_UP</td><td></td><td>32</td><td>-0.35</td><td>-1.08</td><td>0.349</td><td>0.816</td><td>1.000</td><td>2682</td><td>tags=28%, list=23%, signal=37%</td></tr><tr><td class='lessen'>624</td><td>REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING</td><td></td><td>26</td><td>-0.36</td><td>-1.08</td><td>0.341</td><td>0.816</td><td>1.000</td><td>605</td><td>tags=15%, list=5%, signal=16%</td></tr><tr><td class='lessen'>625</td><td>PID_RHOA_PATHWAY</td><td></td><td>39</td><td>-0.33</td><td>-1.08</td><td>0.355</td><td>0.815</td><td>1.000</td><td>605</td><td>tags=18%, list=5%, signal=19%</td></tr><tr><td class='lessen'>626</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td><td></td><td>39</td><td>-0.33</td><td>-1.08</td><td>0.341</td><td>0.816</td><td>1.000</td><td>3768</td><td>tags=49%, list=33%, signal=72%</td></tr><tr><td class='lessen'>627</td><td>KEGG_WNT_SIGNALING_PATHWAY</td><td></td><td>94</td><td>-0.28</td><td>-1.08</td><td>0.319</td><td>0.816</td><td>1.000</td><td>2309</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>628</td><td>LEIN_CEREBELLUM_MARKERS</td><td></td><td>38</td><td>-0.33</td><td>-1.08</td><td>0.341</td><td>0.815</td><td>1.000</td><td>2069</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>629</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td><td></td><td>62</td><td>-0.30</td><td>-1.08</td><td>0.319</td><td>0.814</td><td>1.000</td><td>2293</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>630</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>110</td><td>-0.27</td><td>-1.08</td><td>0.289</td><td>0.812</td><td>1.000</td><td>1730</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>631</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>340</td><td>-0.24</td><td>-1.08</td><td>0.241</td><td>0.812</td><td>1.000</td><td>1702</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>632</td><td>WANG_RESPONSE_TO_BEXAROTENE_UP</td><td></td><td>21</td><td>-0.37</td><td>-1.08</td><td>0.352</td><td>0.811</td><td>1.000</td><td>1502</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>633</td><td>SONG_TARGETS_OF_IE86_CMV_PROTEIN</td><td></td><td>56</td><td>-0.30</td><td>-1.08</td><td>0.330</td><td>0.813</td><td>1.000</td><td>2579</td><td>tags=34%, list=22%, signal=43%</td></tr><tr><td class='lessen'>634</td><td>PID_HEDGEHOG_GLI_PATHWAY</td><td></td><td>36</td><td>-0.33</td><td>-1.08</td><td>0.312</td><td>0.812</td><td>1.000</td><td>2139</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>635</td><td>NAKAMURA_METASTASIS</td><td></td><td>34</td><td>-0.34</td><td>-1.08</td><td>0.346</td><td>0.811</td><td>1.000</td><td>2562</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>636</td><td>WOTTON_RUNX_TARGETS_DN</td><td></td><td>19</td><td>-0.39</td><td>-1.08</td><td>0.358</td><td>0.810</td><td>1.000</td><td>1479</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>637</td><td>ROESSLER_LIVER_CANCER_METASTASIS_DN</td><td></td><td>34</td><td>-0.34</td><td>-1.08</td><td>0.346</td><td>0.809</td><td>1.000</td><td>3413</td><td>tags=50%, list=29%, signal=71%</td></tr><tr><td class='lessen'>638</td><td>REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS</td><td></td><td>71</td><td>-0.29</td><td>-1.07</td><td>0.309</td><td>0.812</td><td>1.000</td><td>1798</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>639</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_DN</td><td></td><td>78</td><td>-0.29</td><td>-1.07</td><td>0.325</td><td>0.811</td><td>1.000</td><td>2173</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>640</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</td><td></td><td>104</td><td>-0.27</td><td>-1.07</td><td>0.311</td><td>0.812</td><td>1.000</td><td>2056</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>641</td><td>BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN</td><td></td><td>20</td><td>-0.38</td><td>-1.07</td><td>0.362</td><td>0.811</td><td>1.000</td><td>883</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>642</td><td>REACTOME_DEVELOPMENTAL_BIOLOGY</td><td></td><td>235</td><td>-0.25</td><td>-1.07</td><td>0.284</td><td>0.810</td><td>1.000</td><td>1851</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>643</td><td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>188</td><td>-0.25</td><td>-1.07</td><td>0.295</td><td>0.812</td><td>1.000</td><td>1729</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>644</td><td>PID_CDC42_PATHWAY</td><td></td><td>63</td><td>-0.30</td><td>-1.07</td><td>0.322</td><td>0.812</td><td>1.000</td><td>2005</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>645</td><td>CROMER_METASTASIS_UP</td><td></td><td>70</td><td>-0.30</td><td>-1.07</td><td>0.329</td><td>0.813</td><td>1.000</td><td>1916</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>646</td><td>REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN</td><td></td><td>23</td><td>-0.37</td><td>-1.07</td><td>0.362</td><td>0.813</td><td>1.000</td><td>3766</td><td>tags=52%, list=33%, signal=77%</td></tr><tr><td class='lessen'>647</td><td>REACTOME_CELL_CELL_COMMUNICATION</td><td></td><td>65</td><td>-0.30</td><td>-1.07</td><td>0.339</td><td>0.813</td><td>1.000</td><td>1730</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>648</td><td>AMIT_EGF_RESPONSE_240_HELA</td><td></td><td>43</td><td>-0.32</td><td>-1.07</td><td>0.347</td><td>0.814</td><td>1.000</td><td>2009</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>649</td><td>BROWNE_HCMV_INFECTION_16HR_DN</td><td></td><td>50</td><td>-0.31</td><td>-1.07</td><td>0.330</td><td>0.813</td><td>1.000</td><td>2406</td><td>tags=36%, list=21%, signal=45%</td></tr><tr><td class='lessen'>650</td><td>REACTOME_PI_METABOLISM</td><td></td><td>43</td><td>-0.33</td><td>-1.07</td><td>0.369</td><td>0.817</td><td>1.000</td><td>2560</td><td>tags=35%, list=22%, signal=45%</td></tr><tr><td class='lessen'>651</td><td>ALCALAY_AML_BY_NPM1_LOCALIZATION_DN</td><td></td><td>151</td><td>-0.26</td><td>-1.07</td><td>0.299</td><td>0.816</td><td>1.000</td><td>1869</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>652</td><td>FALVELLA_SMOKERS_WITH_LUNG_CANCER</td><td></td><td>54</td><td>-0.31</td><td>-1.07</td><td>0.341</td><td>0.815</td><td>1.000</td><td>1470</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>653</td><td>PID_THROMBIN_PAR1_PATHWAY</td><td></td><td>29</td><td>-0.34</td><td>-1.07</td><td>0.345</td><td>0.815</td><td>1.000</td><td>800</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>654</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN</td><td></td><td>16</td><td>-0.40</td><td>-1.07</td><td>0.387</td><td>0.814</td><td>1.000</td><td>1119</td><td>tags=31%, list=10%, signal=35%</td></tr><tr><td class='lessen'>655</td><td>YAMAZAKI_TCEB3_TARGETS_UP</td><td></td><td>120</td><td>-0.27</td><td>-1.07</td><td>0.291</td><td>0.814</td><td>1.000</td><td>1690</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>656</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>327</td><td>-0.24</td><td>-1.07</td><td>0.275</td><td>0.817</td><td>1.000</td><td>2183</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>657</td><td>BIOCARTA_NFKB_PATHWAY</td><td></td><td>22</td><td>-0.37</td><td>-1.07</td><td>0.369</td><td>0.815</td><td>1.000</td><td>467</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>658</td><td>KATSANOU_ELAVL1_TARGETS_UP</td><td></td><td>92</td><td>-0.28</td><td>-1.07</td><td>0.342</td><td>0.814</td><td>1.000</td><td>1479</td><td>tags=20%, list=13%, signal=22%</td></tr><tr><td class='lessen'>659</td><td>REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT</td><td></td><td>21</td><td>-0.38</td><td>-1.07</td><td>0.372</td><td>0.814</td><td>1.000</td><td>2449</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>660</td><td>MOHANKUMAR_TLX1_TARGETS_UP</td><td></td><td>327</td><td>-0.24</td><td>-1.07</td><td>0.291</td><td>0.815</td><td>1.000</td><td>2912</td><td>tags=30%, list=25%, signal=39%</td></tr><tr><td class='lessen'>661</td><td>REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS</td><td></td><td>25</td><td>-0.36</td><td>-1.07</td><td>0.360</td><td>0.815</td><td>1.000</td><td>3766</td><td>tags=48%, list=33%, signal=71%</td></tr><tr><td class='lessen'>662</td><td>SWEET_KRAS_TARGETS_DN</td><td></td><td>40</td><td>-0.32</td><td>-1.07</td><td>0.346</td><td>0.814</td><td>1.000</td><td>1979</td><td>tags=23%, list=17%, signal=27%</td></tr><tr><td class='lessen'>663</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td><td></td><td>175</td><td>-0.25</td><td>-1.07</td><td>0.278</td><td>0.814</td><td>1.000</td><td>3091</td><td>tags=30%, list=27%, signal=41%</td></tr><tr><td class='lessen'>664</td><td>BIOCARTA_MET_PATHWAY</td><td></td><td>34</td><td>-0.33</td><td>-1.07</td><td>0.351</td><td>0.815</td><td>1.000</td><td>1383</td><td>tags=29%, list=12%, signal=33%</td></tr><tr><td class='lessen'>665</td><td>WHITFIELD_CELL_CYCLE_S</td><td></td><td>132</td><td>-0.26</td><td>-1.06</td><td>0.317</td><td>0.816</td><td>1.000</td><td>2935</td><td>tags=34%, list=25%, signal=45%</td></tr><tr><td class='lessen'>666</td><td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN</td><td></td><td>15</td><td>-0.41</td><td>-1.06</td><td>0.390</td><td>0.816</td><td>1.000</td><td>1181</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>667</td><td>ZHU_CMV_8_HR_DN</td><td></td><td>38</td><td>-0.33</td><td>-1.06</td><td>0.332</td><td>0.815</td><td>1.000</td><td>1902</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>668</td><td>STREICHER_LSM1_TARGETS_UP</td><td></td><td>30</td><td>-0.34</td><td>-1.06</td><td>0.363</td><td>0.815</td><td>1.000</td><td>1692</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>669</td><td>DOANE_RESPONSE_TO_ANDROGEN_DN</td><td></td><td>170</td><td>-0.26</td><td>-1.06</td><td>0.323</td><td>0.816</td><td>1.000</td><td>2438</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>670</td><td>LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN</td><td></td><td>59</td><td>-0.30</td><td>-1.06</td><td>0.345</td><td>0.815</td><td>1.000</td><td>1016</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>671</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td><td></td><td>53</td><td>-0.31</td><td>-1.06</td><td>0.335</td><td>0.814</td><td>1.000</td><td>1842</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>672</td><td>STEIN_ESR1_TARGETS</td><td></td><td>58</td><td>-0.30</td><td>-1.06</td><td>0.344</td><td>0.813</td><td>1.000</td><td>2799</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>673</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>42</td><td>-0.32</td><td>-1.06</td><td>0.362</td><td>0.812</td><td>1.000</td><td>2130</td><td>tags=31%, list=18%, signal=38%</td></tr><tr><td class='lessen'>674</td><td>PUJANA_BREAST_CANCER_LIT_INT_NETWORK</td><td></td><td>91</td><td>-0.28</td><td>-1.06</td><td>0.361</td><td>0.815</td><td>1.000</td><td>2429</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>675</td><td>PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN</td><td></td><td>272</td><td>-0.24</td><td>-1.06</td><td>0.283</td><td>0.816</td><td>1.000</td><td>2366</td><td>tags=25%, list=20%, signal=30%</td></tr><tr><td class='lessen'>676</td><td>REACTOME_MEMBRANE_TRAFFICKING</td><td></td><td>102</td><td>-0.27</td><td>-1.06</td><td>0.336</td><td>0.816</td><td>1.000</td><td>2018</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>677</td><td>RODWELL_AGING_KIDNEY_UP</td><td></td><td>325</td><td>-0.23</td><td>-1.06</td><td>0.269</td><td>0.815</td><td>1.000</td><td>1305</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>678</td><td>POOLA_INVASIVE_BREAST_CANCER_DN</td><td></td><td>64</td><td>-0.29</td><td>-1.06</td><td>0.362</td><td>0.815</td><td>1.000</td><td>2210</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>679</td><td>PID_P38_MKK3_6PATHWAY</td><td></td><td>25</td><td>-0.35</td><td>-1.06</td><td>0.382</td><td>0.813</td><td>1.000</td><td>1974</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>680</td><td>REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA</td><td></td><td>20</td><td>-0.38</td><td>-1.06</td><td>0.388</td><td>0.813</td><td>1.000</td><td>1195</td><td>tags=20%, list=10%, signal=22%</td></tr><tr><td class='lessen'>681</td><td>PID_TCR_PATHWAY</td><td></td><td>56</td><td>-0.30</td><td>-1.06</td><td>0.348</td><td>0.812</td><td>1.000</td><td>1887</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>682</td><td>LIU_VMYB_TARGETS_UP</td><td></td><td>95</td><td>-0.27</td><td>-1.06</td><td>0.333</td><td>0.813</td><td>1.000</td><td>2696</td><td>tags=29%, list=23%, signal=38%</td></tr><tr><td class='lessen'>683</td><td>BURTON_ADIPOGENESIS_2</td><td></td><td>57</td><td>-0.30</td><td>-1.06</td><td>0.344</td><td>0.816</td><td>1.000</td><td>1818</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>684</td><td>YAGI_AML_WITH_T_9_11_TRANSLOCATION</td><td></td><td>98</td><td>-0.28</td><td>-1.06</td><td>0.360</td><td>0.815</td><td>1.000</td><td>2605</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>685</td><td>REACTOME_ELONGATION_ARREST_AND_RECOVERY</td><td></td><td>27</td><td>-0.35</td><td>-1.06</td><td>0.374</td><td>0.813</td><td>1.000</td><td>40</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>686</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN</td><td></td><td>20</td><td>-0.38</td><td>-1.06</td><td>0.369</td><td>0.814</td><td>1.000</td><td>1915</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>687</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td><td></td><td>15</td><td>-0.40</td><td>-1.06</td><td>0.397</td><td>0.813</td><td>1.000</td><td>229</td><td>tags=13%, list=2%, signal=14%</td></tr><tr><td class='lessen'>688</td><td>FRASOR_RESPONSE_TO_ESTRADIOL_DN</td><td></td><td>55</td><td>-0.30</td><td>-1.06</td><td>0.378</td><td>0.817</td><td>1.000</td><td>2511</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>689</td><td>IVANOVA_HEMATOPOIESIS_MATURE_CELL</td><td></td><td>212</td><td>-0.25</td><td>-1.06</td><td>0.325</td><td>0.817</td><td>1.000</td><td>2671</td><td>tags=27%, list=23%, signal=34%</td></tr><tr><td class='lessen'>690</td><td>RAMALHO_STEMNESS_DN</td><td></td><td>48</td><td>-0.31</td><td>-1.06</td><td>0.358</td><td>0.816</td><td>1.000</td><td>2080</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>691</td><td>PID_P53_DOWNSTREAM_PATHWAY</td><td></td><td>106</td><td>-0.27</td><td>-1.06</td><td>0.335</td><td>0.816</td><td>1.000</td><td>1137</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>692</td><td>REACTOME_L1CAM_INTERACTIONS</td><td></td><td>50</td><td>-0.31</td><td>-1.06</td><td>0.369</td><td>0.815</td><td>1.000</td><td>1851</td><td>tags=30%, list=16%, signal=36%</td></tr><tr><td class='lessen'>693</td><td>REACTOME_GLYCOSPHINGOLIPID_METABOLISM</td><td></td><td>22</td><td>-0.37</td><td>-1.06</td><td>0.380</td><td>0.815</td><td>1.000</td><td>947</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>694</td><td>REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1</td><td></td><td>17</td><td>-0.39</td><td>-1.06</td><td>0.396</td><td>0.815</td><td>1.000</td><td>562</td><td>tags=12%, list=5%, signal=12%</td></tr><tr><td class='lessen'>695</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>55</td><td>-0.30</td><td>-1.06</td><td>0.358</td><td>0.814</td><td>1.000</td><td>1207</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>696</td><td>PID_E2F_PATHWAY</td><td></td><td>65</td><td>-0.29</td><td>-1.05</td><td>0.344</td><td>0.817</td><td>1.000</td><td>2579</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>697</td><td>PID_FOXO_PATHWAY</td><td></td><td>45</td><td>-0.32</td><td>-1.05</td><td>0.359</td><td>0.818</td><td>1.000</td><td>269</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>698</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>366</td><td>-0.23</td><td>-1.05</td><td>0.306</td><td>0.818</td><td>1.000</td><td>1869</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>699</td><td>MATTIOLI_MGUS_VS_PCL</td><td></td><td>88</td><td>-0.28</td><td>-1.05</td><td>0.361</td><td>0.818</td><td>1.000</td><td>2455</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>700</td><td>KAUFFMANN_MELANOMA_RELAPSE_UP</td><td></td><td>56</td><td>-0.30</td><td>-1.05</td><td>0.367</td><td>0.818</td><td>1.000</td><td>1714</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>701</td><td>KENNY_CTNNB1_TARGETS_UP</td><td></td><td>33</td><td>-0.34</td><td>-1.05</td><td>0.389</td><td>0.816</td><td>1.000</td><td>1812</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>702</td><td>MARTIN_INTERACT_WITH_HDAC</td><td></td><td>33</td><td>-0.33</td><td>-1.05</td><td>0.373</td><td>0.816</td><td>1.000</td><td>507</td><td>tags=15%, list=4%, signal=16%</td></tr><tr><td class='lessen'>703</td><td>MAHAJAN_RESPONSE_TO_IL1A_UP</td><td></td><td>51</td><td>-0.31</td><td>-1.05</td><td>0.373</td><td>0.816</td><td>1.000</td><td>1543</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>704</td><td>WANG_HCP_PROSTATE_CANCER</td><td></td><td>87</td><td>-0.28</td><td>-1.05</td><td>0.354</td><td>0.816</td><td>1.000</td><td>2000</td><td>tags=20%, list=17%, signal=23%</td></tr><tr><td class='lessen'>705</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>29</td><td>-0.34</td><td>-1.05</td><td>0.387</td><td>0.816</td><td>1.000</td><td>1099</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>706</td><td>KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS</td><td></td><td>74</td><td>-0.28</td><td>-1.05</td><td>0.362</td><td>0.816</td><td>1.000</td><td>2232</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>707</td><td>BIOCARTA_NTHI_PATHWAY</td><td></td><td>21</td><td>-0.37</td><td>-1.05</td><td>0.396</td><td>0.816</td><td>1.000</td><td>2063</td><td>tags=33%, list=18%, signal=40%</td></tr><tr><td class='lessen'>708</td><td>REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION</td><td></td><td>16</td><td>-0.39</td><td>-1.05</td><td>0.395</td><td>0.817</td><td>1.000</td><td>1887</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>709</td><td>ONDER_CDH1_TARGETS_1_DN</td><td></td><td>115</td><td>-0.26</td><td>-1.05</td><td>0.328</td><td>0.818</td><td>1.000</td><td>2104</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>710</td><td>REACTOME_CELL_CYCLE_CHECKPOINTS</td><td></td><td>104</td><td>-0.27</td><td>-1.05</td><td>0.352</td><td>0.817</td><td>1.000</td><td>1974</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>711</td><td>VARELA_ZMPSTE24_TARGETS_UP</td><td></td><td>32</td><td>-0.34</td><td>-1.05</td><td>0.366</td><td>0.820</td><td>1.000</td><td>2146</td><td>tags=34%, list=19%, signal=42%</td></tr><tr><td class='lessen'>712</td><td>KEGG_FOCAL_ADHESION</td><td></td><td>115</td><td>-0.27</td><td>-1.05</td><td>0.357</td><td>0.822</td><td>1.000</td><td>2210</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>713</td><td>FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>463</td><td>-0.23</td><td>-1.05</td><td>0.290</td><td>0.821</td><td>1.000</td><td>2682</td><td>tags=28%, list=23%, signal=35%</td></tr><tr><td class='lessen'>714</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_DN</td><td></td><td>22</td><td>-0.37</td><td>-1.05</td><td>0.368</td><td>0.820</td><td>1.000</td><td>1322</td><td>tags=27%, list=11%, signal=31%</td></tr><tr><td class='lessen'>715</td><td>HUANG_GATA2_TARGETS_UP</td><td></td><td>122</td><td>-0.26</td><td>-1.05</td><td>0.352</td><td>0.820</td><td>1.000</td><td>1702</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>716</td><td>ENGELMANN_CANCER_PROGENITORS_UP</td><td></td><td>33</td><td>-0.33</td><td>-1.05</td><td>0.390</td><td>0.819</td><td>1.000</td><td>957</td><td>tags=18%, list=8%, signal=20%</td></tr><tr><td class='lessen'>717</td><td>KATSANOU_ELAVL1_TARGETS_DN</td><td></td><td>90</td><td>-0.27</td><td>-1.05</td><td>0.361</td><td>0.819</td><td>1.000</td><td>2772</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>718</td><td>KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>50</td><td>-0.31</td><td>-1.05</td><td>0.369</td><td>0.820</td><td>1.000</td><td>1894</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>719</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>191</td><td>-0.24</td><td>-1.05</td><td>0.327</td><td>0.821</td><td>1.000</td><td>1223</td><td>tags=14%, list=11%, signal=15%</td></tr><tr><td class='lessen'>720</td><td>REACTOME_CELL_CYCLE_MITOTIC</td><td></td><td>285</td><td>-0.23</td><td>-1.05</td><td>0.327</td><td>0.821</td><td>1.000</td><td>1902</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>721</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>428</td><td>-0.23</td><td>-1.05</td><td>0.313</td><td>0.821</td><td>1.000</td><td>2330</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>722</td><td>TAVAZOIE_METASTASIS</td><td></td><td>51</td><td>-0.31</td><td>-1.05</td><td>0.365</td><td>0.820</td><td>1.000</td><td>2609</td><td>tags=29%, list=23%, signal=38%</td></tr><tr><td class='lessen'>723</td><td>BIOCARTA_IL6_PATHWAY</td><td></td><td>21</td><td>-0.36</td><td>-1.04</td><td>0.396</td><td>0.820</td><td>1.000</td><td>1822</td><td>tags=38%, list=16%, signal=45%</td></tr><tr><td class='lessen'>724</td><td>PID_PDGFRB_PATHWAY</td><td></td><td>114</td><td>-0.26</td><td>-1.04</td><td>0.361</td><td>0.819</td><td>1.000</td><td>1777</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>725</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>138</td><td>-0.26</td><td>-1.04</td><td>0.372</td><td>0.822</td><td>1.000</td><td>1558</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>726</td><td>REACTOME_DOUBLE_STRAND_BREAK_REPAIR</td><td></td><td>19</td><td>-0.38</td><td>-1.04</td><td>0.394</td><td>0.821</td><td>1.000</td><td>2549</td><td>tags=47%, list=22%, signal=61%</td></tr><tr><td class='lessen'>727</td><td>MEDINA_SMARCA4_TARGETS</td><td></td><td>28</td><td>-0.34</td><td>-1.04</td><td>0.382</td><td>0.821</td><td>1.000</td><td>1091</td><td>tags=18%, list=9%, signal=20%</td></tr><tr><td class='lessen'>728</td><td>LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP</td><td></td><td>142</td><td>-0.25</td><td>-1.04</td><td>0.349</td><td>0.820</td><td>1.000</td><td>2043</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>729</td><td>ELLWOOD_MYC_TARGETS_DN</td><td></td><td>29</td><td>-0.34</td><td>-1.04</td><td>0.384</td><td>0.821</td><td>1.000</td><td>1671</td><td>tags=28%, list=14%, signal=32%</td></tr><tr><td class='lessen'>730</td><td>HOOI_ST7_TARGETS_UP</td><td></td><td>51</td><td>-0.30</td><td>-1.04</td><td>0.364</td><td>0.821</td><td>1.000</td><td>850</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>731</td><td>IKEDA_MIR133_TARGETS_UP</td><td></td><td>38</td><td>-0.33</td><td>-1.04</td><td>0.410</td><td>0.823</td><td>1.000</td><td>776</td><td>tags=11%, list=7%, signal=11%</td></tr><tr><td class='lessen'>732</td><td>REACTOME_MICRORNA_MIRNA_BIOGENESIS</td><td></td><td>18</td><td>-0.38</td><td>-1.04</td><td>0.413</td><td>0.824</td><td>1.000</td><td>18</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>733</td><td>KANG_DOXORUBICIN_RESISTANCE_DN</td><td></td><td>17</td><td>-0.39</td><td>-1.04</td><td>0.389</td><td>0.828</td><td>1.000</td><td>1987</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>734</td><td>LEE_LIVER_CANCER_SURVIVAL_UP</td><td></td><td>82</td><td>-0.28</td><td>-1.04</td><td>0.376</td><td>0.828</td><td>1.000</td><td>2043</td><td>tags=26%, list=18%, signal=31%</td></tr><tr><td class='lessen'>735</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td><td></td><td>92</td><td>-0.27</td><td>-1.04</td><td>0.382</td><td>0.827</td><td>1.000</td><td>3251</td><td>tags=33%, list=28%, signal=45%</td></tr><tr><td class='lessen'>736</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>99</td><td>-0.27</td><td>-1.04</td><td>0.364</td><td>0.827</td><td>1.000</td><td>1129</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>737</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>108</td><td>-0.26</td><td>-1.04</td><td>0.358</td><td>0.826</td><td>1.000</td><td>2348</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>738</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td><td></td><td>150</td><td>-0.25</td><td>-1.04</td><td>0.383</td><td>0.826</td><td>1.000</td><td>1991</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>739</td><td>REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE</td><td></td><td>28</td><td>-0.34</td><td>-1.04</td><td>0.384</td><td>0.828</td><td>1.000</td><td>3001</td><td>tags=39%, list=26%, signal=53%</td></tr><tr><td class='lessen'>740</td><td>HOELZEL_NF1_TARGETS_UP</td><td></td><td>75</td><td>-0.28</td><td>-1.04</td><td>0.372</td><td>0.827</td><td>1.000</td><td>628</td><td>tags=12%, list=5%, signal=13%</td></tr><tr><td class='lessen'>741</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>351</td><td>-0.23</td><td>-1.04</td><td>0.348</td><td>0.826</td><td>1.000</td><td>1987</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>742</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_UP</td><td></td><td>28</td><td>-0.34</td><td>-1.04</td><td>0.404</td><td>0.830</td><td>1.000</td><td>1623</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>743</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>369</td><td>-0.23</td><td>-1.04</td><td>0.340</td><td>0.829</td><td>1.000</td><td>1872</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>744</td><td>YE_METASTATIC_LIVER_CANCER</td><td></td><td>15</td><td>-0.39</td><td>-1.04</td><td>0.398</td><td>0.828</td><td>1.000</td><td>1473</td><td>tags=40%, list=13%, signal=46%</td></tr><tr><td class='lessen'>745</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>54</td><td>-0.29</td><td>-1.04</td><td>0.399</td><td>0.829</td><td>1.000</td><td>1161</td><td>tags=17%, list=10%, signal=18%</td></tr><tr><td class='lessen'>746</td><td>REACTOME_DNA_STRAND_ELONGATION</td><td></td><td>29</td><td>-0.33</td><td>-1.03</td><td>0.410</td><td>0.831</td><td>1.000</td><td>3606</td><td>tags=48%, list=31%, signal=70%</td></tr><tr><td class='lessen'>747</td><td>WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN</td><td></td><td>40</td><td>-0.31</td><td>-1.03</td><td>0.390</td><td>0.831</td><td>1.000</td><td>2039</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>748</td><td>SAGIV_CD24_TARGETS_UP</td><td></td><td>15</td><td>-0.40</td><td>-1.03</td><td>0.410</td><td>0.831</td><td>1.000</td><td>3616</td><td>tags=47%, list=31%, signal=68%</td></tr><tr><td class='lessen'>749</td><td>BROWNE_HCMV_INFECTION_48HR_DN</td><td></td><td>318</td><td>-0.23</td><td>-1.03</td><td>0.339</td><td>0.831</td><td>1.000</td><td>2556</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>750</td><td>LUI_THYROID_CANCER_CLUSTER_1</td><td></td><td>40</td><td>-0.32</td><td>-1.03</td><td>0.424</td><td>0.831</td><td>1.000</td><td>2634</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>751</td><td>RIZKI_TUMOR_INVASIVENESS_2D_UP</td><td></td><td>51</td><td>-0.30</td><td>-1.03</td><td>0.368</td><td>0.831</td><td>1.000</td><td>2397</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>752</td><td>REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES</td><td></td><td>57</td><td>-0.30</td><td>-1.03</td><td>0.419</td><td>0.830</td><td>1.000</td><td>2202</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>753</td><td>SU_THYMUS</td><td></td><td>16</td><td>-0.39</td><td>-1.03</td><td>0.408</td><td>0.830</td><td>1.000</td><td>2696</td><td>tags=50%, list=23%, signal=65%</td></tr><tr><td class='lessen'>754</td><td>REACTOME_RNA_POL_I_PROMOTER_OPENING</td><td></td><td>50</td><td>-0.30</td><td>-1.03</td><td>0.391</td><td>0.831</td><td>1.000</td><td>1915</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>755</td><td>REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM</td><td></td><td>26</td><td>-0.34</td><td>-1.03</td><td>0.399</td><td>0.830</td><td>1.000</td><td>2610</td><td>tags=23%, list=23%, signal=30%</td></tr><tr><td class='lessen'>756</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>424</td><td>-0.22</td><td>-1.03</td><td>0.345</td><td>0.829</td><td>1.000</td><td>1627</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>757</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>242</td><td>-0.24</td><td>-1.03</td><td>0.355</td><td>0.829</td><td>1.000</td><td>2203</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>758</td><td>PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP</td><td></td><td>97</td><td>-0.27</td><td>-1.03</td><td>0.397</td><td>0.831</td><td>1.000</td><td>2587</td><td>tags=28%, list=22%, signal=36%</td></tr><tr><td class='lessen'>759</td><td>ST_JNK_MAPK_PATHWAY</td><td></td><td>35</td><td>-0.32</td><td>-1.03</td><td>0.429</td><td>0.830</td><td>1.000</td><td>1887</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>760</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP</td><td></td><td>176</td><td>-0.25</td><td>-1.03</td><td>0.367</td><td>0.829</td><td>1.000</td><td>2306</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>761</td><td>JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN</td><td></td><td>36</td><td>-0.32</td><td>-1.03</td><td>0.411</td><td>0.828</td><td>1.000</td><td>1810</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>762</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP</td><td></td><td>93</td><td>-0.27</td><td>-1.03</td><td>0.385</td><td>0.827</td><td>1.000</td><td>2802</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>763</td><td>BIOCARTA_TOLL_PATHWAY</td><td></td><td>33</td><td>-0.32</td><td>-1.03</td><td>0.412</td><td>0.827</td><td>1.000</td><td>1887</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>764</td><td>DOANE_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>114</td><td>-0.26</td><td>-1.03</td><td>0.395</td><td>0.827</td><td>1.000</td><td>2089</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>765</td><td>REACTOME_TELOMERE_MAINTENANCE</td><td></td><td>64</td><td>-0.29</td><td>-1.03</td><td>0.400</td><td>0.828</td><td>1.000</td><td>1966</td><td>tags=27%, list=17%, signal=32%</td></tr><tr><td class='lessen'>766</td><td>WILCOX_RESPONSE_TO_PROGESTERONE_DN</td><td></td><td>29</td><td>-0.33</td><td>-1.03</td><td>0.420</td><td>0.832</td><td>1.000</td><td>2695</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>767</td><td>KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN</td><td></td><td>162</td><td>-0.25</td><td>-1.03</td><td>0.383</td><td>0.832</td><td>1.000</td><td>2475</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>768</td><td>BARRIER_COLON_CANCER_RECURRENCE_UP</td><td></td><td>36</td><td>-0.32</td><td>-1.03</td><td>0.442</td><td>0.836</td><td>1.000</td><td>407</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>769</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN</td><td></td><td>18</td><td>-0.37</td><td>-1.03</td><td>0.434</td><td>0.836</td><td>1.000</td><td>1943</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>770</td><td>MCCLUNG_COCAINE_REWARD_5D</td><td></td><td>52</td><td>-0.30</td><td>-1.03</td><td>0.411</td><td>0.836</td><td>1.000</td><td>1526</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>771</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>104</td><td>-0.26</td><td>-1.03</td><td>0.399</td><td>0.837</td><td>1.000</td><td>2397</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>772</td><td>ZHAN_MULTIPLE_MYELOMA_MF_DN</td><td></td><td>25</td><td>-0.34</td><td>-1.03</td><td>0.426</td><td>0.837</td><td>1.000</td><td>2242</td><td>tags=28%, list=19%, signal=35%</td></tr><tr><td class='lessen'>773</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP</td><td></td><td>34</td><td>-0.32</td><td>-1.02</td><td>0.426</td><td>0.837</td><td>1.000</td><td>2570</td><td>tags=32%, list=22%, signal=41%</td></tr><tr><td class='lessen'>774</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td><td></td><td>19</td><td>-0.37</td><td>-1.02</td><td>0.428</td><td>0.837</td><td>1.000</td><td>578</td><td>tags=11%, list=5%, signal=11%</td></tr><tr><td class='lessen'>775</td><td>REACTOME_INNATE_IMMUNE_SYSTEM</td><td></td><td>170</td><td>-0.24</td><td>-1.02</td><td>0.396</td><td>0.837</td><td>1.000</td><td>2290</td><td>tags=25%, list=20%, signal=30%</td></tr><tr><td class='lessen'>776</td><td>RUAN_RESPONSE_TO_TNF_DN</td><td></td><td>55</td><td>-0.29</td><td>-1.02</td><td>0.415</td><td>0.838</td><td>1.000</td><td>1293</td><td>tags=22%, list=11%, signal=24%</td></tr><tr><td class='lessen'>777</td><td>KEGG_INSULIN_SIGNALING_PATHWAY</td><td></td><td>100</td><td>-0.27</td><td>-1.02</td><td>0.401</td><td>0.840</td><td>1.000</td><td>1317</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>778</td><td>REACTOME_REGULATORY_RNA_PATHWAYS</td><td></td><td>20</td><td>-0.36</td><td>-1.02</td><td>0.437</td><td>0.839</td><td>1.000</td><td>18</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>779</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>42</td><td>-0.30</td><td>-1.02</td><td>0.428</td><td>0.840</td><td>1.000</td><td>2039</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>780</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td><td></td><td>33</td><td>-0.32</td><td>-1.02</td><td>0.408</td><td>0.841</td><td>1.000</td><td>333</td><td>tags=12%, list=3%, signal=12%</td></tr><tr><td class='lessen'>781</td><td>MARTINEZ_TP53_TARGETS_UP</td><td></td><td>416</td><td>-0.22</td><td>-1.02</td><td>0.374</td><td>0.844</td><td>1.000</td><td>1741</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>782</td><td>SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES</td><td></td><td>41</td><td>-0.31</td><td>-1.02</td><td>0.425</td><td>0.844</td><td>1.000</td><td>1262</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>783</td><td>GYORFFY_MITOXANTRONE_RESISTANCE</td><td></td><td>34</td><td>-0.33</td><td>-1.02</td><td>0.414</td><td>0.846</td><td>1.000</td><td>1378</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>784</td><td>BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN</td><td></td><td>17</td><td>-0.38</td><td>-1.02</td><td>0.435</td><td>0.845</td><td>1.000</td><td>1401</td><td>tags=24%, list=12%, signal=27%</td></tr><tr><td class='lessen'>785</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>278</td><td>-0.23</td><td>-1.02</td><td>0.380</td><td>0.846</td><td>1.000</td><td>2178</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>786</td><td>BENPORATH_ES_1</td><td></td><td>271</td><td>-0.23</td><td>-1.02</td><td>0.396</td><td>0.845</td><td>1.000</td><td>2541</td><td>tags=23%, list=22%, signal=28%</td></tr><tr><td class='lessen'>787</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN</td><td></td><td>129</td><td>-0.25</td><td>-1.02</td><td>0.404</td><td>0.845</td><td>1.000</td><td>1293</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>788</td><td>BEIER_GLIOMA_STEM_CELL_UP</td><td></td><td>16</td><td>-0.38</td><td>-1.02</td><td>0.428</td><td>0.844</td><td>1.000</td><td>2270</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>789</td><td>REACTOME_SIGNALING_BY_ERBB2</td><td></td><td>73</td><td>-0.28</td><td>-1.02</td><td>0.417</td><td>0.843</td><td>1.000</td><td>1720</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>790</td><td>GROSS_HYPOXIA_VIA_ELK3_UP</td><td></td><td>171</td><td>-0.24</td><td>-1.02</td><td>0.405</td><td>0.843</td><td>1.000</td><td>2752</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>791</td><td>CAFFAREL_RESPONSE_TO_THC_24HR_5_DN</td><td></td><td>51</td><td>-0.29</td><td>-1.02</td><td>0.427</td><td>0.843</td><td>1.000</td><td>2522</td><td>tags=33%, list=22%, signal=42%</td></tr><tr><td class='lessen'>792</td><td>GOLDRATH_IMMUNE_MEMORY</td><td></td><td>53</td><td>-0.29</td><td>-1.02</td><td>0.408</td><td>0.847</td><td>1.000</td><td>1131</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>793</td><td>TERAO_AOX4_TARGETS_HG_UP</td><td></td><td>23</td><td>-0.34</td><td>-1.02</td><td>0.439</td><td>0.846</td><td>1.000</td><td>1218</td><td>tags=26%, list=11%, signal=29%</td></tr><tr><td class='lessen'>794</td><td>VALK_AML_CLUSTER_10</td><td></td><td>21</td><td>-0.36</td><td>-1.02</td><td>0.424</td><td>0.847</td><td>1.000</td><td>1646</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>795</td><td>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</td><td></td><td>22</td><td>-0.36</td><td>-1.02</td><td>0.467</td><td>0.847</td><td>1.000</td><td>1479</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>796</td><td>REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP</td><td></td><td>17</td><td>-0.38</td><td>-1.01</td><td>0.457</td><td>0.847</td><td>1.000</td><td>2541</td><td>tags=29%, list=22%, signal=38%</td></tr><tr><td class='lessen'>797</td><td>FERRANDO_HOX11_NEIGHBORS</td><td></td><td>16</td><td>-0.38</td><td>-1.01</td><td>0.430</td><td>0.848</td><td>1.000</td><td>4049</td><td>tags=50%, list=35%, signal=77%</td></tr><tr><td class='lessen'>798</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_UP</td><td></td><td>24</td><td>-0.35</td><td>-1.01</td><td>0.435</td><td>0.848</td><td>1.000</td><td>115</td><td>tags=8%, list=1%, signal=8%</td></tr><tr><td class='lessen'>799</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>339</td><td>-0.22</td><td>-1.01</td><td>0.414</td><td>0.848</td><td>1.000</td><td>1721</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>800</td><td>LABBE_TGFB1_TARGETS_UP</td><td></td><td>57</td><td>-0.28</td><td>-1.01</td><td>0.414</td><td>0.847</td><td>1.000</td><td>2701</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>801</td><td>RIZ_ERYTHROID_DIFFERENTIATION_6HR</td><td></td><td>19</td><td>-0.36</td><td>-1.01</td><td>0.439</td><td>0.846</td><td>1.000</td><td>1244</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>802</td><td>WANG_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>21</td><td>-0.36</td><td>-1.01</td><td>0.456</td><td>0.847</td><td>1.000</td><td>2219</td><td>tags=43%, list=19%, signal=53%</td></tr><tr><td class='lessen'>803</td><td>BIOCARTA_HIVNEF_PATHWAY</td><td></td><td>56</td><td>-0.29</td><td>-1.01</td><td>0.442</td><td>0.847</td><td>1.000</td><td>1755</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>804</td><td>BIDUS_METASTASIS_UP</td><td></td><td>188</td><td>-0.24</td><td>-1.01</td><td>0.400</td><td>0.848</td><td>1.000</td><td>1619</td><td>tags=19%, list=14%, signal=21%</td></tr><tr><td class='lessen'>805</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D</td><td></td><td>151</td><td>-0.24</td><td>-1.01</td><td>0.422</td><td>0.848</td><td>1.000</td><td>2011</td><td>tags=25%, list=17%, signal=29%</td></tr><tr><td class='lessen'>806</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP</td><td></td><td>43</td><td>-0.30</td><td>-1.01</td><td>0.422</td><td>0.848</td><td>1.000</td><td>2216</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>807</td><td>REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE</td><td></td><td>50</td><td>-0.29</td><td>-1.01</td><td>0.443</td><td>0.849</td><td>1.000</td><td>2973</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>808</td><td>SCHEIDEREIT_IKK_INTERACTING_PROTEINS</td><td></td><td>51</td><td>-0.30</td><td>-1.01</td><td>0.421</td><td>0.850</td><td>1.000</td><td>1974</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>809</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>301</td><td>-0.22</td><td>-1.01</td><td>0.404</td><td>0.851</td><td>1.000</td><td>2048</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>810</td><td>REACTOME_PI3K_CASCADE</td><td></td><td>47</td><td>-0.30</td><td>-1.01</td><td>0.421</td><td>0.853</td><td>1.000</td><td>2004</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>811</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>372</td><td>-0.22</td><td>-1.01</td><td>0.443</td><td>0.854</td><td>1.000</td><td>3242</td><td>tags=33%, list=28%, signal=44%</td></tr><tr><td class='lessen'>812</td><td>DOANE_BREAST_CANCER_ESR1_DN</td><td></td><td>15</td><td>-0.39</td><td>-1.01</td><td>0.451</td><td>0.853</td><td>1.000</td><td>2468</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>813</td><td>GUO_HEX_TARGETS_UP</td><td></td><td>57</td><td>-0.29</td><td>-1.01</td><td>0.451</td><td>0.853</td><td>1.000</td><td>2510</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>814</td><td>PID_MET_PATHWAY</td><td></td><td>71</td><td>-0.27</td><td>-1.01</td><td>0.429</td><td>0.853</td><td>1.000</td><td>1892</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>815</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2</td><td></td><td>109</td><td>-0.25</td><td>-1.01</td><td>0.416</td><td>0.856</td><td>1.000</td><td>2348</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>816</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>325</td><td>-0.22</td><td>-1.01</td><td>0.415</td><td>0.857</td><td>1.000</td><td>2008</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>817</td><td>JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP</td><td></td><td>50</td><td>-0.29</td><td>-1.01</td><td>0.440</td><td>0.859</td><td>1.000</td><td>1558</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>818</td><td>KEGG_REGULATION_OF_ACTIN_CYTOSKELETON</td><td></td><td>138</td><td>-0.24</td><td>-1.01</td><td>0.447</td><td>0.858</td><td>1.000</td><td>2269</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>819</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP</td><td></td><td>153</td><td>-0.24</td><td>-1.01</td><td>0.431</td><td>0.857</td><td>1.000</td><td>2337</td><td>tags=25%, list=20%, signal=32%</td></tr><tr><td class='lessen'>820</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>310</td><td>-0.22</td><td>-1.00</td><td>0.449</td><td>0.857</td><td>1.000</td><td>2060</td><td>tags=20%, list=18%, signal=23%</td></tr><tr><td class='lessen'>821</td><td>KEEN_RESPONSE_TO_ROSIGLITAZONE_UP</td><td></td><td>28</td><td>-0.33</td><td>-1.00</td><td>0.446</td><td>0.857</td><td>1.000</td><td>3496</td><td>tags=32%, list=30%, signal=46%</td></tr><tr><td class='lessen'>822</td><td>PID_CASPASE_PATHWAY</td><td></td><td>46</td><td>-0.30</td><td>-1.00</td><td>0.453</td><td>0.857</td><td>1.000</td><td>2657</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>823</td><td>REACTOME_SIGNALING_BY_PDGF</td><td></td><td>79</td><td>-0.27</td><td>-1.00</td><td>0.452</td><td>0.858</td><td>1.000</td><td>1730</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>824</td><td>CHEBOTAEV_GR_TARGETS_UP</td><td></td><td>44</td><td>-0.30</td><td>-1.00</td><td>0.437</td><td>0.857</td><td>1.000</td><td>2948</td><td>tags=36%, list=25%, signal=49%</td></tr><tr><td class='lessen'>825</td><td>LIU_SOX4_TARGETS_DN</td><td></td><td>259</td><td>-0.23</td><td>-1.00</td><td>0.418</td><td>0.858</td><td>1.000</td><td>2419</td><td>tags=22%, list=21%, signal=27%</td></tr><tr><td class='lessen'>826</td><td>KORKOLA_SEMINOMA_UP</td><td></td><td>33</td><td>-0.32</td><td>-1.00</td><td>0.432</td><td>0.860</td><td>1.000</td><td>2759</td><td>tags=27%, list=24%, signal=36%</td></tr><tr><td class='lessen'>827</td><td>KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS</td><td></td><td>31</td><td>-0.33</td><td>-1.00</td><td>0.457</td><td>0.859</td><td>1.000</td><td>2575</td><td>tags=42%, list=22%, signal=54%</td></tr><tr><td class='lessen'>828</td><td>NOJIMA_SFRP2_TARGETS_DN</td><td></td><td>19</td><td>-0.36</td><td>-1.00</td><td>0.475</td><td>0.860</td><td>1.000</td><td>1218</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>829</td><td>BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN</td><td></td><td>33</td><td>-0.32</td><td>-1.00</td><td>0.447</td><td>0.862</td><td>1.000</td><td>2333</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>830</td><td>REACTOME_SIGNALING_BY_ERBB4</td><td></td><td>66</td><td>-0.27</td><td>-1.00</td><td>0.441</td><td>0.861</td><td>1.000</td><td>1826</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>831</td><td>KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES</td><td></td><td>168</td><td>-0.24</td><td>-1.00</td><td>0.472</td><td>0.861</td><td>1.000</td><td>2332</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>832</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_DN</td><td></td><td>101</td><td>-0.25</td><td>-1.00</td><td>0.467</td><td>0.860</td><td>1.000</td><td>1258</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>833</td><td>CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN</td><td></td><td>96</td><td>-0.26</td><td>-1.00</td><td>0.450</td><td>0.859</td><td>1.000</td><td>2351</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>834</td><td>KOYAMA_SEMA3B_TARGETS_UP</td><td></td><td>174</td><td>-0.23</td><td>-1.00</td><td>0.447</td><td>0.860</td><td>1.000</td><td>2715</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>835</td><td>SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP</td><td></td><td>18</td><td>-0.36</td><td>-1.00</td><td>0.451</td><td>0.859</td><td>1.000</td><td>2107</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>836</td><td>LIANG_SILENCED_BY_METHYLATION_UP</td><td></td><td>15</td><td>-0.38</td><td>-1.00</td><td>0.469</td><td>0.859</td><td>1.000</td><td>25</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>837</td><td>HASLINGER_B_CLL_WITH_6Q21_DELETION</td><td></td><td>16</td><td>-0.37</td><td>-1.00</td><td>0.446</td><td>0.859</td><td>1.000</td><td>467</td><td>tags=19%, list=4%, signal=20%</td></tr><tr><td class='lessen'>838</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>184</td><td>-0.24</td><td>-1.00</td><td>0.463</td><td>0.858</td><td>1.000</td><td>1906</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>839</td><td>WANG_RESPONSE_TO_BEXAROTENE_DN</td><td></td><td>18</td><td>-0.37</td><td>-1.00</td><td>0.467</td><td>0.857</td><td>1.000</td><td>1491</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>840</td><td>YANG_BREAST_CANCER_ESR1_DN</td><td></td><td>15</td><td>-0.39</td><td>-1.00</td><td>0.466</td><td>0.856</td><td>1.000</td><td>1711</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>841</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>230</td><td>-0.23</td><td>-1.00</td><td>0.442</td><td>0.856</td><td>1.000</td><td>1572</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>842</td><td>PID_CD8_TCR_DOWNSTREAM_PATHWAY</td><td></td><td>43</td><td>-0.30</td><td>-1.00</td><td>0.445</td><td>0.857</td><td>1.000</td><td>1525</td><td>tags=26%, list=13%, signal=29%</td></tr><tr><td class='lessen'>843</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td><td></td><td>27</td><td>-0.33</td><td>-1.00</td><td>0.438</td><td>0.857</td><td>1.000</td><td>2432</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>844</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>143</td><td>-0.24</td><td>-1.00</td><td>0.469</td><td>0.857</td><td>1.000</td><td>2794</td><td>tags=31%, list=24%, signal=40%</td></tr><tr><td class='lessen'>845</td><td>PID_IL8_CXCR1_PATHWAY</td><td></td><td>20</td><td>-0.35</td><td>-1.00</td><td>0.468</td><td>0.857</td><td>1.000</td><td>957</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>846</td><td>BASAKI_YBX1_TARGETS_DN</td><td></td><td>291</td><td>-0.22</td><td>-1.00</td><td>0.443</td><td>0.858</td><td>1.000</td><td>3026</td><td>tags=31%, list=26%, signal=40%</td></tr><tr><td class='lessen'>847</td><td>DELASERNA_MYOD_TARGETS_UP</td><td></td><td>54</td><td>-0.28</td><td>-1.00</td><td>0.460</td><td>0.857</td><td>1.000</td><td>1827</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>848</td><td>IKEDA_MIR1_TARGETS_UP</td><td></td><td>47</td><td>-0.29</td><td>-1.00</td><td>0.474</td><td>0.858</td><td>1.000</td><td>1401</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>849</td><td>ZHOU_INFLAMMATORY_RESPONSE_LPS_UP</td><td></td><td>200</td><td>-0.23</td><td>-1.00</td><td>0.460</td><td>0.858</td><td>1.000</td><td>2276</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>850</td><td>PID_AMB2_NEUTROPHILS_PATHWAY</td><td></td><td>30</td><td>-0.32</td><td>-1.00</td><td>0.459</td><td>0.857</td><td>1.000</td><td>2149</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>851</td><td>GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP</td><td></td><td>60</td><td>-0.28</td><td>-1.00</td><td>0.454</td><td>0.857</td><td>1.000</td><td>1739</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>852</td><td>ZHAN_MULTIPLE_MYELOMA_SUBGROUPS</td><td></td><td>29</td><td>-0.32</td><td>-1.00</td><td>0.450</td><td>0.856</td><td>1.000</td><td>2549</td><td>tags=31%, list=22%, signal=40%</td></tr><tr><td class='lessen'>853</td><td>MARZEC_IL2_SIGNALING_DN</td><td></td><td>28</td><td>-0.33</td><td>-0.99</td><td>0.453</td><td>0.859</td><td>1.000</td><td>3299</td><td>tags=46%, list=28%, signal=65%</td></tr><tr><td class='lessen'>854</td><td>PID_HIF1A_PATHWAY</td><td></td><td>17</td><td>-0.37</td><td>-0.99</td><td>0.475</td><td>0.859</td><td>1.000</td><td>2238</td><td>tags=35%, list=19%, signal=44%</td></tr><tr><td class='lessen'>855</td><td>MAYBURD_RESPONSE_TO_L663536_UP</td><td></td><td>21</td><td>-0.35</td><td>-0.99</td><td>0.428</td><td>0.859</td><td>1.000</td><td>4727</td><td>tags=57%, list=41%, signal=96%</td></tr><tr><td class='lessen'>856</td><td>WOOD_EBV_EBNA1_TARGETS_DN</td><td></td><td>35</td><td>-0.31</td><td>-0.99</td><td>0.466</td><td>0.861</td><td>1.000</td><td>1216</td><td>tags=23%, list=11%, signal=25%</td></tr><tr><td class='lessen'>857</td><td>REACTOME_CTLA4_INHIBITORY_SIGNALING</td><td></td><td>19</td><td>-0.35</td><td>-0.99</td><td>0.481</td><td>0.861</td><td>1.000</td><td>2675</td><td>tags=37%, list=23%, signal=48%</td></tr><tr><td class='lessen'>858</td><td>MARTINEZ_RB1_TARGETS_UP</td><td></td><td>461</td><td>-0.21</td><td>-0.99</td><td>0.493</td><td>0.864</td><td>1.000</td><td>2178</td><td>tags=22%, list=19%, signal=26%</td></tr><tr><td class='lessen'>859</td><td>NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON</td><td></td><td>32</td><td>-0.31</td><td>-0.99</td><td>0.488</td><td>0.864</td><td>1.000</td><td>411</td><td>tags=13%, list=4%, signal=13%</td></tr><tr><td class='lessen'>860</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3</td><td></td><td>38</td><td>-0.30</td><td>-0.99</td><td>0.476</td><td>0.865</td><td>1.000</td><td>1790</td><td>tags=18%, list=15%, signal=22%</td></tr><tr><td class='lessen'>861</td><td>KONDO_PROSTATE_CANCER_WITH_H3K27ME3</td><td></td><td>47</td><td>-0.29</td><td>-0.99</td><td>0.443</td><td>0.864</td><td>1.000</td><td>2013</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>862</td><td>BAKKER_FOXO3_TARGETS_UP</td><td></td><td>47</td><td>-0.29</td><td>-0.99</td><td>0.470</td><td>0.863</td><td>1.000</td><td>1810</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>863</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>250</td><td>-0.22</td><td>-0.99</td><td>0.489</td><td>0.864</td><td>1.000</td><td>3136</td><td>tags=31%, list=27%, signal=41%</td></tr><tr><td class='lessen'>864</td><td>GENTILE_UV_LOW_DOSE_DN</td><td></td><td>46</td><td>-0.29</td><td>-0.99</td><td>0.442</td><td>0.865</td><td>1.000</td><td>2125</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>865</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td><td></td><td>168</td><td>-0.23</td><td>-0.99</td><td>0.493</td><td>0.867</td><td>1.000</td><td>2752</td><td>tags=25%, list=24%, signal=32%</td></tr><tr><td class='lessen'>866</td><td>BIOCARTA_ETS_PATHWAY</td><td></td><td>16</td><td>-0.37</td><td>-0.99</td><td>0.466</td><td>0.866</td><td>1.000</td><td>1120</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>867</td><td>REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION</td><td></td><td>72</td><td>-0.27</td><td>-0.99</td><td>0.468</td><td>0.867</td><td>1.000</td><td>1730</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>868</td><td>MARKEY_RB1_CHRONIC_LOF_UP</td><td></td><td>78</td><td>-0.27</td><td>-0.99</td><td>0.490</td><td>0.867</td><td>1.000</td><td>2024</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>869</td><td>ELVIDGE_HYPOXIA_BY_DMOG_DN</td><td></td><td>47</td><td>-0.29</td><td>-0.99</td><td>0.501</td><td>0.866</td><td>1.000</td><td>2570</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>870</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>240</td><td>-0.23</td><td>-0.99</td><td>0.502</td><td>0.867</td><td>1.000</td><td>2190</td><td>tags=23%, list=19%, signal=27%</td></tr><tr><td class='lessen'>871</td><td>DAWSON_METHYLATED_IN_LYMPHOMA_TCL1</td><td></td><td>19</td><td>-0.35</td><td>-0.99</td><td>0.479</td><td>0.866</td><td>1.000</td><td>1244</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>872</td><td>REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE</td><td></td><td>44</td><td>-0.30</td><td>-0.99</td><td>0.468</td><td>0.866</td><td>1.000</td><td>2444</td><td>tags=30%, list=21%, signal=37%</td></tr><tr><td class='lessen'>873</td><td>BIOCARTA_TH1TH2_PATHWAY</td><td></td><td>15</td><td>-0.37</td><td>-0.99</td><td>0.473</td><td>0.865</td><td>1.000</td><td>1746</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>874</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td><td></td><td>91</td><td>-0.26</td><td>-0.99</td><td>0.475</td><td>0.864</td><td>1.000</td><td>2449</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>875</td><td>MORI_MATURE_B_LYMPHOCYTE_UP</td><td></td><td>78</td><td>-0.26</td><td>-0.99</td><td>0.489</td><td>0.864</td><td>1.000</td><td>3119</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>876</td><td>DUTTA_APOPTOSIS_VIA_NFKB</td><td></td><td>30</td><td>-0.32</td><td>-0.99</td><td>0.460</td><td>0.863</td><td>1.000</td><td>1755</td><td>tags=27%, list=15%, signal=31%</td></tr><tr><td class='lessen'>877</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>294</td><td>-0.22</td><td>-0.99</td><td>0.508</td><td>0.863</td><td>1.000</td><td>2005</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>878</td><td>NICK_RESPONSE_TO_PROC_TREATMENT_DN</td><td></td><td>22</td><td>-0.34</td><td>-0.99</td><td>0.503</td><td>0.863</td><td>1.000</td><td>1022</td><td>tags=18%, list=9%, signal=20%</td></tr><tr><td class='lessen'>879</td><td>AFFAR_YY1_TARGETS_DN</td><td></td><td>156</td><td>-0.24</td><td>-0.99</td><td>0.478</td><td>0.864</td><td>1.000</td><td>1714</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>880</td><td>GRADE_COLON_CANCER_DN</td><td></td><td>25</td><td>-0.33</td><td>-0.99</td><td>0.473</td><td>0.864</td><td>1.000</td><td>2948</td><td>tags=40%, list=25%, signal=54%</td></tr><tr><td class='lessen'>881</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN</td><td></td><td>195</td><td>-0.23</td><td>-0.99</td><td>0.479</td><td>0.863</td><td>1.000</td><td>2605</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>882</td><td>PID_ERA_GENOMIC_PATHWAY</td><td></td><td>49</td><td>-0.29</td><td>-0.98</td><td>0.486</td><td>0.864</td><td>1.000</td><td>703</td><td>tags=10%, list=6%, signal=11%</td></tr><tr><td class='lessen'>883</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td><td></td><td>180</td><td>-0.24</td><td>-0.98</td><td>0.489</td><td>0.864</td><td>1.000</td><td>2336</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>884</td><td>HU_GENOTOXIC_DAMAGE_4HR</td><td></td><td>34</td><td>-0.31</td><td>-0.98</td><td>0.490</td><td>0.864</td><td>1.000</td><td>1739</td><td>tags=29%, list=15%, signal=35%</td></tr><tr><td class='lessen'>885</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>160</td><td>-0.24</td><td>-0.98</td><td>0.482</td><td>0.863</td><td>1.000</td><td>2887</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>886</td><td>REACTOME_TRANSCRIPTION</td><td></td><td>181</td><td>-0.23</td><td>-0.98</td><td>0.512</td><td>0.864</td><td>1.000</td><td>1915</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>887</td><td>CHESLER_BRAIN_QTL_CIS</td><td></td><td>59</td><td>-0.27</td><td>-0.98</td><td>0.503</td><td>0.864</td><td>1.000</td><td>1473</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>888</td><td>BIOCARTA_BCR_PATHWAY</td><td></td><td>32</td><td>-0.31</td><td>-0.98</td><td>0.460</td><td>0.864</td><td>1.000</td><td>1516</td><td>tags=28%, list=13%, signal=32%</td></tr><tr><td class='lessen'>889</td><td>REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES</td><td></td><td>203</td><td>-0.23</td><td>-0.98</td><td>0.485</td><td>0.863</td><td>1.000</td><td>1364</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>890</td><td>CHANDRAN_METASTASIS_UP</td><td></td><td>167</td><td>-0.23</td><td>-0.98</td><td>0.487</td><td>0.865</td><td>1.000</td><td>2388</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>891</td><td>SESTO_RESPONSE_TO_UV_C2</td><td></td><td>44</td><td>-0.30</td><td>-0.98</td><td>0.495</td><td>0.864</td><td>1.000</td><td>1573</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>892</td><td>LU_TUMOR_ANGIOGENESIS_UP</td><td></td><td>20</td><td>-0.34</td><td>-0.98</td><td>0.477</td><td>0.866</td><td>1.000</td><td>1614</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>893</td><td>PLASARI_TGFB1_TARGETS_10HR_DN</td><td></td><td>137</td><td>-0.24</td><td>-0.98</td><td>0.486</td><td>0.865</td><td>1.000</td><td>1648</td><td>tags=20%, list=14%, signal=23%</td></tr><tr><td class='lessen'>894</td><td>NABA_ECM_AFFILIATED</td><td></td><td>52</td><td>-0.29</td><td>-0.98</td><td>0.476</td><td>0.865</td><td>1.000</td><td>1609</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>895</td><td>KERLEY_RESPONSE_TO_CISPLATIN_UP</td><td></td><td>33</td><td>-0.31</td><td>-0.98</td><td>0.495</td><td>0.865</td><td>1.000</td><td>2696</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>896</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN</td><td></td><td>208</td><td>-0.23</td><td>-0.98</td><td>0.505</td><td>0.865</td><td>1.000</td><td>2058</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>897</td><td>BOYLAN_MULTIPLE_MYELOMA_C_DN</td><td></td><td>37</td><td>-0.30</td><td>-0.98</td><td>0.451</td><td>0.866</td><td>1.000</td><td>1979</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>898</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_3_UP</td><td></td><td>278</td><td>-0.22</td><td>-0.98</td><td>0.522</td><td>0.866</td><td>1.000</td><td>1837</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>899</td><td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td><td></td><td>55</td><td>-0.28</td><td>-0.98</td><td>0.481</td><td>0.869</td><td>1.000</td><td>2823</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>900</td><td>PID_AJDISS_2PATHWAY</td><td></td><td>35</td><td>-0.30</td><td>-0.98</td><td>0.491</td><td>0.870</td><td>1.000</td><td>1892</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>901</td><td>MORI_SMALL_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>69</td><td>-0.27</td><td>-0.98</td><td>0.506</td><td>0.873</td><td>1.000</td><td>2381</td><td>tags=28%, list=21%, signal=34%</td></tr><tr><td class='lessen'>902</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>24</td><td>-0.33</td><td>-0.98</td><td>0.492</td><td>0.873</td><td>1.000</td><td>2313</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>903</td><td>ST_P38_MAPK_PATHWAY</td><td></td><td>36</td><td>-0.29</td><td>-0.98</td><td>0.486</td><td>0.873</td><td>1.000</td><td>1887</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>904</td><td>PID_BETA_CATENIN_NUC_PATHWAY</td><td></td><td>49</td><td>-0.28</td><td>-0.98</td><td>0.499</td><td>0.874</td><td>1.000</td><td>1134</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>905</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP</td><td></td><td>285</td><td>-0.22</td><td>-0.97</td><td>0.522</td><td>0.875</td><td>1.000</td><td>2703</td><td>tags=27%, list=23%, signal=34%</td></tr><tr><td class='lessen'>906</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>315</td><td>-0.22</td><td>-0.97</td><td>0.526</td><td>0.877</td><td>1.000</td><td>1766</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>907</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN</td><td></td><td>255</td><td>-0.22</td><td>-0.97</td><td>0.555</td><td>0.877</td><td>1.000</td><td>2616</td><td>tags=25%, list=23%, signal=31%</td></tr><tr><td class='lessen'>908</td><td>BIOCARTA_MITOCHONDRIA_PATHWAY</td><td></td><td>21</td><td>-0.34</td><td>-0.97</td><td>0.489</td><td>0.879</td><td>1.000</td><td>1137</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>909</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP</td><td></td><td>49</td><td>-0.28</td><td>-0.97</td><td>0.514</td><td>0.879</td><td>1.000</td><td>1805</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>910</td><td>VECCHI_GASTRIC_CANCER_EARLY_DN</td><td></td><td>138</td><td>-0.24</td><td>-0.97</td><td>0.515</td><td>0.878</td><td>1.000</td><td>884</td><td>tags=12%, list=8%, signal=13%</td></tr><tr><td class='lessen'>911</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td><td></td><td>135</td><td>-0.24</td><td>-0.97</td><td>0.498</td><td>0.879</td><td>1.000</td><td>2205</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>912</td><td>HELLER_SILENCED_BY_METHYLATION_DN</td><td></td><td>82</td><td>-0.26</td><td>-0.97</td><td>0.534</td><td>0.881</td><td>1.000</td><td>2122</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>913</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td><td></td><td>20</td><td>-0.34</td><td>-0.97</td><td>0.515</td><td>0.882</td><td>1.000</td><td>1919</td><td>tags=30%, list=17%, signal=36%</td></tr><tr><td class='lessen'>914</td><td>KEGG_OOCYTE_MEIOSIS</td><td></td><td>83</td><td>-0.25</td><td>-0.97</td><td>0.504</td><td>0.881</td><td>1.000</td><td>2871</td><td>tags=37%, list=25%, signal=49%</td></tr><tr><td class='lessen'>915</td><td>SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER</td><td></td><td>23</td><td>-0.34</td><td>-0.97</td><td>0.507</td><td>0.880</td><td>1.000</td><td>1521</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>916</td><td>BIOCARTA_TCR_PATHWAY</td><td></td><td>37</td><td>-0.30</td><td>-0.97</td><td>0.494</td><td>0.880</td><td>1.000</td><td>1516</td><td>tags=24%, list=13%, signal=28%</td></tr><tr><td class='lessen'>917</td><td>ONO_AML1_TARGETS_DN</td><td></td><td>27</td><td>-0.32</td><td>-0.97</td><td>0.504</td><td>0.879</td><td>1.000</td><td>2491</td><td>tags=41%, list=22%, signal=52%</td></tr><tr><td class='lessen'>918</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR</td><td></td><td>110</td><td>-0.25</td><td>-0.97</td><td>0.508</td><td>0.878</td><td>1.000</td><td>1208</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>919</td><td>BROWNE_HCMV_INFECTION_8HR_DN</td><td></td><td>33</td><td>-0.31</td><td>-0.97</td><td>0.516</td><td>0.877</td><td>1.000</td><td>690</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>920</td><td>KRIEG_KDM3A_TARGETS_NOT_HYPOXIA</td><td></td><td>165</td><td>-0.23</td><td>-0.97</td><td>0.523</td><td>0.877</td><td>1.000</td><td>1670</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>921</td><td>WINNEPENNINCKX_MELANOMA_METASTASIS_DN</td><td></td><td>26</td><td>-0.32</td><td>-0.97</td><td>0.508</td><td>0.876</td><td>1.000</td><td>2623</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>922</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>338</td><td>-0.21</td><td>-0.97</td><td>0.563</td><td>0.877</td><td>1.000</td><td>1766</td><td>tags=16%, list=15%, signal=18%</td></tr><tr><td class='lessen'>923</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G2</td><td></td><td>20</td><td>-0.34</td><td>-0.97</td><td>0.502</td><td>0.876</td><td>1.000</td><td>1287</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>924</td><td>REACTOME_MITOTIC_PROMETAPHASE</td><td></td><td>78</td><td>-0.26</td><td>-0.97</td><td>0.513</td><td>0.876</td><td>1.000</td><td>2444</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>925</td><td>TARTE_PLASMA_CELL_VS_PLASMABLAST_DN</td><td></td><td>296</td><td>-0.22</td><td>-0.97</td><td>0.553</td><td>0.876</td><td>1.000</td><td>2701</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>926</td><td>REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS</td><td></td><td>29</td><td>-0.32</td><td>-0.97</td><td>0.502</td><td>0.877</td><td>1.000</td><td>2360</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>927</td><td>BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP</td><td></td><td>19</td><td>-0.35</td><td>-0.97</td><td>0.509</td><td>0.876</td><td>1.000</td><td>287</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>928</td><td>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</td><td></td><td>60</td><td>-0.27</td><td>-0.97</td><td>0.495</td><td>0.877</td><td>1.000</td><td>3014</td><td>tags=33%, list=26%, signal=45%</td></tr><tr><td class='lessen'>929</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>98</td><td>-0.25</td><td>-0.97</td><td>0.513</td><td>0.878</td><td>1.000</td><td>1270</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>930</td><td>GEISS_RESPONSE_TO_DSRNA_UP</td><td></td><td>33</td><td>-0.30</td><td>-0.97</td><td>0.506</td><td>0.878</td><td>1.000</td><td>2442</td><td>tags=39%, list=21%, signal=50%</td></tr><tr><td class='lessen'>931</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>419</td><td>-0.21</td><td>-0.97</td><td>0.574</td><td>0.880</td><td>1.000</td><td>2443</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>932</td><td>PID_RAC1_PATHWAY</td><td></td><td>48</td><td>-0.28</td><td>-0.97</td><td>0.528</td><td>0.881</td><td>1.000</td><td>2049</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>933</td><td>BENPORATH_ES_2</td><td></td><td>23</td><td>-0.33</td><td>-0.96</td><td>0.489</td><td>0.880</td><td>1.000</td><td>932</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>934</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>347</td><td>-0.21</td><td>-0.96</td><td>0.567</td><td>0.882</td><td>1.000</td><td>1847</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>935</td><td>BIOCARTA_HER2_PATHWAY</td><td></td><td>17</td><td>-0.35</td><td>-0.96</td><td>0.499</td><td>0.885</td><td>1.000</td><td>1264</td><td>tags=29%, list=11%, signal=33%</td></tr><tr><td class='lessen'>936</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>284</td><td>-0.22</td><td>-0.96</td><td>0.573</td><td>0.885</td><td>1.000</td><td>1296</td><td>tags=14%, list=11%, signal=16%</td></tr><tr><td class='lessen'>937</td><td>BROWNE_HCMV_INFECTION_18HR_UP</td><td></td><td>138</td><td>-0.24</td><td>-0.96</td><td>0.555</td><td>0.884</td><td>1.000</td><td>2338</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>938</td><td>WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH</td><td></td><td>42</td><td>-0.29</td><td>-0.96</td><td>0.534</td><td>0.883</td><td>1.000</td><td>1944</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>939</td><td>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>16</td><td>-0.36</td><td>-0.96</td><td>0.508</td><td>0.888</td><td>1.000</td><td>1343</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>940</td><td>LEE_LIVER_CANCER_MYC_E2F1_UP</td><td></td><td>33</td><td>-0.30</td><td>-0.96</td><td>0.497</td><td>0.888</td><td>1.000</td><td>937</td><td>tags=18%, list=8%, signal=20%</td></tr><tr><td class='lessen'>941</td><td>HEIDENBLAD_AMPLICON_8Q24_DN</td><td></td><td>35</td><td>-0.30</td><td>-0.96</td><td>0.517</td><td>0.889</td><td>1.000</td><td>1802</td><td>tags=29%, list=16%, signal=34%</td></tr><tr><td class='lessen'>942</td><td>TENEDINI_MEGAKARYOCYTE_MARKERS</td><td></td><td>46</td><td>-0.28</td><td>-0.96</td><td>0.539</td><td>0.888</td><td>1.000</td><td>1644</td><td>tags=22%, list=14%, signal=25%</td></tr><tr><td class='lessen'>943</td><td>CUI_TCF21_TARGETS_UP</td><td></td><td>17</td><td>-0.36</td><td>-0.96</td><td>0.498</td><td>0.887</td><td>1.000</td><td>465</td><td>tags=12%, list=4%, signal=12%</td></tr><tr><td class='lessen'>944</td><td>VISALA_AGING_LYMPHOCYTE_DN</td><td></td><td>16</td><td>-0.35</td><td>-0.96</td><td>0.528</td><td>0.888</td><td>1.000</td><td>2385</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>945</td><td>KIM_WT1_TARGETS_8HR_UP</td><td></td><td>113</td><td>-0.24</td><td>-0.96</td><td>0.547</td><td>0.887</td><td>1.000</td><td>2468</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>946</td><td>REACTOME_MITOTIC_M_M_G1_PHASES</td><td></td><td>157</td><td>-0.23</td><td>-0.96</td><td>0.573</td><td>0.887</td><td>1.000</td><td>2968</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>947</td><td>MCBRYAN_PUBERTAL_BREAST_6_7WK_DN</td><td></td><td>50</td><td>-0.27</td><td>-0.96</td><td>0.524</td><td>0.889</td><td>1.000</td><td>1941</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>948</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>320</td><td>-0.21</td><td>-0.96</td><td>0.581</td><td>0.888</td><td>1.000</td><td>2124</td><td>tags=21%, list=18%, signal=25%</td></tr><tr><td class='lessen'>949</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>230</td><td>-0.22</td><td>-0.96</td><td>0.558</td><td>0.888</td><td>1.000</td><td>2763</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>950</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>24</td><td>-0.33</td><td>-0.96</td><td>0.498</td><td>0.887</td><td>1.000</td><td>1228</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>951</td><td>MORI_LARGE_PRE_BII_LYMPHOCYTE_DN</td><td></td><td>52</td><td>-0.27</td><td>-0.96</td><td>0.550</td><td>0.887</td><td>1.000</td><td>2152</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>952</td><td>PLASARI_TGFB1_TARGETS_10HR_UP</td><td></td><td>113</td><td>-0.24</td><td>-0.96</td><td>0.546</td><td>0.887</td><td>1.000</td><td>2779</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>953</td><td>GEORGANTAS_HSC_MARKERS</td><td></td><td>53</td><td>-0.27</td><td>-0.96</td><td>0.513</td><td>0.887</td><td>1.000</td><td>2406</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>954</td><td>REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR</td><td></td><td>116</td><td>-0.24</td><td>-0.96</td><td>0.564</td><td>0.890</td><td>1.000</td><td>1720</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>955</td><td>KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>83</td><td>-0.25</td><td>-0.96</td><td>0.574</td><td>0.889</td><td>1.000</td><td>1516</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>956</td><td>SU_PANCREAS</td><td></td><td>22</td><td>-0.33</td><td>-0.96</td><td>0.541</td><td>0.889</td><td>1.000</td><td>615</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>957</td><td>PID_VEGFR1_PATHWAY</td><td></td><td>20</td><td>-0.34</td><td>-0.95</td><td>0.552</td><td>0.891</td><td>1.000</td><td>1170</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>958</td><td>PID_AR_TF_PATHWAY</td><td></td><td>41</td><td>-0.29</td><td>-0.95</td><td>0.559</td><td>0.896</td><td>1.000</td><td>2561</td><td>tags=34%, list=22%, signal=44%</td></tr><tr><td class='lessen'>959</td><td>ONDER_CDH1_TARGETS_1_UP</td><td></td><td>96</td><td>-0.25</td><td>-0.95</td><td>0.559</td><td>0.895</td><td>1.000</td><td>1231</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>960</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>275</td><td>-0.22</td><td>-0.95</td><td>0.604</td><td>0.894</td><td>1.000</td><td>2739</td><td>tags=29%, list=24%, signal=37%</td></tr><tr><td class='lessen'>961</td><td>KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY</td><td></td><td>75</td><td>-0.26</td><td>-0.95</td><td>0.571</td><td>0.894</td><td>1.000</td><td>2273</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>962</td><td>CHICAS_RB1_TARGETS_GROWING</td><td></td><td>165</td><td>-0.23</td><td>-0.95</td><td>0.551</td><td>0.894</td><td>1.000</td><td>2663</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>963</td><td>LIM_MAMMARY_LUMINAL_MATURE_DN</td><td></td><td>60</td><td>-0.26</td><td>-0.95</td><td>0.525</td><td>0.894</td><td>1.000</td><td>1979</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>964</td><td>BEIER_GLIOMA_STEM_CELL_DN</td><td></td><td>50</td><td>-0.27</td><td>-0.95</td><td>0.528</td><td>0.894</td><td>1.000</td><td>3952</td><td>tags=44%, list=34%, signal=67%</td></tr><tr><td class='lessen'>965</td><td>HENDRICKS_SMARCA4_TARGETS_DN</td><td></td><td>30</td><td>-0.31</td><td>-0.95</td><td>0.539</td><td>0.893</td><td>1.000</td><td>2420</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>966</td><td>REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S</td><td></td><td>42</td><td>-0.28</td><td>-0.95</td><td>0.536</td><td>0.893</td><td>1.000</td><td>2919</td><td>tags=33%, list=25%, signal=44%</td></tr><tr><td class='lessen'>967</td><td>MCCLUNG_DELTA_FOSB_TARGETS_8WK</td><td></td><td>32</td><td>-0.30</td><td>-0.95</td><td>0.534</td><td>0.893</td><td>1.000</td><td>1819</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>968</td><td>CHICAS_RB1_TARGETS_SENESCENT</td><td></td><td>409</td><td>-0.21</td><td>-0.95</td><td>0.629</td><td>0.894</td><td>1.000</td><td>2618</td><td>tags=23%, list=23%, signal=29%</td></tr><tr><td class='lessen'>969</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>221</td><td>-0.22</td><td>-0.95</td><td>0.616</td><td>0.894</td><td>1.000</td><td>2303</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>970</td><td>REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION</td><td></td><td>126</td><td>-0.24</td><td>-0.95</td><td>0.574</td><td>0.894</td><td>1.000</td><td>1993</td><td>tags=21%, list=17%, signal=26%</td></tr><tr><td class='lessen'>971</td><td>BURTON_ADIPOGENESIS_PEAK_AT_8HR</td><td></td><td>31</td><td>-0.31</td><td>-0.95</td><td>0.520</td><td>0.894</td><td>1.000</td><td>532</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>972</td><td>KEGG_MTOR_SIGNALING_PATHWAY</td><td></td><td>44</td><td>-0.28</td><td>-0.95</td><td>0.561</td><td>0.893</td><td>1.000</td><td>3064</td><td>tags=36%, list=26%, signal=49%</td></tr><tr><td class='lessen'>973</td><td>VANHARANTA_UTERINE_FIBROID_DN</td><td></td><td>43</td><td>-0.28</td><td>-0.95</td><td>0.555</td><td>0.893</td><td>1.000</td><td>748</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>974</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN</td><td></td><td>17</td><td>-0.35</td><td>-0.95</td><td>0.525</td><td>0.892</td><td>1.000</td><td>1807</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>975</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR</td><td></td><td>24</td><td>-0.32</td><td>-0.95</td><td>0.501</td><td>0.892</td><td>1.000</td><td>2129</td><td>tags=33%, list=18%, signal=41%</td></tr><tr><td class='lessen'>976</td><td>ZHAN_MULTIPLE_MYELOMA_DN</td><td></td><td>25</td><td>-0.32</td><td>-0.95</td><td>0.551</td><td>0.892</td><td>1.000</td><td>2232</td><td>tags=36%, list=19%, signal=45%</td></tr><tr><td class='lessen'>977</td><td>KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE</td><td></td><td>15</td><td>-0.36</td><td>-0.95</td><td>0.528</td><td>0.892</td><td>1.000</td><td>3836</td><td>tags=33%, list=33%, signal=50%</td></tr><tr><td class='lessen'>978</td><td>BIOCARTA_STRESS_PATHWAY</td><td></td><td>25</td><td>-0.32</td><td>-0.95</td><td>0.518</td><td>0.896</td><td>1.000</td><td>1841</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>979</td><td>AMUNDSON_GAMMA_RADIATION_RESPONSE</td><td></td><td>39</td><td>-0.29</td><td>-0.95</td><td>0.560</td><td>0.895</td><td>1.000</td><td>2619</td><td>tags=38%, list=23%, signal=50%</td></tr><tr><td class='lessen'>980</td><td>ZHU_CMV_ALL_DN</td><td></td><td>76</td><td>-0.25</td><td>-0.95</td><td>0.544</td><td>0.895</td><td>1.000</td><td>1676</td><td>tags=17%, list=14%, signal=20%</td></tr><tr><td class='lessen'>981</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN</td><td></td><td>207</td><td>-0.22</td><td>-0.95</td><td>0.588</td><td>0.896</td><td>1.000</td><td>1517</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>982</td><td>KEGG_ACUTE_MYELOID_LEUKEMIA</td><td></td><td>48</td><td>-0.28</td><td>-0.95</td><td>0.537</td><td>0.895</td><td>1.000</td><td>1720</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>983</td><td>VANTVEER_BREAST_CANCER_ESR1_UP</td><td></td><td>115</td><td>-0.24</td><td>-0.95</td><td>0.573</td><td>0.894</td><td>1.000</td><td>2311</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>984</td><td>PID_IL2_1PATHWAY</td><td></td><td>51</td><td>-0.27</td><td>-0.95</td><td>0.561</td><td>0.894</td><td>1.000</td><td>2263</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>985</td><td>PID_TRAIL_PATHWAY</td><td></td><td>28</td><td>-0.31</td><td>-0.95</td><td>0.529</td><td>0.894</td><td>1.000</td><td>1718</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>986</td><td>LY_AGING_OLD_DN</td><td></td><td>50</td><td>-0.27</td><td>-0.95</td><td>0.559</td><td>0.894</td><td>1.000</td><td>1739</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>987</td><td>CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP</td><td></td><td>31</td><td>-0.30</td><td>-0.94</td><td>0.544</td><td>0.896</td><td>1.000</td><td>936</td><td>tags=16%, list=8%, signal=18%</td></tr><tr><td class='lessen'>988</td><td>REACTOME_HIV_LIFE_CYCLE</td><td></td><td>105</td><td>-0.24</td><td>-0.94</td><td>0.603</td><td>0.896</td><td>1.000</td><td>1939</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>989</td><td>ZHENG_GLIOBLASTOMA_PLASTICITY_UP</td><td></td><td>163</td><td>-0.23</td><td>-0.94</td><td>0.600</td><td>0.895</td><td>1.000</td><td>1729</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>990</td><td>EHLERS_ANEUPLOIDY_UP</td><td></td><td>35</td><td>-0.29</td><td>-0.94</td><td>0.531</td><td>0.896</td><td>1.000</td><td>3077</td><td>tags=40%, list=27%, signal=54%</td></tr><tr><td class='lessen'>991</td><td>YANG_BCL3_TARGETS_UP</td><td></td><td>234</td><td>-0.22</td><td>-0.94</td><td>0.618</td><td>0.897</td><td>1.000</td><td>1322</td><td>tags=14%, list=11%, signal=15%</td></tr><tr><td class='lessen'>992</td><td>WELCSH_BRCA1_TARGETS_UP</td><td></td><td>177</td><td>-0.23</td><td>-0.94</td><td>0.614</td><td>0.897</td><td>1.000</td><td>2663</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>993</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN</td><td></td><td>28</td><td>-0.31</td><td>-0.94</td><td>0.553</td><td>0.896</td><td>1.000</td><td>4029</td><td>tags=46%, list=35%, signal=71%</td></tr><tr><td class='lessen'>994</td><td>REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR</td><td></td><td>68</td><td>-0.26</td><td>-0.94</td><td>0.543</td><td>0.896</td><td>1.000</td><td>1213</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>995</td><td>WIERENGA_STAT5A_TARGETS_GROUP2</td><td></td><td>48</td><td>-0.28</td><td>-0.94</td><td>0.574</td><td>0.897</td><td>1.000</td><td>2194</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>996</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>55</td><td>-0.27</td><td>-0.94</td><td>0.587</td><td>0.897</td><td>1.000</td><td>1835</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>997</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP</td><td></td><td>140</td><td>-0.23</td><td>-0.94</td><td>0.596</td><td>0.898</td><td>1.000</td><td>2968</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>998</td><td>LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE</td><td></td><td>28</td><td>-0.31</td><td>-0.94</td><td>0.565</td><td>0.899</td><td>1.000</td><td>2425</td><td>tags=32%, list=21%, signal=41%</td></tr><tr><td class='lessen'>999</td><td>CHUNG_BLISTER_CYTOTOXICITY_DN</td><td></td><td>34</td><td>-0.29</td><td>-0.94</td><td>0.551</td><td>0.899</td><td>1.000</td><td>876</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>1000</td><td>MAYBURD_RESPONSE_TO_L663536_DN</td><td></td><td>46</td><td>-0.28</td><td>-0.94</td><td>0.542</td><td>0.899</td><td>1.000</td><td>1919</td><td>tags=22%, list=17%, signal=26%</td></tr><tr><td class='lessen'>1001</td><td>BROWNE_HCMV_INFECTION_1HR_UP</td><td></td><td>26</td><td>-0.31</td><td>-0.94</td><td>0.538</td><td>0.900</td><td>1.000</td><td>1101</td><td>tags=19%, list=10%, signal=21%</td></tr><tr><td class='lessen'>1002</td><td>SCHLOSSER_SERUM_RESPONSE_UP</td><td></td><td>104</td><td>-0.24</td><td>-0.94</td><td>0.598</td><td>0.900</td><td>1.000</td><td>2596</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>1003</td><td>BROWNE_HCMV_INFECTION_24HR_UP</td><td></td><td>107</td><td>-0.24</td><td>-0.94</td><td>0.603</td><td>0.903</td><td>1.000</td><td>2362</td><td>tags=25%, list=20%, signal=31%</td></tr><tr><td class='lessen'>1004</td><td>REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING</td><td></td><td>50</td><td>-0.27</td><td>-0.94</td><td>0.550</td><td>0.902</td><td>1.000</td><td>1329</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>1005</td><td>PID_FOXM1_PATHWAY</td><td></td><td>31</td><td>-0.30</td><td>-0.94</td><td>0.531</td><td>0.903</td><td>1.000</td><td>359</td><td>tags=13%, list=3%, signal=13%</td></tr><tr><td class='lessen'>1006</td><td>KANNAN_TP53_TARGETS_DN</td><td></td><td>16</td><td>-0.35</td><td>-0.94</td><td>0.541</td><td>0.902</td><td>1.000</td><td>63</td><td>tags=13%, list=1%, signal=13%</td></tr><tr><td class='lessen'>1007</td><td>DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN</td><td></td><td>21</td><td>-0.33</td><td>-0.94</td><td>0.544</td><td>0.902</td><td>1.000</td><td>690</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1008</td><td>HASLINGER_B_CLL_WITH_11Q23_DELETION</td><td></td><td>19</td><td>-0.34</td><td>-0.94</td><td>0.540</td><td>0.901</td><td>1.000</td><td>868</td><td>tags=16%, list=7%, signal=17%</td></tr><tr><td class='lessen'>1009</td><td>MA_PITUITARY_FETAL_VS_ADULT_DN</td><td></td><td>15</td><td>-0.36</td><td>-0.94</td><td>0.570</td><td>0.901</td><td>1.000</td><td>2133</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>1010</td><td>NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON</td><td></td><td>41</td><td>-0.28</td><td>-0.94</td><td>0.563</td><td>0.900</td><td>1.000</td><td>1209</td><td>tags=22%, list=10%, signal=24%</td></tr><tr><td class='lessen'>1011</td><td>LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN</td><td></td><td>35</td><td>-0.29</td><td>-0.94</td><td>0.567</td><td>0.901</td><td>1.000</td><td>845</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>1012</td><td>SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES</td><td></td><td>55</td><td>-0.26</td><td>-0.94</td><td>0.576</td><td>0.900</td><td>1.000</td><td>1720</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>1013</td><td>REACTOME_DNA_REPLICATION</td><td></td><td>175</td><td>-0.22</td><td>-0.94</td><td>0.612</td><td>0.900</td><td>1.000</td><td>3251</td><td>tags=33%, list=28%, signal=45%</td></tr><tr><td class='lessen'>1014</td><td>PETRETTO_CARDIAC_HYPERTROPHY</td><td></td><td>22</td><td>-0.32</td><td>-0.94</td><td>0.545</td><td>0.900</td><td>1.000</td><td>1648</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>1015</td><td>SESTO_RESPONSE_TO_UV_C8</td><td></td><td>61</td><td>-0.26</td><td>-0.94</td><td>0.569</td><td>0.899</td><td>1.000</td><td>1698</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1016</td><td>NABA_CORE_MATRISOME</td><td></td><td>68</td><td>-0.25</td><td>-0.94</td><td>0.599</td><td>0.898</td><td>1.000</td><td>1502</td><td>tags=16%, list=13%, signal=18%</td></tr><tr><td class='lessen'>1017</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN</td><td></td><td>29</td><td>-0.30</td><td>-0.94</td><td>0.544</td><td>0.898</td><td>1.000</td><td>986</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>1018</td><td>BIOCARTA_TNFR2_PATHWAY</td><td></td><td>18</td><td>-0.34</td><td>-0.94</td><td>0.562</td><td>0.897</td><td>1.000</td><td>269</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>1019</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>447</td><td>-0.20</td><td>-0.94</td><td>0.691</td><td>0.897</td><td>1.000</td><td>2322</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1020</td><td>LUI_THYROID_CANCER_CLUSTER_2</td><td></td><td>26</td><td>-0.31</td><td>-0.93</td><td>0.547</td><td>0.899</td><td>1.000</td><td>2366</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>1021</td><td>PID_AURORA_B_PATHWAY</td><td></td><td>32</td><td>-0.30</td><td>-0.93</td><td>0.536</td><td>0.898</td><td>1.000</td><td>2968</td><td>tags=38%, list=26%, signal=50%</td></tr><tr><td class='lessen'>1022</td><td>BALDWIN_PRKCI_TARGETS_UP</td><td></td><td>26</td><td>-0.31</td><td>-0.93</td><td>0.568</td><td>0.898</td><td>1.000</td><td>2615</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>1023</td><td>LY_AGING_PREMATURE_DN</td><td></td><td>26</td><td>-0.31</td><td>-0.93</td><td>0.564</td><td>0.898</td><td>1.000</td><td>1739</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>1024</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td><td></td><td>312</td><td>-0.21</td><td>-0.93</td><td>0.666</td><td>0.898</td><td>1.000</td><td>2262</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1025</td><td>REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK</td><td></td><td>90</td><td>-0.25</td><td>-0.93</td><td>0.577</td><td>0.897</td><td>1.000</td><td>1798</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1026</td><td>PID_A6B1_A6B4_INTEGRIN_PATHWAY</td><td></td><td>28</td><td>-0.30</td><td>-0.93</td><td>0.536</td><td>0.896</td><td>1.000</td><td>1690</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1027</td><td>KIM_WT1_TARGETS_UP</td><td></td><td>151</td><td>-0.23</td><td>-0.93</td><td>0.624</td><td>0.896</td><td>1.000</td><td>2226</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1028</td><td>WONG_PROTEASOME_GENE_MODULE</td><td></td><td>49</td><td>-0.27</td><td>-0.93</td><td>0.581</td><td>0.897</td><td>1.000</td><td>2164</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>1029</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>50</td><td>-0.27</td><td>-0.93</td><td>0.588</td><td>0.901</td><td>1.000</td><td>1806</td><td>tags=22%, list=16%, signal=26%</td></tr><tr><td class='lessen'>1030</td><td>PENG_GLUCOSE_DEPRIVATION_DN</td><td></td><td>137</td><td>-0.23</td><td>-0.93</td><td>0.607</td><td>0.901</td><td>1.000</td><td>1335</td><td>tags=15%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1031</td><td>REACTOME_SIGNALING_BY_EGFR_IN_CANCER</td><td></td><td>86</td><td>-0.24</td><td>-0.93</td><td>0.589</td><td>0.900</td><td>1.000</td><td>1720</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1032</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP</td><td></td><td>102</td><td>-0.24</td><td>-0.93</td><td>0.621</td><td>0.899</td><td>1.000</td><td>997</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>1033</td><td>KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP</td><td></td><td>30</td><td>-0.30</td><td>-0.93</td><td>0.569</td><td>0.900</td><td>1.000</td><td>2139</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>1034</td><td>AFFAR_YY1_TARGETS_UP</td><td></td><td>110</td><td>-0.24</td><td>-0.93</td><td>0.629</td><td>0.899</td><td>1.000</td><td>1755</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>1035</td><td>KOHOUTEK_CCNT2_TARGETS</td><td></td><td>28</td><td>-0.31</td><td>-0.93</td><td>0.566</td><td>0.900</td><td>1.000</td><td>1000</td><td>tags=14%, list=9%, signal=16%</td></tr><tr><td class='lessen'>1036</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>33</td><td>-0.29</td><td>-0.93</td><td>0.570</td><td>0.900</td><td>1.000</td><td>756</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>1037</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td><td></td><td>104</td><td>-0.24</td><td>-0.93</td><td>0.612</td><td>0.900</td><td>1.000</td><td>2842</td><td>tags=32%, list=25%, signal=42%</td></tr><tr><td class='lessen'>1038</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>288</td><td>-0.21</td><td>-0.93</td><td>0.685</td><td>0.900</td><td>1.000</td><td>2114</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>1039</td><td>NGUYEN_NOTCH1_TARGETS_DN</td><td></td><td>74</td><td>-0.25</td><td>-0.93</td><td>0.582</td><td>0.900</td><td>1.000</td><td>2358</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1040</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN</td><td></td><td>81</td><td>-0.25</td><td>-0.93</td><td>0.624</td><td>0.901</td><td>1.000</td><td>1106</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>1041</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>369</td><td>-0.20</td><td>-0.93</td><td>0.706</td><td>0.900</td><td>1.000</td><td>2622</td><td>tags=25%, list=23%, signal=31%</td></tr><tr><td class='lessen'>1042</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td><td></td><td>195</td><td>-0.22</td><td>-0.93</td><td>0.649</td><td>0.901</td><td>1.000</td><td>2343</td><td>tags=26%, list=20%, signal=32%</td></tr><tr><td class='lessen'>1043</td><td>KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY</td><td></td><td>87</td><td>-0.25</td><td>-0.93</td><td>0.637</td><td>0.901</td><td>1.000</td><td>1976</td><td>tags=25%, list=17%, signal=30%</td></tr><tr><td class='lessen'>1044</td><td>REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER</td><td></td><td>33</td><td>-0.29</td><td>-0.93</td><td>0.574</td><td>0.901</td><td>1.000</td><td>1649</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>1045</td><td>YAGI_AML_WITH_11Q23_REARRANGED</td><td></td><td>258</td><td>-0.21</td><td>-0.93</td><td>0.680</td><td>0.900</td><td>1.000</td><td>2628</td><td>tags=24%, list=23%, signal=31%</td></tr><tr><td class='lessen'>1046</td><td>ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN</td><td></td><td>39</td><td>-0.28</td><td>-0.93</td><td>0.602</td><td>0.902</td><td>1.000</td><td>2436</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>1047</td><td>BIOCARTA_CHEMICAL_PATHWAY</td><td></td><td>22</td><td>-0.32</td><td>-0.93</td><td>0.595</td><td>0.902</td><td>1.000</td><td>1974</td><td>tags=32%, list=17%, signal=38%</td></tr><tr><td class='lessen'>1048</td><td>REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_</td><td></td><td>39</td><td>-0.28</td><td>-0.92</td><td>0.566</td><td>0.904</td><td>1.000</td><td>40</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>1049</td><td>RICKMAN_HEAD_AND_NECK_CANCER_E</td><td></td><td>15</td><td>-0.36</td><td>-0.92</td><td>0.541</td><td>0.905</td><td>1.000</td><td>1416</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1050</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7</td><td></td><td>284</td><td>-0.21</td><td>-0.92</td><td>0.679</td><td>0.904</td><td>1.000</td><td>2333</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1051</td><td>HOOI_ST7_TARGETS_DN</td><td></td><td>63</td><td>-0.26</td><td>-0.92</td><td>0.587</td><td>0.904</td><td>1.000</td><td>2615</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>1052</td><td>KYNG_DNA_DAMAGE_UP</td><td></td><td>154</td><td>-0.22</td><td>-0.92</td><td>0.659</td><td>0.904</td><td>1.000</td><td>2678</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>1053</td><td>REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS</td><td></td><td>43</td><td>-0.27</td><td>-0.92</td><td>0.576</td><td>0.904</td><td>1.000</td><td>1329</td><td>tags=23%, list=11%, signal=26%</td></tr><tr><td class='lessen'>1054</td><td>BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE</td><td></td><td>116</td><td>-0.23</td><td>-0.92</td><td>0.642</td><td>0.905</td><td>1.000</td><td>1753</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1055</td><td>ZHAN_MULTIPLE_MYELOMA_MF_UP</td><td></td><td>28</td><td>-0.30</td><td>-0.92</td><td>0.576</td><td>0.905</td><td>1.000</td><td>2161</td><td>tags=32%, list=19%, signal=39%</td></tr><tr><td class='lessen'>1056</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN</td><td></td><td>27</td><td>-0.31</td><td>-0.92</td><td>0.586</td><td>0.904</td><td>1.000</td><td>1264</td><td>tags=22%, list=11%, signal=25%</td></tr><tr><td class='lessen'>1057</td><td>POOLA_INVASIVE_BREAST_CANCER_UP</td><td></td><td>195</td><td>-0.22</td><td>-0.92</td><td>0.671</td><td>0.904</td><td>1.000</td><td>1588</td><td>tags=17%, list=14%, signal=20%</td></tr><tr><td class='lessen'>1058</td><td>HAN_SATB1_TARGETS_UP</td><td></td><td>248</td><td>-0.21</td><td>-0.92</td><td>0.668</td><td>0.904</td><td>1.000</td><td>2337</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>1059</td><td>BIOCARTA_RELA_PATHWAY</td><td></td><td>16</td><td>-0.35</td><td>-0.92</td><td>0.569</td><td>0.905</td><td>1.000</td><td>269</td><td>tags=13%, list=2%, signal=13%</td></tr><tr><td class='lessen'>1060</td><td>KEGG_HEMATOPOIETIC_CELL_LINEAGE</td><td></td><td>47</td><td>-0.27</td><td>-0.92</td><td>0.587</td><td>0.904</td><td>1.000</td><td>1746</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>1061</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN</td><td></td><td>18</td><td>-0.33</td><td>-0.92</td><td>0.568</td><td>0.903</td><td>1.000</td><td>2949</td><td>tags=44%, list=25%, signal=60%</td></tr><tr><td class='lessen'>1062</td><td>SHEN_SMARCA2_TARGETS_DN</td><td></td><td>100</td><td>-0.23</td><td>-0.92</td><td>0.618</td><td>0.903</td><td>1.000</td><td>1943</td><td>tags=17%, list=17%, signal=20%</td></tr><tr><td class='lessen'>1063</td><td>DITTMER_PTHLH_TARGETS_UP</td><td></td><td>96</td><td>-0.24</td><td>-0.92</td><td>0.630</td><td>0.903</td><td>1.000</td><td>2766</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>1064</td><td>PID_RB_1PATHWAY</td><td></td><td>53</td><td>-0.27</td><td>-0.92</td><td>0.614</td><td>0.903</td><td>1.000</td><td>1702</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1065</td><td>KEGG_INOSITOL_PHOSPHATE_METABOLISM</td><td></td><td>41</td><td>-0.28</td><td>-0.92</td><td>0.578</td><td>0.902</td><td>1.000</td><td>601</td><td>tags=12%, list=5%, signal=13%</td></tr><tr><td class='lessen'>1066</td><td>OKUMURA_INFLAMMATORY_RESPONSE_LPS</td><td></td><td>129</td><td>-0.23</td><td>-0.92</td><td>0.621</td><td>0.901</td><td>1.000</td><td>1969</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1067</td><td>PID_CD8_TCR_PATHWAY</td><td></td><td>44</td><td>-0.27</td><td>-0.92</td><td>0.605</td><td>0.901</td><td>1.000</td><td>1281</td><td>tags=20%, list=11%, signal=23%</td></tr><tr><td class='lessen'>1068</td><td>BIOCARTA_MAPK_PATHWAY</td><td></td><td>78</td><td>-0.25</td><td>-0.92</td><td>0.593</td><td>0.901</td><td>1.000</td><td>1652</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>1069</td><td>TSENG_ADIPOGENIC_POTENTIAL_DN</td><td></td><td>20</td><td>-0.32</td><td>-0.92</td><td>0.576</td><td>0.905</td><td>1.000</td><td>3430</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>1070</td><td>WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP</td><td></td><td>40</td><td>-0.28</td><td>-0.92</td><td>0.603</td><td>0.907</td><td>1.000</td><td>971</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>1071</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td><td></td><td>36</td><td>-0.29</td><td>-0.92</td><td>0.607</td><td>0.908</td><td>1.000</td><td>864</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>1072</td><td>PID_LYMPH_ANGIOGENESIS_PATHWAY</td><td></td><td>18</td><td>-0.33</td><td>-0.92</td><td>0.567</td><td>0.907</td><td>1.000</td><td>1690</td><td>tags=33%, list=15%, signal=39%</td></tr><tr><td class='lessen'>1073</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>393</td><td>-0.20</td><td>-0.92</td><td>0.756</td><td>0.907</td><td>1.000</td><td>2047</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>1074</td><td>BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN</td><td></td><td>19</td><td>-0.33</td><td>-0.92</td><td>0.580</td><td>0.908</td><td>1.000</td><td>2629</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1075</td><td>MATZUK_SPERMATOZOA</td><td></td><td>62</td><td>-0.25</td><td>-0.92</td><td>0.615</td><td>0.909</td><td>1.000</td><td>2075</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>1076</td><td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td><td></td><td>113</td><td>-0.23</td><td>-0.92</td><td>0.648</td><td>0.908</td><td>1.000</td><td>1804</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1077</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>236</td><td>-0.21</td><td>-0.92</td><td>0.708</td><td>0.908</td><td>1.000</td><td>1921</td><td>tags=17%, list=17%, signal=20%</td></tr><tr><td class='lessen'>1078</td><td>XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP</td><td></td><td>29</td><td>-0.30</td><td>-0.92</td><td>0.598</td><td>0.907</td><td>1.000</td><td>1989</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>1079</td><td>ASTIER_INTEGRIN_SIGNALING</td><td></td><td>45</td><td>-0.27</td><td>-0.91</td><td>0.611</td><td>0.907</td><td>1.000</td><td>2365</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>1080</td><td>MOHANKUMAR_TLX1_TARGETS_DN</td><td></td><td>77</td><td>-0.25</td><td>-0.91</td><td>0.626</td><td>0.909</td><td>1.000</td><td>2749</td><td>tags=29%, list=24%, signal=37%</td></tr><tr><td class='lessen'>1081</td><td>PARENT_MTOR_SIGNALING_UP</td><td></td><td>442</td><td>-0.20</td><td>-0.91</td><td>0.747</td><td>0.908</td><td>1.000</td><td>2120</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1082</td><td>MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN</td><td></td><td>107</td><td>-0.23</td><td>-0.91</td><td>0.661</td><td>0.908</td><td>1.000</td><td>2047</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>1083</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP</td><td></td><td>49</td><td>-0.26</td><td>-0.91</td><td>0.577</td><td>0.908</td><td>1.000</td><td>2418</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>1084</td><td>BIOCARTA_CELLCYCLE_PATHWAY</td><td></td><td>22</td><td>-0.32</td><td>-0.91</td><td>0.573</td><td>0.907</td><td>1.000</td><td>1702</td><td>tags=23%, list=15%, signal=27%</td></tr><tr><td class='lessen'>1085</td><td>LEE_CALORIE_RESTRICTION_NEOCORTEX_DN</td><td></td><td>62</td><td>-0.26</td><td>-0.91</td><td>0.591</td><td>0.906</td><td>1.000</td><td>938</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>1086</td><td>REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING</td><td></td><td>18</td><td>-0.33</td><td>-0.91</td><td>0.581</td><td>0.908</td><td>1.000</td><td>1383</td><td>tags=28%, list=12%, signal=31%</td></tr><tr><td class='lessen'>1087</td><td>KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS</td><td></td><td>38</td><td>-0.28</td><td>-0.91</td><td>0.605</td><td>0.908</td><td>1.000</td><td>1892</td><td>tags=26%, list=16%, signal=31%</td></tr><tr><td class='lessen'>1088</td><td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td><td></td><td>15</td><td>-0.35</td><td>-0.91</td><td>0.595</td><td>0.911</td><td>1.000</td><td>3786</td><td>tags=53%, list=33%, signal=79%</td></tr><tr><td class='lessen'>1089</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN</td><td></td><td>22</td><td>-0.32</td><td>-0.91</td><td>0.593</td><td>0.911</td><td>1.000</td><td>1401</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>1090</td><td>REACTOME_SIGNALING_BY_FGFR</td><td></td><td>78</td><td>-0.25</td><td>-0.91</td><td>0.653</td><td>0.912</td><td>1.000</td><td>1720</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1091</td><td>REACTOME_UNFOLDED_PROTEIN_RESPONSE</td><td></td><td>71</td><td>-0.25</td><td>-0.91</td><td>0.631</td><td>0.912</td><td>1.000</td><td>2919</td><td>tags=30%, list=25%, signal=39%</td></tr><tr><td class='lessen'>1092</td><td>KOBAYASHI_EGFR_SIGNALING_24HR_UP</td><td></td><td>61</td><td>-0.25</td><td>-0.91</td><td>0.642</td><td>0.911</td><td>1.000</td><td>3069</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>1093</td><td>LIAO_METASTASIS</td><td></td><td>390</td><td>-0.20</td><td>-0.91</td><td>0.793</td><td>0.910</td><td>1.000</td><td>2337</td><td>tags=21%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1094</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12</td><td></td><td>64</td><td>-0.25</td><td>-0.91</td><td>0.614</td><td>0.910</td><td>1.000</td><td>1131</td><td>tags=11%, list=10%, signal=12%</td></tr><tr><td class='lessen'>1095</td><td>EPPERT_CE_HSC_LSC</td><td></td><td>24</td><td>-0.31</td><td>-0.91</td><td>0.625</td><td>0.910</td><td>1.000</td><td>1711</td><td>tags=21%, list=15%, signal=24%</td></tr><tr><td class='lessen'>1096</td><td>BOQUEST_STEM_CELL_DN</td><td></td><td>130</td><td>-0.22</td><td>-0.91</td><td>0.682</td><td>0.909</td><td>1.000</td><td>2205</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1097</td><td>PID_RET_PATHWAY</td><td></td><td>29</td><td>-0.30</td><td>-0.91</td><td>0.606</td><td>0.909</td><td>1.000</td><td>1383</td><td>tags=28%, list=12%, signal=31%</td></tr><tr><td class='lessen'>1098</td><td>REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE</td><td></td><td>15</td><td>-0.35</td><td>-0.91</td><td>0.589</td><td>0.909</td><td>1.000</td><td>1539</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>1099</td><td>REACTOME_GLUCOSE_TRANSPORT</td><td></td><td>29</td><td>-0.30</td><td>-0.91</td><td>0.601</td><td>0.908</td><td>1.000</td><td>937</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>1100</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP</td><td></td><td>113</td><td>-0.23</td><td>-0.91</td><td>0.659</td><td>0.910</td><td>1.000</td><td>1762</td><td>tags=19%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1101</td><td>RODRIGUES_NTN1_TARGETS_DN</td><td></td><td>92</td><td>-0.23</td><td>-0.91</td><td>0.660</td><td>0.913</td><td>1.000</td><td>1872</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>1102</td><td>ISHIDA_E2F_TARGETS</td><td></td><td>48</td><td>-0.26</td><td>-0.91</td><td>0.611</td><td>0.913</td><td>1.000</td><td>2579</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1103</td><td>PID_IL12_2PATHWAY</td><td></td><td>47</td><td>-0.26</td><td>-0.91</td><td>0.618</td><td>0.913</td><td>1.000</td><td>1841</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1104</td><td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td><td></td><td>454</td><td>-0.20</td><td>-0.91</td><td>0.772</td><td>0.912</td><td>1.000</td><td>2061</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1105</td><td>MIKKELSEN_MCV6_LCP_WITH_H3K4ME3</td><td></td><td>79</td><td>-0.24</td><td>-0.91</td><td>0.652</td><td>0.913</td><td>1.000</td><td>2203</td><td>tags=23%, list=19%, signal=28%</td></tr><tr><td class='lessen'>1106</td><td>INGRAM_SHH_TARGETS_UP</td><td></td><td>62</td><td>-0.25</td><td>-0.91</td><td>0.625</td><td>0.913</td><td>1.000</td><td>1135</td><td>tags=15%, list=10%, signal=16%</td></tr><tr><td class='lessen'>1107</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>59</td><td>-0.25</td><td>-0.90</td><td>0.669</td><td>0.913</td><td>1.000</td><td>1702</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1108</td><td>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</td><td></td><td>130</td><td>-0.23</td><td>-0.90</td><td>0.665</td><td>0.912</td><td>1.000</td><td>1727</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1109</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>50</td><td>-0.26</td><td>-0.90</td><td>0.639</td><td>0.913</td><td>1.000</td><td>2379</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>1110</td><td>SANA_RESPONSE_TO_IFNG_UP</td><td></td><td>64</td><td>-0.25</td><td>-0.90</td><td>0.646</td><td>0.913</td><td>1.000</td><td>657</td><td>tags=11%, list=6%, signal=12%</td></tr><tr><td class='lessen'>1111</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN</td><td></td><td>19</td><td>-0.33</td><td>-0.90</td><td>0.588</td><td>0.913</td><td>1.000</td><td>3610</td><td>tags=53%, list=31%, signal=76%</td></tr><tr><td class='lessen'>1112</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP</td><td></td><td>19</td><td>-0.33</td><td>-0.90</td><td>0.609</td><td>0.912</td><td>1.000</td><td>1647</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>1113</td><td>CORRE_MULTIPLE_MYELOMA_UP</td><td></td><td>32</td><td>-0.29</td><td>-0.90</td><td>0.601</td><td>0.913</td><td>1.000</td><td>996</td><td>tags=19%, list=9%, signal=20%</td></tr><tr><td class='lessen'>1114</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S1</td><td></td><td>194</td><td>-0.21</td><td>-0.90</td><td>0.716</td><td>0.913</td><td>1.000</td><td>2846</td><td>tags=28%, list=25%, signal=36%</td></tr><tr><td class='lessen'>1115</td><td>REACTOME_HEMOSTASIS</td><td></td><td>289</td><td>-0.20</td><td>-0.90</td><td>0.758</td><td>0.913</td><td>1.000</td><td>3010</td><td>tags=30%, list=26%, signal=39%</td></tr><tr><td class='lessen'>1116</td><td>YUAN_ZNF143_PARTNERS</td><td></td><td>19</td><td>-0.33</td><td>-0.90</td><td>0.570</td><td>0.912</td><td>1.000</td><td>1387</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>1117</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP</td><td></td><td>47</td><td>-0.27</td><td>-0.90</td><td>0.645</td><td>0.912</td><td>1.000</td><td>1535</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>1118</td><td>KYNG_DNA_DAMAGE_BY_4NQO_OR_UV</td><td></td><td>47</td><td>-0.26</td><td>-0.90</td><td>0.653</td><td>0.913</td><td>1.000</td><td>1401</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>1119</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_DN</td><td></td><td>116</td><td>-0.23</td><td>-0.90</td><td>0.684</td><td>0.912</td><td>1.000</td><td>815</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>1120</td><td>LINDSTEDT_DENDRITIC_CELL_MATURATION_A</td><td></td><td>46</td><td>-0.27</td><td>-0.90</td><td>0.626</td><td>0.912</td><td>1.000</td><td>901</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>1121</td><td>PID_SMAD2_3PATHWAY</td><td></td><td>16</td><td>-0.33</td><td>-0.90</td><td>0.608</td><td>0.911</td><td>1.000</td><td>1846</td><td>tags=31%, list=16%, signal=37%</td></tr><tr><td class='lessen'>1122</td><td>CHENG_IMPRINTED_BY_ESTRADIOL</td><td></td><td>65</td><td>-0.25</td><td>-0.90</td><td>0.656</td><td>0.914</td><td>1.000</td><td>1232</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>1123</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>381</td><td>-0.20</td><td>-0.90</td><td>0.812</td><td>0.913</td><td>1.000</td><td>2218</td><td>tags=21%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1124</td><td>COLLER_MYC_TARGETS_UP</td><td></td><td>24</td><td>-0.31</td><td>-0.90</td><td>0.603</td><td>0.913</td><td>1.000</td><td>495</td><td>tags=8%, list=4%, signal=9%</td></tr><tr><td class='lessen'>1125</td><td>JACKSON_DNMT1_TARGETS_DN</td><td></td><td>15</td><td>-0.34</td><td>-0.90</td><td>0.614</td><td>0.913</td><td>1.000</td><td>1379</td><td>tags=33%, list=12%, signal=38%</td></tr><tr><td class='lessen'>1126</td><td>PID_TXA2PATHWAY</td><td></td><td>41</td><td>-0.27</td><td>-0.90</td><td>0.635</td><td>0.912</td><td>1.000</td><td>1491</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1127</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10</td><td></td><td>62</td><td>-0.25</td><td>-0.90</td><td>0.648</td><td>0.913</td><td>1.000</td><td>1333</td><td>tags=18%, list=12%, signal=20%</td></tr><tr><td class='lessen'>1128</td><td>SASSON_RESPONSE_TO_GONADOTROPHINS_UP</td><td></td><td>71</td><td>-0.25</td><td>-0.90</td><td>0.692</td><td>0.914</td><td>1.000</td><td>2701</td><td>tags=28%, list=23%, signal=37%</td></tr><tr><td class='lessen'>1129</td><td>REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE</td><td></td><td>22</td><td>-0.31</td><td>-0.90</td><td>0.607</td><td>0.914</td><td>1.000</td><td>605</td><td>tags=14%, list=5%, signal=14%</td></tr><tr><td class='lessen'>1130</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP</td><td></td><td>58</td><td>-0.25</td><td>-0.90</td><td>0.656</td><td>0.914</td><td>1.000</td><td>3393</td><td>tags=36%, list=29%, signal=51%</td></tr><tr><td class='lessen'>1131</td><td>WIERENGA_PML_INTERACTOME</td><td></td><td>35</td><td>-0.28</td><td>-0.90</td><td>0.653</td><td>0.915</td><td>1.000</td><td>2781</td><td>tags=34%, list=24%, signal=45%</td></tr><tr><td class='lessen'>1132</td><td>BIOCARTA_PTEN_PATHWAY</td><td></td><td>17</td><td>-0.33</td><td>-0.89</td><td>0.624</td><td>0.921</td><td>1.000</td><td>1690</td><td>tags=35%, list=15%, signal=41%</td></tr><tr><td class='lessen'>1133</td><td>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</td><td></td><td>50</td><td>-0.26</td><td>-0.89</td><td>0.670</td><td>0.920</td><td>1.000</td><td>2363</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>1134</td><td>PID_ERBB4_PATHWAY</td><td></td><td>29</td><td>-0.29</td><td>-0.89</td><td>0.630</td><td>0.920</td><td>1.000</td><td>2172</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>1135</td><td>REACTOME_MITOTIC_G1_G1_S_PHASES</td><td></td><td>126</td><td>-0.22</td><td>-0.89</td><td>0.711</td><td>0.921</td><td>1.000</td><td>1702</td><td>tags=17%, list=15%, signal=19%</td></tr><tr><td class='lessen'>1136</td><td>ZHANG_TLX_TARGETS_36HR_UP</td><td></td><td>161</td><td>-0.21</td><td>-0.89</td><td>0.745</td><td>0.921</td><td>1.000</td><td>1727</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1137</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_UP</td><td></td><td>178</td><td>-0.21</td><td>-0.89</td><td>0.753</td><td>0.922</td><td>1.000</td><td>2353</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>1138</td><td>SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP</td><td></td><td>28</td><td>-0.29</td><td>-0.89</td><td>0.631</td><td>0.922</td><td>1.000</td><td>3141</td><td>tags=32%, list=27%, signal=44%</td></tr><tr><td class='lessen'>1139</td><td>GREENBAUM_E2A_TARGETS_DN</td><td></td><td>16</td><td>-0.34</td><td>-0.89</td><td>0.630</td><td>0.922</td><td>1.000</td><td>1777</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>1140</td><td>LANDIS_BREAST_CANCER_PROGRESSION_DN</td><td></td><td>42</td><td>-0.27</td><td>-0.89</td><td>0.657</td><td>0.922</td><td>1.000</td><td>2343</td><td>tags=29%, list=20%, signal=36%</td></tr><tr><td class='lessen'>1141</td><td>LUCAS_HNF4A_TARGETS_UP</td><td></td><td>41</td><td>-0.27</td><td>-0.89</td><td>0.647</td><td>0.921</td><td>1.000</td><td>1600</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1142</td><td>GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN</td><td></td><td>79</td><td>-0.24</td><td>-0.89</td><td>0.695</td><td>0.921</td><td>1.000</td><td>4049</td><td>tags=43%, list=35%, signal=66%</td></tr><tr><td class='lessen'>1143</td><td>WEI_MIR34A_TARGETS</td><td></td><td>116</td><td>-0.23</td><td>-0.89</td><td>0.709</td><td>0.921</td><td>1.000</td><td>1586</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1144</td><td>TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP</td><td></td><td>50</td><td>-0.26</td><td>-0.89</td><td>0.641</td><td>0.921</td><td>1.000</td><td>2706</td><td>tags=34%, list=23%, signal=44%</td></tr><tr><td class='lessen'>1145</td><td>JOHNSTONE_PARVB_TARGETS_2_UP</td><td></td><td>110</td><td>-0.23</td><td>-0.89</td><td>0.685</td><td>0.920</td><td>1.000</td><td>665</td><td>tags=9%, list=6%, signal=10%</td></tr><tr><td class='lessen'>1146</td><td>PID_ENDOTHELIN_PATHWAY</td><td></td><td>39</td><td>-0.27</td><td>-0.89</td><td>0.663</td><td>0.920</td><td>1.000</td><td>1644</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1147</td><td>PID_PI3K_PLC_TRK_PATHWAY</td><td></td><td>29</td><td>-0.29</td><td>-0.89</td><td>0.628</td><td>0.920</td><td>1.000</td><td>1134</td><td>tags=17%, list=10%, signal=19%</td></tr><tr><td class='lessen'>1148</td><td>LANDIS_BREAST_CANCER_PROGRESSION_UP</td><td></td><td>34</td><td>-0.28</td><td>-0.89</td><td>0.663</td><td>0.920</td><td>1.000</td><td>2779</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1149</td><td>REACTOME_SIGNALLING_BY_NGF</td><td></td><td>169</td><td>-0.21</td><td>-0.89</td><td>0.743</td><td>0.920</td><td>1.000</td><td>1720</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1150</td><td>FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN</td><td></td><td>79</td><td>-0.24</td><td>-0.89</td><td>0.670</td><td>0.919</td><td>1.000</td><td>2606</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>1151</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>191</td><td>-0.21</td><td>-0.89</td><td>0.742</td><td>0.918</td><td>1.000</td><td>2153</td><td>tags=18%, list=19%, signal=22%</td></tr><tr><td class='lessen'>1152</td><td>REACTOME_EGFR_DOWNREGULATION</td><td></td><td>21</td><td>-0.30</td><td>-0.89</td><td>0.619</td><td>0.918</td><td>1.000</td><td>2360</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1153</td><td>REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS</td><td></td><td>49</td><td>-0.26</td><td>-0.89</td><td>0.644</td><td>0.917</td><td>1.000</td><td>2677</td><td>tags=39%, list=23%, signal=50%</td></tr><tr><td class='lessen'>1154</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>151</td><td>-0.22</td><td>-0.89</td><td>0.734</td><td>0.916</td><td>1.000</td><td>2423</td><td>tags=23%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1155</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>31</td><td>-0.29</td><td>-0.89</td><td>0.632</td><td>0.916</td><td>1.000</td><td>2267</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>1156</td><td>REACTOME_FANCONI_ANEMIA_PATHWAY</td><td></td><td>16</td><td>-0.34</td><td>-0.89</td><td>0.620</td><td>0.915</td><td>1.000</td><td>2980</td><td>tags=44%, list=26%, signal=59%</td></tr><tr><td class='lessen'>1157</td><td>REACTOME_LYSOSOME_VESICLE_BIOGENESIS</td><td></td><td>20</td><td>-0.32</td><td>-0.89</td><td>0.643</td><td>0.916</td><td>1.000</td><td>1637</td><td>tags=30%, list=14%, signal=35%</td></tr><tr><td class='lessen'>1158</td><td>LEI_MYB_TARGETS</td><td></td><td>235</td><td>-0.20</td><td>-0.89</td><td>0.799</td><td>0.915</td><td>1.000</td><td>2032</td><td>tags=19%, list=18%, signal=23%</td></tr><tr><td class='lessen'>1159</td><td>TSAI_RESPONSE_TO_IONIZING_RADIATION</td><td></td><td>118</td><td>-0.22</td><td>-0.89</td><td>0.714</td><td>0.918</td><td>1.000</td><td>1893</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1160</td><td>BURTON_ADIPOGENESIS_PEAK_AT_24HR</td><td></td><td>36</td><td>-0.27</td><td>-0.89</td><td>0.638</td><td>0.917</td><td>1.000</td><td>3036</td><td>tags=33%, list=26%, signal=45%</td></tr><tr><td class='lessen'>1161</td><td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td><td></td><td>85</td><td>-0.24</td><td>-0.89</td><td>0.708</td><td>0.918</td><td>1.000</td><td>2340</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>1162</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>117</td><td>-0.22</td><td>-0.89</td><td>0.719</td><td>0.918</td><td>1.000</td><td>3749</td><td>tags=40%, list=32%, signal=59%</td></tr><tr><td class='lessen'>1163</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td><td></td><td>132</td><td>-0.22</td><td>-0.89</td><td>0.738</td><td>0.917</td><td>1.000</td><td>1178</td><td>tags=13%, list=10%, signal=14%</td></tr><tr><td class='lessen'>1164</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15</td><td></td><td>23</td><td>-0.30</td><td>-0.89</td><td>0.670</td><td>0.918</td><td>1.000</td><td>2765</td><td>tags=35%, list=24%, signal=46%</td></tr><tr><td class='lessen'>1165</td><td>PID_EPHRINB_REV_PATHWAY</td><td></td><td>19</td><td>-0.33</td><td>-0.89</td><td>0.626</td><td>0.918</td><td>1.000</td><td>1730</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>1166</td><td>LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP</td><td></td><td>17</td><td>-0.32</td><td>-0.89</td><td>0.623</td><td>0.917</td><td>1.000</td><td>1513</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1167</td><td>REACTOME_GLUCOSE_METABOLISM</td><td></td><td>49</td><td>-0.26</td><td>-0.89</td><td>0.651</td><td>0.917</td><td>1.000</td><td>3455</td><td>tags=39%, list=30%, signal=55%</td></tr><tr><td class='lessen'>1168</td><td>WILLIAMS_ESR1_TARGETS_UP</td><td></td><td>19</td><td>-0.32</td><td>-0.89</td><td>0.632</td><td>0.917</td><td>1.000</td><td>141</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>1169</td><td>RHODES_UNDIFFERENTIATED_CANCER</td><td></td><td>63</td><td>-0.24</td><td>-0.89</td><td>0.701</td><td>0.917</td><td>1.000</td><td>3158</td><td>tags=29%, list=27%, signal=39%</td></tr><tr><td class='lessen'>1170</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN</td><td></td><td>49</td><td>-0.26</td><td>-0.89</td><td>0.655</td><td>0.917</td><td>1.000</td><td>2872</td><td>tags=33%, list=25%, signal=43%</td></tr><tr><td class='lessen'>1171</td><td>REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION</td><td></td><td>20</td><td>-0.32</td><td>-0.88</td><td>0.631</td><td>0.919</td><td>1.000</td><td>1383</td><td>tags=25%, list=12%, signal=28%</td></tr><tr><td class='lessen'>1172</td><td>RADMACHER_AML_PROGNOSIS</td><td></td><td>54</td><td>-0.26</td><td>-0.88</td><td>0.675</td><td>0.919</td><td>1.000</td><td>2705</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>1173</td><td>SU_TESTIS</td><td></td><td>44</td><td>-0.26</td><td>-0.88</td><td>0.650</td><td>0.918</td><td>1.000</td><td>779</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>1174</td><td>GROSS_HYPOXIA_VIA_HIF1A_UP</td><td></td><td>65</td><td>-0.25</td><td>-0.88</td><td>0.676</td><td>0.920</td><td>1.000</td><td>1668</td><td>tags=15%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1175</td><td>REACTOME_M_G1_TRANSITION</td><td></td><td>75</td><td>-0.24</td><td>-0.88</td><td>0.671</td><td>0.919</td><td>1.000</td><td>1842</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1176</td><td>SESTO_RESPONSE_TO_UV_C7</td><td></td><td>58</td><td>-0.25</td><td>-0.88</td><td>0.680</td><td>0.919</td><td>1.000</td><td>1690</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1177</td><td>PETRETTO_HEART_MASS_QTL_CIS_DN</td><td></td><td>19</td><td>-0.31</td><td>-0.88</td><td>0.620</td><td>0.919</td><td>1.000</td><td>3443</td><td>tags=42%, list=30%, signal=60%</td></tr><tr><td class='lessen'>1178</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN</td><td></td><td>63</td><td>-0.24</td><td>-0.88</td><td>0.681</td><td>0.919</td><td>1.000</td><td>1817</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1179</td><td>KAYO_AGING_MUSCLE_UP</td><td></td><td>133</td><td>-0.22</td><td>-0.88</td><td>0.734</td><td>0.918</td><td>1.000</td><td>2993</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>1180</td><td>YU_MYC_TARGETS_UP</td><td></td><td>38</td><td>-0.27</td><td>-0.88</td><td>0.649</td><td>0.918</td><td>1.000</td><td>588</td><td>tags=5%, list=5%, signal=6%</td></tr><tr><td class='lessen'>1181</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_DN</td><td></td><td>99</td><td>-0.23</td><td>-0.88</td><td>0.729</td><td>0.918</td><td>1.000</td><td>2737</td><td>tags=28%, list=24%, signal=37%</td></tr><tr><td class='lessen'>1182</td><td>SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN</td><td></td><td>17</td><td>-0.33</td><td>-0.88</td><td>0.632</td><td>0.918</td><td>1.000</td><td>2431</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>1183</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN</td><td></td><td>217</td><td>-0.20</td><td>-0.88</td><td>0.797</td><td>0.920</td><td>1.000</td><td>2472</td><td>tags=23%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1184</td><td>BIOCARTA_IGF1_PATHWAY</td><td></td><td>19</td><td>-0.32</td><td>-0.88</td><td>0.629</td><td>0.919</td><td>1.000</td><td>1822</td><td>tags=32%, list=16%, signal=37%</td></tr><tr><td class='lessen'>1185</td><td>SENESE_HDAC2_TARGETS_UP</td><td></td><td>84</td><td>-0.23</td><td>-0.88</td><td>0.747</td><td>0.919</td><td>1.000</td><td>1427</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1186</td><td>REACTOME_SIGNALING_BY_RHO_GTPASES</td><td></td><td>77</td><td>-0.24</td><td>-0.88</td><td>0.682</td><td>0.922</td><td>1.000</td><td>3449</td><td>tags=39%, list=30%, signal=55%</td></tr><tr><td class='lessen'>1187</td><td>REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR</td><td></td><td>87</td><td>-0.23</td><td>-0.88</td><td>0.705</td><td>0.923</td><td>1.000</td><td>1720</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1188</td><td>CHANDRAN_METASTASIS_DN</td><td></td><td>181</td><td>-0.21</td><td>-0.88</td><td>0.786</td><td>0.922</td><td>1.000</td><td>1802</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1189</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>258</td><td>-0.20</td><td>-0.88</td><td>0.831</td><td>0.923</td><td>1.000</td><td>3142</td><td>tags=31%, list=27%, signal=42%</td></tr><tr><td class='lessen'>1190</td><td>BIOCARTA_CHREBP2_PATHWAY</td><td></td><td>32</td><td>-0.29</td><td>-0.88</td><td>0.656</td><td>0.923</td><td>1.000</td><td>2699</td><td>tags=34%, list=23%, signal=45%</td></tr><tr><td class='lessen'>1191</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>298</td><td>-0.20</td><td>-0.88</td><td>0.835</td><td>0.923</td><td>1.000</td><td>2723</td><td>tags=26%, list=24%, signal=32%</td></tr><tr><td class='lessen'>1192</td><td>SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM</td><td></td><td>34</td><td>-0.28</td><td>-0.88</td><td>0.640</td><td>0.922</td><td>1.000</td><td>1857</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1193</td><td>REACTOME_SIGNALING_BY_HIPPO</td><td></td><td>15</td><td>-0.33</td><td>-0.88</td><td>0.626</td><td>0.922</td><td>1.000</td><td>2202</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1194</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP</td><td></td><td>266</td><td>-0.20</td><td>-0.88</td><td>0.848</td><td>0.922</td><td>1.000</td><td>2493</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>1195</td><td>BURTON_ADIPOGENESIS_PEAK_AT_16HR</td><td></td><td>38</td><td>-0.27</td><td>-0.88</td><td>0.694</td><td>0.921</td><td>1.000</td><td>1629</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1196</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP</td><td></td><td>119</td><td>-0.22</td><td>-0.88</td><td>0.745</td><td>0.921</td><td>1.000</td><td>2599</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>1197</td><td>CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN</td><td></td><td>21</td><td>-0.31</td><td>-0.88</td><td>0.630</td><td>0.920</td><td>1.000</td><td>2820</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>1198</td><td>BIOCARTA_P53HYPOXIA_PATHWAY</td><td></td><td>22</td><td>-0.30</td><td>-0.88</td><td>0.656</td><td>0.921</td><td>1.000</td><td>2920</td><td>tags=50%, list=25%, signal=67%</td></tr><tr><td class='lessen'>1199</td><td>KANG_CISPLATIN_RESISTANCE_UP</td><td></td><td>15</td><td>-0.33</td><td>-0.87</td><td>0.663</td><td>0.922</td><td>1.000</td><td>3661</td><td>tags=47%, list=32%, signal=68%</td></tr><tr><td class='lessen'>1200</td><td>LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN</td><td></td><td>41</td><td>-0.27</td><td>-0.87</td><td>0.667</td><td>0.921</td><td>1.000</td><td>811</td><td>tags=15%, list=7%, signal=16%</td></tr><tr><td class='lessen'>1201</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN</td><td></td><td>137</td><td>-0.22</td><td>-0.87</td><td>0.763</td><td>0.923</td><td>1.000</td><td>2325</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1202</td><td>BOQUEST_STEM_CELL_UP</td><td></td><td>103</td><td>-0.22</td><td>-0.87</td><td>0.716</td><td>0.923</td><td>1.000</td><td>2197</td><td>tags=24%, list=19%, signal=30%</td></tr><tr><td class='lessen'>1203</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP</td><td></td><td>116</td><td>-0.22</td><td>-0.87</td><td>0.765</td><td>0.923</td><td>1.000</td><td>1558</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>1204</td><td>REACTOME_APOPTOTIC_EXECUTION_PHASE</td><td></td><td>39</td><td>-0.27</td><td>-0.87</td><td>0.670</td><td>0.922</td><td>1.000</td><td>1383</td><td>tags=15%, list=12%, signal=17%</td></tr><tr><td class='lessen'>1205</td><td>RODRIGUES_THYROID_CARCINOMA_DN</td><td></td><td>52</td><td>-0.25</td><td>-0.87</td><td>0.647</td><td>0.922</td><td>1.000</td><td>2488</td><td>tags=29%, list=21%, signal=37%</td></tr><tr><td class='lessen'>1206</td><td>SIG_BCR_SIGNALING_PATHWAY</td><td></td><td>42</td><td>-0.26</td><td>-0.87</td><td>0.689</td><td>0.925</td><td>1.000</td><td>2426</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>1207</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_DN</td><td></td><td>184</td><td>-0.21</td><td>-0.87</td><td>0.793</td><td>0.924</td><td>1.000</td><td>2017</td><td>tags=17%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1208</td><td>REACTOME_SIGNALING_BY_ROBO_RECEPTOR</td><td></td><td>20</td><td>-0.30</td><td>-0.87</td><td>0.621</td><td>0.924</td><td>1.000</td><td>1909</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1209</td><td>SIMBULAN_UV_RESPONSE_NORMAL_DN</td><td></td><td>23</td><td>-0.30</td><td>-0.87</td><td>0.670</td><td>0.924</td><td>1.000</td><td>2431</td><td>tags=43%, list=21%, signal=55%</td></tr><tr><td class='lessen'>1210</td><td>PEREZ_TP53_AND_TP63_TARGETS</td><td></td><td>101</td><td>-0.22</td><td>-0.87</td><td>0.758</td><td>0.923</td><td>1.000</td><td>1684</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1211</td><td>BARIS_THYROID_CANCER_UP</td><td></td><td>20</td><td>-0.31</td><td>-0.87</td><td>0.650</td><td>0.924</td><td>1.000</td><td>1278</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>1212</td><td>PID_INTEGRIN1_PATHWAY</td><td></td><td>32</td><td>-0.28</td><td>-0.87</td><td>0.692</td><td>0.924</td><td>1.000</td><td>1847</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1213</td><td>REACTOME_S_PHASE</td><td></td><td>103</td><td>-0.22</td><td>-0.87</td><td>0.744</td><td>0.924</td><td>1.000</td><td>1702</td><td>tags=16%, list=15%, signal=18%</td></tr><tr><td class='lessen'>1214</td><td>PACHER_TARGETS_OF_IGF1_AND_IGF2_UP</td><td></td><td>28</td><td>-0.28</td><td>-0.87</td><td>0.653</td><td>0.925</td><td>1.000</td><td>2777</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>1215</td><td>GENTILE_UV_RESPONSE_CLUSTER_D4</td><td></td><td>48</td><td>-0.25</td><td>-0.87</td><td>0.711</td><td>0.924</td><td>1.000</td><td>1001</td><td>tags=17%, list=9%, signal=18%</td></tr><tr><td class='lessen'>1216</td><td>KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION</td><td></td><td>24</td><td>-0.30</td><td>-0.87</td><td>0.642</td><td>0.925</td><td>1.000</td><td>2172</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>1217</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>286</td><td>-0.19</td><td>-0.87</td><td>0.852</td><td>0.924</td><td>1.000</td><td>1666</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1218</td><td>FRIDMAN_SENESCENCE_UP</td><td></td><td>56</td><td>-0.24</td><td>-0.87</td><td>0.709</td><td>0.924</td><td>1.000</td><td>1906</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1219</td><td>REACTOME_GPCR_DOWNSTREAM_SIGNALING</td><td></td><td>194</td><td>-0.20</td><td>-0.87</td><td>0.830</td><td>0.925</td><td>1.000</td><td>1867</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>1220</td><td>NAKAMURA_METASTASIS_MODEL_UP</td><td></td><td>31</td><td>-0.28</td><td>-0.87</td><td>0.686</td><td>0.926</td><td>1.000</td><td>2141</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1221</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP</td><td></td><td>50</td><td>-0.25</td><td>-0.87</td><td>0.694</td><td>0.926</td><td>1.000</td><td>1603</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1222</td><td>LINDVALL_IMMORTALIZED_BY_TERT_UP</td><td></td><td>52</td><td>-0.25</td><td>-0.87</td><td>0.724</td><td>0.925</td><td>1.000</td><td>1390</td><td>tags=17%, list=12%, signal=20%</td></tr><tr><td class='lessen'>1223</td><td>LY_AGING_MIDDLE_DN</td><td></td><td>15</td><td>-0.34</td><td>-0.87</td><td>0.658</td><td>0.926</td><td>1.000</td><td>2968</td><td>tags=47%, list=26%, signal=63%</td></tr><tr><td class='lessen'>1224</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS</td><td></td><td>25</td><td>-0.29</td><td>-0.86</td><td>0.667</td><td>0.928</td><td>1.000</td><td>3065</td><td>tags=36%, list=26%, signal=49%</td></tr><tr><td class='lessen'>1225</td><td>FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP</td><td></td><td>51</td><td>-0.25</td><td>-0.86</td><td>0.690</td><td>0.932</td><td>1.000</td><td>2301</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1226</td><td>BIDUS_METASTASIS_DN</td><td></td><td>118</td><td>-0.21</td><td>-0.86</td><td>0.785</td><td>0.932</td><td>1.000</td><td>3745</td><td>tags=40%, list=32%, signal=58%</td></tr><tr><td class='lessen'>1227</td><td>LEE_LIVER_CANCER_MYC_E2F1_DN</td><td></td><td>29</td><td>-0.28</td><td>-0.86</td><td>0.686</td><td>0.932</td><td>1.000</td><td>1401</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>1228</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>365</td><td>-0.19</td><td>-0.86</td><td>0.915</td><td>0.932</td><td>1.000</td><td>2104</td><td>tags=19%, list=18%, signal=22%</td></tr><tr><td class='lessen'>1229</td><td>NAKAMURA_CANCER_MICROENVIRONMENT_DN</td><td></td><td>43</td><td>-0.26</td><td>-0.86</td><td>0.712</td><td>0.932</td><td>1.000</td><td>1531</td><td>tags=14%, list=13%, signal=16%</td></tr><tr><td class='lessen'>1230</td><td>PID_AR_PATHWAY</td><td></td><td>52</td><td>-0.25</td><td>-0.86</td><td>0.720</td><td>0.932</td><td>1.000</td><td>1573</td><td>tags=15%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1231</td><td>WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN</td><td></td><td>16</td><td>-0.33</td><td>-0.86</td><td>0.649</td><td>0.931</td><td>1.000</td><td>16</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>1232</td><td>THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN</td><td></td><td>207</td><td>-0.20</td><td>-0.86</td><td>0.836</td><td>0.931</td><td>1.000</td><td>2399</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>1233</td><td>REACTOME_G1_S_SPECIFIC_TRANSCRIPTION</td><td></td><td>16</td><td>-0.33</td><td>-0.86</td><td>0.642</td><td>0.933</td><td>1.000</td><td>343</td><td>tags=13%, list=3%, signal=13%</td></tr><tr><td class='lessen'>1234</td><td>TING_SILENCED_BY_DICER</td><td></td><td>20</td><td>-0.31</td><td>-0.86</td><td>0.662</td><td>0.933</td><td>1.000</td><td>898</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>1235</td><td>REACTOME_CHROMOSOME_MAINTENANCE</td><td></td><td>96</td><td>-0.22</td><td>-0.86</td><td>0.767</td><td>0.934</td><td>1.000</td><td>2853</td><td>tags=32%, list=25%, signal=42%</td></tr><tr><td class='lessen'>1236</td><td>SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP</td><td></td><td>74</td><td>-0.23</td><td>-0.86</td><td>0.753</td><td>0.934</td><td>1.000</td><td>2229</td><td>tags=26%, list=19%, signal=32%</td></tr><tr><td class='lessen'>1237</td><td>SANA_TNF_SIGNALING_DN</td><td></td><td>53</td><td>-0.25</td><td>-0.86</td><td>0.708</td><td>0.933</td><td>1.000</td><td>836</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>1238</td><td>KEGG_SPHINGOLIPID_METABOLISM</td><td></td><td>24</td><td>-0.29</td><td>-0.86</td><td>0.668</td><td>0.933</td><td>1.000</td><td>1718</td><td>tags=29%, list=15%, signal=34%</td></tr><tr><td class='lessen'>1239</td><td>COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN</td><td></td><td>20</td><td>-0.30</td><td>-0.86</td><td>0.672</td><td>0.933</td><td>1.000</td><td>2032</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>1240</td><td>GROSS_HYPOXIA_VIA_HIF1A_DN</td><td></td><td>84</td><td>-0.23</td><td>-0.86</td><td>0.757</td><td>0.933</td><td>1.000</td><td>2224</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>1241</td><td>CHOI_ATL_STAGE_PREDICTOR</td><td></td><td>37</td><td>-0.26</td><td>-0.86</td><td>0.698</td><td>0.933</td><td>1.000</td><td>1274</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>1242</td><td>PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION</td><td></td><td>18</td><td>-0.31</td><td>-0.86</td><td>0.674</td><td>0.933</td><td>1.000</td><td>693</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>1243</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>159</td><td>-0.20</td><td>-0.86</td><td>0.835</td><td>0.932</td><td>1.000</td><td>2178</td><td>tags=19%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1244</td><td>REACTOME_TRNA_AMINOACYLATION</td><td></td><td>41</td><td>-0.26</td><td>-0.86</td><td>0.713</td><td>0.932</td><td>1.000</td><td>2010</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1245</td><td>REN_BOUND_BY_E2F</td><td></td><td>60</td><td>-0.24</td><td>-0.86</td><td>0.727</td><td>0.931</td><td>1.000</td><td>1739</td><td>tags=22%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1246</td><td>YAGI_AML_RELAPSE_PROGNOSIS</td><td></td><td>31</td><td>-0.28</td><td>-0.85</td><td>0.683</td><td>0.934</td><td>1.000</td><td>2133</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1247</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA</td><td></td><td>42</td><td>-0.25</td><td>-0.85</td><td>0.691</td><td>0.935</td><td>1.000</td><td>2171</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>1248</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>107</td><td>-0.22</td><td>-0.85</td><td>0.794</td><td>0.935</td><td>1.000</td><td>2358</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1249</td><td>REACTOME_SIGNALING_BY_FGFR_IN_DISEASE</td><td></td><td>92</td><td>-0.22</td><td>-0.85</td><td>0.763</td><td>0.937</td><td>1.000</td><td>1759</td><td>tags=17%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1250</td><td>PID_DELTA_NP63_PATHWAY</td><td></td><td>33</td><td>-0.27</td><td>-0.85</td><td>0.702</td><td>0.937</td><td>1.000</td><td>2358</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>1251</td><td>VALK_AML_CLUSTER_2</td><td></td><td>21</td><td>-0.30</td><td>-0.85</td><td>0.667</td><td>0.937</td><td>1.000</td><td>676</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1252</td><td>BIOCARTA_TPO_PATHWAY</td><td></td><td>22</td><td>-0.30</td><td>-0.85</td><td>0.671</td><td>0.936</td><td>1.000</td><td>1822</td><td>tags=32%, list=16%, signal=38%</td></tr><tr><td class='lessen'>1253</td><td>REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM</td><td></td><td>26</td><td>-0.29</td><td>-0.85</td><td>0.677</td><td>0.936</td><td>1.000</td><td>2610</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1254</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN</td><td></td><td>37</td><td>-0.26</td><td>-0.85</td><td>0.720</td><td>0.936</td><td>1.000</td><td>3594</td><td>tags=38%, list=31%, signal=55%</td></tr><tr><td class='lessen'>1255</td><td>KEGG_NEUROTROPHIN_SIGNALING_PATHWAY</td><td></td><td>103</td><td>-0.22</td><td>-0.85</td><td>0.777</td><td>0.938</td><td>1.000</td><td>1286</td><td>tags=14%, list=11%, signal=15%</td></tr><tr><td class='lessen'>1256</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>135</td><td>-0.21</td><td>-0.85</td><td>0.842</td><td>0.938</td><td>1.000</td><td>1238</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>1257</td><td>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN</td><td></td><td>18</td><td>-0.31</td><td>-0.85</td><td>0.685</td><td>0.937</td><td>1.000</td><td>2556</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>1258</td><td>LOPES_METHYLATED_IN_COLON_CANCER_DN</td><td></td><td>16</td><td>-0.31</td><td>-0.85</td><td>0.691</td><td>0.937</td><td>1.000</td><td>2561</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>1259</td><td>CHOW_RASSF1_TARGETS_UP</td><td></td><td>26</td><td>-0.29</td><td>-0.85</td><td>0.684</td><td>0.936</td><td>1.000</td><td>2629</td><td>tags=38%, list=23%, signal=50%</td></tr><tr><td class='lessen'>1260</td><td>NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON</td><td></td><td>81</td><td>-0.23</td><td>-0.85</td><td>0.788</td><td>0.936</td><td>1.000</td><td>3203</td><td>tags=35%, list=28%, signal=47%</td></tr><tr><td class='lessen'>1261</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN</td><td></td><td>39</td><td>-0.26</td><td>-0.85</td><td>0.702</td><td>0.936</td><td>1.000</td><td>2725</td><td>tags=28%, list=24%, signal=37%</td></tr><tr><td class='lessen'>1262</td><td>NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON</td><td></td><td>209</td><td>-0.19</td><td>-0.85</td><td>0.865</td><td>0.935</td><td>1.000</td><td>1873</td><td>tags=16%, list=16%, signal=19%</td></tr><tr><td class='lessen'>1263</td><td>PID_PDGFRA_PATHWAY</td><td></td><td>20</td><td>-0.30</td><td>-0.85</td><td>0.685</td><td>0.935</td><td>1.000</td><td>973</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>1264</td><td>REACTOME_SIGNALING_BY_INSULIN_RECEPTOR</td><td></td><td>76</td><td>-0.23</td><td>-0.85</td><td>0.780</td><td>0.935</td><td>1.000</td><td>2004</td><td>tags=21%, list=17%, signal=25%</td></tr><tr><td class='lessen'>1265</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN</td><td></td><td>16</td><td>-0.32</td><td>-0.85</td><td>0.679</td><td>0.935</td><td>1.000</td><td>944</td><td>tags=19%, list=8%, signal=20%</td></tr><tr><td class='lessen'>1266</td><td>BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS</td><td></td><td>54</td><td>-0.24</td><td>-0.85</td><td>0.740</td><td>0.934</td><td>1.000</td><td>1078</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>1267</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>193</td><td>-0.20</td><td>-0.85</td><td>0.855</td><td>0.934</td><td>1.000</td><td>2273</td><td>tags=20%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1268</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>330</td><td>-0.19</td><td>-0.85</td><td>0.916</td><td>0.935</td><td>1.000</td><td>2935</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>1269</td><td>KIM_WT1_TARGETS_8HR_DN</td><td></td><td>79</td><td>-0.23</td><td>-0.85</td><td>0.773</td><td>0.934</td><td>1.000</td><td>2474</td><td>tags=28%, list=21%, signal=35%</td></tr><tr><td class='lessen'>1270</td><td>KAUFFMANN_DNA_REPLICATION_GENES</td><td></td><td>121</td><td>-0.21</td><td>-0.85</td><td>0.813</td><td>0.934</td><td>1.000</td><td>1842</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1271</td><td>BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN</td><td></td><td>29</td><td>-0.27</td><td>-0.85</td><td>0.718</td><td>0.934</td><td>1.000</td><td>306</td><td>tags=7%, list=3%, signal=7%</td></tr><tr><td class='lessen'>1272</td><td>WHITFIELD_CELL_CYCLE_LITERATURE</td><td></td><td>43</td><td>-0.25</td><td>-0.85</td><td>0.738</td><td>0.934</td><td>1.000</td><td>1702</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1273</td><td>REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING</td><td></td><td>39</td><td>-0.26</td><td>-0.85</td><td>0.732</td><td>0.933</td><td>1.000</td><td>3351</td><td>tags=36%, list=29%, signal=50%</td></tr><tr><td class='lessen'>1274</td><td>ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP</td><td></td><td>27</td><td>-0.28</td><td>-0.85</td><td>0.701</td><td>0.935</td><td>1.000</td><td>1466</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>1275</td><td>PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN</td><td></td><td>104</td><td>-0.22</td><td>-0.84</td><td>0.802</td><td>0.937</td><td>1.000</td><td>1695</td><td>tags=15%, list=15%, signal=18%</td></tr><tr><td class='lessen'>1276</td><td>REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION</td><td></td><td>71</td><td>-0.23</td><td>-0.84</td><td>0.780</td><td>0.936</td><td>1.000</td><td>862</td><td>tags=13%, list=7%, signal=14%</td></tr><tr><td class='lessen'>1277</td><td>SCHRAETS_MLL_TARGETS_UP</td><td></td><td>21</td><td>-0.29</td><td>-0.84</td><td>0.698</td><td>0.936</td><td>1.000</td><td>2075</td><td>tags=29%, list=18%, signal=35%</td></tr><tr><td class='lessen'>1278</td><td>GAVIN_FOXP3_TARGETS_CLUSTER_P2</td><td></td><td>50</td><td>-0.25</td><td>-0.84</td><td>0.754</td><td>0.936</td><td>1.000</td><td>2619</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>1279</td><td>REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S</td><td></td><td>57</td><td>-0.24</td><td>-0.84</td><td>0.762</td><td>0.935</td><td>1.000</td><td>3358</td><td>tags=46%, list=29%, signal=64%</td></tr><tr><td class='lessen'>1280</td><td>NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_DN</td><td></td><td>91</td><td>-0.22</td><td>-0.84</td><td>0.783</td><td>0.935</td><td>1.000</td><td>2010</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1281</td><td>PID_TCPTP_PATHWAY</td><td></td><td>32</td><td>-0.27</td><td>-0.84</td><td>0.701</td><td>0.935</td><td>1.000</td><td>1690</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1282</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP</td><td></td><td>113</td><td>-0.21</td><td>-0.84</td><td>0.829</td><td>0.935</td><td>1.000</td><td>2557</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>1283</td><td>PID_FRA_PATHWAY</td><td></td><td>22</td><td>-0.30</td><td>-0.84</td><td>0.727</td><td>0.934</td><td>1.000</td><td>443</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>1284</td><td>MARSHALL_VIRAL_INFECTION_RESPONSE_DN</td><td></td><td>27</td><td>-0.28</td><td>-0.84</td><td>0.705</td><td>0.934</td><td>1.000</td><td>2705</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>1285</td><td>VALK_AML_CLUSTER_15</td><td></td><td>27</td><td>-0.28</td><td>-0.84</td><td>0.705</td><td>0.933</td><td>1.000</td><td>5</td><td>tags=4%, list=0%, signal=4%</td></tr><tr><td class='lessen'>1286</td><td>NAKAMURA_ADIPOGENESIS_LATE_UP</td><td></td><td>75</td><td>-0.23</td><td>-0.84</td><td>0.789</td><td>0.933</td><td>1.000</td><td>2149</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>1287</td><td>BIOCARTA_GSK3_PATHWAY</td><td></td><td>20</td><td>-0.30</td><td>-0.84</td><td>0.690</td><td>0.932</td><td>1.000</td><td>957</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>1288</td><td>BAKKER_FOXO3_TARGETS_DN</td><td></td><td>123</td><td>-0.21</td><td>-0.84</td><td>0.844</td><td>0.932</td><td>1.000</td><td>1235</td><td>tags=11%, list=11%, signal=13%</td></tr><tr><td class='lessen'>1289</td><td>BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN</td><td></td><td>95</td><td>-0.22</td><td>-0.84</td><td>0.813</td><td>0.932</td><td>1.000</td><td>1707</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1290</td><td>DORN_ADENOVIRUS_INFECTION_48HR_DN</td><td></td><td>29</td><td>-0.27</td><td>-0.84</td><td>0.708</td><td>0.932</td><td>1.000</td><td>983</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>1291</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>71</td><td>-0.23</td><td>-0.84</td><td>0.784</td><td>0.932</td><td>1.000</td><td>3073</td><td>tags=25%, list=27%, signal=34%</td></tr><tr><td class='lessen'>1292</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>90</td><td>-0.22</td><td>-0.84</td><td>0.783</td><td>0.931</td><td>1.000</td><td>1916</td><td>tags=19%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1293</td><td>PID_HDAC_CLASSI_PATHWAY</td><td></td><td>57</td><td>-0.24</td><td>-0.84</td><td>0.780</td><td>0.932</td><td>1.000</td><td>1264</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>1294</td><td>KEGG_MELANOMA</td><td></td><td>43</td><td>-0.25</td><td>-0.84</td><td>0.749</td><td>0.931</td><td>1.000</td><td>2210</td><td>tags=26%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1295</td><td>IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP</td><td></td><td>16</td><td>-0.32</td><td>-0.84</td><td>0.668</td><td>0.931</td><td>1.000</td><td>250</td><td>tags=13%, list=2%, signal=13%</td></tr><tr><td class='lessen'>1296</td><td>OUYANG_PROSTATE_CANCER_PROGRESSION_UP</td><td></td><td>15</td><td>-0.32</td><td>-0.84</td><td>0.662</td><td>0.930</td><td>1.000</td><td>3500</td><td>tags=47%, list=30%, signal=67%</td></tr><tr><td class='lessen'>1297</td><td>PID_EPHA2_FWD_PATHWAY</td><td></td><td>16</td><td>-0.31</td><td>-0.84</td><td>0.687</td><td>0.930</td><td>1.000</td><td>2360</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>1298</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>160</td><td>-0.20</td><td>-0.84</td><td>0.871</td><td>0.930</td><td>1.000</td><td>1784</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1299</td><td>KIM_WT1_TARGETS_12HR_UP</td><td></td><td>109</td><td>-0.21</td><td>-0.84</td><td>0.819</td><td>0.930</td><td>1.000</td><td>1857</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1300</td><td>BROWNE_HCMV_INFECTION_12HR_UP</td><td></td><td>83</td><td>-0.23</td><td>-0.84</td><td>0.785</td><td>0.930</td><td>1.000</td><td>1887</td><td>tags=18%, list=16%, signal=21%</td></tr><tr><td class='lessen'>1301</td><td>DORN_ADENOVIRUS_INFECTION_12HR_DN</td><td></td><td>30</td><td>-0.27</td><td>-0.84</td><td>0.727</td><td>0.929</td><td>1.000</td><td>1807</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1302</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN</td><td></td><td>46</td><td>-0.25</td><td>-0.84</td><td>0.750</td><td>0.928</td><td>1.000</td><td>3158</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>1303</td><td>REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE</td><td></td><td>61</td><td>-0.24</td><td>-0.84</td><td>0.755</td><td>0.928</td><td>1.000</td><td>2004</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>1304</td><td>KEGG_VEGF_SIGNALING_PATHWAY</td><td></td><td>55</td><td>-0.24</td><td>-0.84</td><td>0.749</td><td>0.929</td><td>1.000</td><td>1516</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1305</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN</td><td></td><td>23</td><td>-0.29</td><td>-0.84</td><td>0.701</td><td>0.930</td><td>1.000</td><td>2413</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1306</td><td>REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT</td><td></td><td>26</td><td>-0.28</td><td>-0.84</td><td>0.726</td><td>0.930</td><td>1.000</td><td>2018</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>1307</td><td>ZHAN_MULTIPLE_MYELOMA_LB_UP</td><td></td><td>29</td><td>-0.27</td><td>-0.84</td><td>0.729</td><td>0.930</td><td>1.000</td><td>1648</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1308</td><td>REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE</td><td></td><td>108</td><td>-0.21</td><td>-0.84</td><td>0.828</td><td>0.929</td><td>1.000</td><td>1720</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1309</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR</td><td></td><td>113</td><td>-0.21</td><td>-0.84</td><td>0.840</td><td>0.928</td><td>1.000</td><td>2218</td><td>tags=21%, list=19%, signal=26%</td></tr><tr><td class='lessen'>1310</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN</td><td></td><td>30</td><td>-0.27</td><td>-0.84</td><td>0.746</td><td>0.928</td><td>1.000</td><td>2006</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>1311</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>18</td><td>-0.31</td><td>-0.84</td><td>0.710</td><td>0.929</td><td>1.000</td><td>717</td><td>tags=17%, list=6%, signal=18%</td></tr><tr><td class='lessen'>1312</td><td>DITTMER_PTHLH_TARGETS_DN</td><td></td><td>59</td><td>-0.23</td><td>-0.84</td><td>0.772</td><td>0.928</td><td>1.000</td><td>2534</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>1313</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN</td><td></td><td>275</td><td>-0.19</td><td>-0.84</td><td>0.923</td><td>0.928</td><td>1.000</td><td>3156</td><td>tags=27%, list=27%, signal=36%</td></tr><tr><td class='lessen'>1314</td><td>PIONTEK_PKD1_TARGETS_UP</td><td></td><td>22</td><td>-0.30</td><td>-0.83</td><td>0.731</td><td>0.928</td><td>1.000</td><td>3657</td><td>tags=45%, list=32%, signal=66%</td></tr><tr><td class='lessen'>1315</td><td>SMID_BREAST_CANCER_LUMINAL_A_UP</td><td></td><td>28</td><td>-0.27</td><td>-0.83</td><td>0.720</td><td>0.927</td><td>1.000</td><td>1522</td><td>tags=21%, list=13%, signal=25%</td></tr><tr><td class='lessen'>1316</td><td>VANOEVELEN_MYOGENESIS_SIN3A_TARGETS</td><td></td><td>180</td><td>-0.20</td><td>-0.83</td><td>0.878</td><td>0.927</td><td>1.000</td><td>3481</td><td>tags=32%, list=30%, signal=45%</td></tr><tr><td class='lessen'>1317</td><td>MORI_PRE_BI_LYMPHOCYTE_DN</td><td></td><td>67</td><td>-0.23</td><td>-0.83</td><td>0.767</td><td>0.927</td><td>1.000</td><td>1626</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>1318</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>17</td><td>-0.31</td><td>-0.83</td><td>0.674</td><td>0.926</td><td>1.000</td><td>1137</td><td>tags=18%, list=10%, signal=20%</td></tr><tr><td class='lessen'>1319</td><td>RUIZ_TNC_TARGETS_DN</td><td></td><td>116</td><td>-0.21</td><td>-0.83</td><td>0.829</td><td>0.926</td><td>1.000</td><td>2178</td><td>tags=19%, list=19%, signal=23%</td></tr><tr><td class='lessen'>1320</td><td>THILLAINADESAN_ZNF217_TARGETS_UP</td><td></td><td>38</td><td>-0.26</td><td>-0.83</td><td>0.731</td><td>0.926</td><td>1.000</td><td>3337</td><td>tags=37%, list=29%, signal=52%</td></tr><tr><td class='lessen'>1321</td><td>STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP</td><td></td><td>24</td><td>-0.28</td><td>-0.83</td><td>0.709</td><td>0.926</td><td>1.000</td><td>2701</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>1322</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP</td><td></td><td>22</td><td>-0.30</td><td>-0.83</td><td>0.740</td><td>0.925</td><td>1.000</td><td>37</td><td>tags=5%, list=0%, signal=5%</td></tr><tr><td class='lessen'>1323</td><td>RODRIGUES_DCC_TARGETS_DN</td><td></td><td>93</td><td>-0.22</td><td>-0.83</td><td>0.811</td><td>0.927</td><td>1.000</td><td>1606</td><td>tags=16%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1324</td><td>REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION</td><td></td><td>66</td><td>-0.23</td><td>-0.83</td><td>0.790</td><td>0.927</td><td>1.000</td><td>1887</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1325</td><td>KEGG_HEDGEHOG_SIGNALING_PATHWAY</td><td></td><td>20</td><td>-0.30</td><td>-0.83</td><td>0.710</td><td>0.928</td><td>1.000</td><td>2469</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>1326</td><td>BAE_BRCA1_TARGETS_DN</td><td></td><td>23</td><td>-0.29</td><td>-0.83</td><td>0.722</td><td>0.929</td><td>1.000</td><td>2314</td><td>tags=30%, list=20%, signal=38%</td></tr><tr><td class='lessen'>1327</td><td>REACTOME_SYNTHESIS_OF_PA</td><td></td><td>17</td><td>-0.31</td><td>-0.83</td><td>0.713</td><td>0.931</td><td>1.000</td><td>1929</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>1328</td><td>KIM_HYPOXIA</td><td></td><td>22</td><td>-0.29</td><td>-0.83</td><td>0.703</td><td>0.930</td><td>1.000</td><td>2671</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1329</td><td>EPPERT_PROGENITOR</td><td></td><td>108</td><td>-0.21</td><td>-0.83</td><td>0.880</td><td>0.931</td><td>1.000</td><td>2999</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>1330</td><td>SERVITJA_LIVER_HNF1A_TARGETS_DN</td><td></td><td>62</td><td>-0.23</td><td>-0.83</td><td>0.797</td><td>0.931</td><td>1.000</td><td>588</td><td>tags=10%, list=5%, signal=10%</td></tr><tr><td class='lessen'>1331</td><td>KANG_IMMORTALIZED_BY_TERT_UP</td><td></td><td>52</td><td>-0.24</td><td>-0.83</td><td>0.789</td><td>0.931</td><td>1.000</td><td>1137</td><td>tags=15%, list=10%, signal=17%</td></tr><tr><td class='lessen'>1332</td><td>ACEVEDO_LIVER_CANCER_DN</td><td></td><td>370</td><td>-0.18</td><td>-0.83</td><td>0.973</td><td>0.930</td><td>1.000</td><td>2068</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1333</td><td>YOKOE_CANCER_TESTIS_ANTIGENS</td><td></td><td>23</td><td>-0.29</td><td>-0.83</td><td>0.748</td><td>0.931</td><td>1.000</td><td>1470</td><td>tags=26%, list=13%, signal=30%</td></tr><tr><td class='lessen'>1334</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP</td><td></td><td>64</td><td>-0.23</td><td>-0.83</td><td>0.798</td><td>0.931</td><td>1.000</td><td>2992</td><td>tags=33%, list=26%, signal=44%</td></tr><tr><td class='lessen'>1335</td><td>ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR</td><td></td><td>74</td><td>-0.22</td><td>-0.83</td><td>0.807</td><td>0.931</td><td>1.000</td><td>1742</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1336</td><td>MATZUK_SPERMATOCYTE</td><td></td><td>45</td><td>-0.25</td><td>-0.83</td><td>0.770</td><td>0.931</td><td>1.000</td><td>2661</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>1337</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>44</td><td>-0.25</td><td>-0.83</td><td>0.756</td><td>0.930</td><td>1.000</td><td>1517</td><td>tags=20%, list=13%, signal=23%</td></tr><tr><td class='lessen'>1338</td><td>REACTOME_DARPP_32_EVENTS</td><td></td><td>20</td><td>-0.29</td><td>-0.83</td><td>0.747</td><td>0.930</td><td>1.000</td><td>3252</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>1339</td><td>REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX</td><td></td><td>29</td><td>-0.27</td><td>-0.83</td><td>0.764</td><td>0.930</td><td>1.000</td><td>18</td><td>tags=3%, list=0%, signal=3%</td></tr><tr><td class='lessen'>1340</td><td>PID_ARF6_PATHWAY</td><td></td><td>23</td><td>-0.28</td><td>-0.82</td><td>0.744</td><td>0.931</td><td>1.000</td><td>2117</td><td>tags=30%, list=18%, signal=37%</td></tr><tr><td class='lessen'>1341</td><td>AMIT_SERUM_RESPONSE_480_MCF10A</td><td></td><td>25</td><td>-0.27</td><td>-0.82</td><td>0.726</td><td>0.930</td><td>1.000</td><td>2108</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>1342</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_DN</td><td></td><td>147</td><td>-0.20</td><td>-0.82</td><td>0.886</td><td>0.932</td><td>1.000</td><td>2194</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1343</td><td>DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP</td><td></td><td>37</td><td>-0.26</td><td>-0.82</td><td>0.754</td><td>0.931</td><td>1.000</td><td>2497</td><td>tags=27%, list=22%, signal=34%</td></tr><tr><td class='lessen'>1344</td><td>ST_FAS_SIGNALING_PATHWAY</td><td></td><td>52</td><td>-0.24</td><td>-0.82</td><td>0.800</td><td>0.930</td><td>1.000</td><td>2705</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1345</td><td>SMID_BREAST_CANCER_ERBB2_UP</td><td></td><td>74</td><td>-0.22</td><td>-0.82</td><td>0.812</td><td>0.930</td><td>1.000</td><td>2836</td><td>tags=27%, list=24%, signal=36%</td></tr><tr><td class='lessen'>1346</td><td>REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL</td><td></td><td>52</td><td>-0.24</td><td>-0.82</td><td>0.802</td><td>0.930</td><td>1.000</td><td>1690</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>1347</td><td>PID_LYSOPHOSPHOLIPID_PATHWAY</td><td></td><td>44</td><td>-0.25</td><td>-0.82</td><td>0.750</td><td>0.929</td><td>1.000</td><td>831</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>1348</td><td>MARCHINI_TRABECTEDIN_RESISTANCE_DN</td><td></td><td>32</td><td>-0.26</td><td>-0.82</td><td>0.719</td><td>0.928</td><td>1.000</td><td>2032</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>1349</td><td>CAIRO_LIVER_DEVELOPMENT_DN</td><td></td><td>114</td><td>-0.21</td><td>-0.82</td><td>0.856</td><td>0.929</td><td>1.000</td><td>1729</td><td>tags=18%, list=15%, signal=20%</td></tr><tr><td class='lessen'>1350</td><td>CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE</td><td></td><td>30</td><td>-0.26</td><td>-0.82</td><td>0.738</td><td>0.931</td><td>1.000</td><td>1975</td><td>tags=23%, list=17%, signal=28%</td></tr><tr><td class='lessen'>1351</td><td>PID_REELIN_PATHWAY</td><td></td><td>24</td><td>-0.28</td><td>-0.82</td><td>0.720</td><td>0.931</td><td>1.000</td><td>1730</td><td>tags=25%, list=15%, signal=29%</td></tr><tr><td class='lessen'>1352</td><td>STEARMAN_TUMOR_FIELD_EFFECT_UP</td><td></td><td>24</td><td>-0.28</td><td>-0.82</td><td>0.728</td><td>0.930</td><td>1.000</td><td>1588</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>1353</td><td>REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX</td><td></td><td>62</td><td>-0.23</td><td>-0.82</td><td>0.786</td><td>0.930</td><td>1.000</td><td>1647</td><td>tags=16%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1354</td><td>REACTOME_ACTIVATED_TLR4_SIGNALLING</td><td></td><td>79</td><td>-0.22</td><td>-0.82</td><td>0.809</td><td>0.934</td><td>1.000</td><td>2807</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1355</td><td>TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN</td><td></td><td>83</td><td>-0.22</td><td>-0.82</td><td>0.835</td><td>0.933</td><td>1.000</td><td>2639</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>1356</td><td>REACTOME_SYNTHESIS_OF_DNA</td><td></td><td>87</td><td>-0.21</td><td>-0.82</td><td>0.837</td><td>0.933</td><td>1.000</td><td>1842</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1357</td><td>MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS</td><td></td><td>27</td><td>-0.27</td><td>-0.82</td><td>0.755</td><td>0.933</td><td>1.000</td><td>2140</td><td>tags=30%, list=18%, signal=36%</td></tr><tr><td class='lessen'>1358</td><td>PID_ANTHRAX_PATHWAY</td><td></td><td>15</td><td>-0.31</td><td>-0.82</td><td>0.710</td><td>0.935</td><td>1.000</td><td>7</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>1359</td><td>BIOCARTA_EGF_PATHWAY</td><td></td><td>29</td><td>-0.26</td><td>-0.81</td><td>0.773</td><td>0.939</td><td>1.000</td><td>1264</td><td>tags=21%, list=11%, signal=23%</td></tr><tr><td class='lessen'>1360</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>362</td><td>-0.18</td><td>-0.81</td><td>0.977</td><td>0.940</td><td>1.000</td><td>2875</td><td>tags=24%, list=25%, signal=31%</td></tr><tr><td class='lessen'>1361</td><td>REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE</td><td></td><td>70</td><td>-0.22</td><td>-0.81</td><td>0.848</td><td>0.941</td><td>1.000</td><td>1887</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1362</td><td>SHIPP_DLBCL_CURED_VS_FATAL_DN</td><td></td><td>38</td><td>-0.25</td><td>-0.81</td><td>0.800</td><td>0.942</td><td>1.000</td><td>1047</td><td>tags=16%, list=9%, signal=17%</td></tr><tr><td class='lessen'>1363</td><td>MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP</td><td></td><td>61</td><td>-0.22</td><td>-0.81</td><td>0.837</td><td>0.942</td><td>1.000</td><td>2922</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>1364</td><td>BIOCARTA_INSULIN_PATHWAY</td><td></td><td>18</td><td>-0.30</td><td>-0.81</td><td>0.745</td><td>0.942</td><td>1.000</td><td>1170</td><td>tags=22%, list=10%, signal=25%</td></tr><tr><td class='lessen'>1365</td><td>CERVERA_SDHB_TARGETS_2</td><td></td><td>51</td><td>-0.24</td><td>-0.81</td><td>0.804</td><td>0.942</td><td>1.000</td><td>1807</td><td>tags=22%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1366</td><td>REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE</td><td></td><td>15</td><td>-0.30</td><td>-0.81</td><td>0.743</td><td>0.943</td><td>1.000</td><td>2156</td><td>tags=40%, list=19%, signal=49%</td></tr><tr><td class='lessen'>1367</td><td>HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN</td><td></td><td>37</td><td>-0.25</td><td>-0.81</td><td>0.790</td><td>0.942</td><td>1.000</td><td>3236</td><td>tags=35%, list=28%, signal=49%</td></tr><tr><td class='lessen'>1368</td><td>APPIERTO_RESPONSE_TO_FENRETINIDE_DN</td><td></td><td>44</td><td>-0.24</td><td>-0.81</td><td>0.802</td><td>0.942</td><td>1.000</td><td>1015</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>1369</td><td>REACTOME_PERK_REGULATED_GENE_EXPRESSION</td><td></td><td>24</td><td>-0.28</td><td>-0.81</td><td>0.770</td><td>0.942</td><td>1.000</td><td>2541</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>1370</td><td>SABATES_COLORECTAL_ADENOMA_UP</td><td></td><td>42</td><td>-0.25</td><td>-0.81</td><td>0.791</td><td>0.942</td><td>1.000</td><td>945</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>1371</td><td>XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN</td><td></td><td>22</td><td>-0.29</td><td>-0.81</td><td>0.745</td><td>0.942</td><td>1.000</td><td>788</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>1372</td><td>SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM</td><td></td><td>149</td><td>-0.19</td><td>-0.81</td><td>0.934</td><td>0.942</td><td>1.000</td><td>1686</td><td>tags=14%, list=15%, signal=16%</td></tr><tr><td class='lessen'>1373</td><td>BIOCARTA_GCR_PATHWAY</td><td></td><td>15</td><td>-0.31</td><td>-0.80</td><td>0.731</td><td>0.945</td><td>1.000</td><td>48</td><td>tags=7%, list=0%, signal=7%</td></tr><tr><td class='lessen'>1374</td><td>DARWICHE_PAPILLOMA_PROGRESSION_RISK</td><td></td><td>38</td><td>-0.25</td><td>-0.80</td><td>0.811</td><td>0.945</td><td>1.000</td><td>2469</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>1375</td><td>MMS_MOUSE_LYMPH_HIGH_4HRS_UP</td><td></td><td>33</td><td>-0.26</td><td>-0.80</td><td>0.809</td><td>0.945</td><td>1.000</td><td>1618</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>1376</td><td>LANDIS_ERBB2_BREAST_TUMORS_65_UP</td><td></td><td>19</td><td>-0.29</td><td>-0.80</td><td>0.760</td><td>0.945</td><td>1.000</td><td>2779</td><td>tags=32%, list=24%, signal=41%</td></tr><tr><td class='lessen'>1377</td><td>LIM_MAMMARY_LUMINAL_MATURE_UP</td><td></td><td>65</td><td>-0.22</td><td>-0.80</td><td>0.847</td><td>0.945</td><td>1.000</td><td>1633</td><td>tags=15%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1378</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN</td><td></td><td>28</td><td>-0.26</td><td>-0.80</td><td>0.771</td><td>0.945</td><td>1.000</td><td>2429</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>1379</td><td>BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP</td><td></td><td>173</td><td>-0.19</td><td>-0.80</td><td>0.932</td><td>0.944</td><td>1.000</td><td>2585</td><td>tags=23%, list=22%, signal=29%</td></tr><tr><td class='lessen'>1380</td><td>KEGG_OLFACTORY_TRANSDUCTION</td><td></td><td>19</td><td>-0.29</td><td>-0.80</td><td>0.736</td><td>0.943</td><td>1.000</td><td>62</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>1381</td><td>NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN</td><td></td><td>24</td><td>-0.27</td><td>-0.80</td><td>0.778</td><td>0.943</td><td>1.000</td><td>1869</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>1382</td><td>REACTOME_MRNA_CAPPING</td><td></td><td>29</td><td>-0.26</td><td>-0.80</td><td>0.764</td><td>0.943</td><td>1.000</td><td>872</td><td>tags=7%, list=8%, signal=7%</td></tr><tr><td class='lessen'>1383</td><td>KEGG_SPLICEOSOME</td><td></td><td>118</td><td>-0.20</td><td>-0.80</td><td>0.895</td><td>0.943</td><td>1.000</td><td>935</td><td>tags=10%, list=8%, signal=11%</td></tr><tr><td class='lessen'>1384</td><td>GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP</td><td></td><td>150</td><td>-0.20</td><td>-0.80</td><td>0.921</td><td>0.943</td><td>1.000</td><td>1800</td><td>tags=17%, list=16%, signal=20%</td></tr><tr><td class='lessen'>1385</td><td>PID_ECADHERIN_KERATINOCYTE_PATHWAY</td><td></td><td>16</td><td>-0.30</td><td>-0.80</td><td>0.734</td><td>0.943</td><td>1.000</td><td>48</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>1386</td><td>LIU_LIVER_CANCER</td><td></td><td>18</td><td>-0.29</td><td>-0.80</td><td>0.757</td><td>0.943</td><td>1.000</td><td>3339</td><td>tags=39%, list=29%, signal=55%</td></tr><tr><td class='lessen'>1387</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td><td></td><td>43</td><td>-0.24</td><td>-0.80</td><td>0.821</td><td>0.946</td><td>1.000</td><td>2686</td><td>tags=33%, list=23%, signal=42%</td></tr><tr><td class='lessen'>1388</td><td>OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP</td><td></td><td>58</td><td>-0.23</td><td>-0.80</td><td>0.831</td><td>0.945</td><td>1.000</td><td>2850</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>1389</td><td>BIOCARTA_NKCELLS_PATHWAY</td><td></td><td>15</td><td>-0.30</td><td>-0.80</td><td>0.745</td><td>0.945</td><td>1.000</td><td>2232</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1390</td><td>PID_EPO_PATHWAY</td><td></td><td>32</td><td>-0.25</td><td>-0.80</td><td>0.796</td><td>0.946</td><td>1.000</td><td>2360</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>1391</td><td>SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP</td><td></td><td>17</td><td>-0.30</td><td>-0.80</td><td>0.765</td><td>0.946</td><td>1.000</td><td>1627</td><td>tags=29%, list=14%, signal=34%</td></tr><tr><td class='lessen'>1392</td><td>NADERI_BREAST_CANCER_PROGNOSIS_UP</td><td></td><td>31</td><td>-0.26</td><td>-0.79</td><td>0.789</td><td>0.947</td><td>1.000</td><td>1759</td><td>tags=19%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1393</td><td>HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR</td><td></td><td>47</td><td>-0.24</td><td>-0.79</td><td>0.834</td><td>0.947</td><td>1.000</td><td>3113</td><td>tags=36%, list=27%, signal=49%</td></tr><tr><td class='lessen'>1394</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>74</td><td>-0.22</td><td>-0.79</td><td>0.849</td><td>0.946</td><td>1.000</td><td>2141</td><td>tags=18%, list=18%, signal=21%</td></tr><tr><td class='lessen'>1395</td><td>GENTILE_RESPONSE_CLUSTER_D3</td><td></td><td>52</td><td>-0.23</td><td>-0.79</td><td>0.827</td><td>0.946</td><td>1.000</td><td>1335</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1396</td><td>FRIDMAN_IMMORTALIZATION_DN</td><td></td><td>25</td><td>-0.26</td><td>-0.79</td><td>0.784</td><td>0.945</td><td>1.000</td><td>1906</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1397</td><td>REACTOME_HIV_INFECTION</td><td></td><td>179</td><td>-0.19</td><td>-0.79</td><td>0.933</td><td>0.946</td><td>1.000</td><td>1665</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1398</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td><td></td><td>87</td><td>-0.21</td><td>-0.79</td><td>0.894</td><td>0.946</td><td>1.000</td><td>2291</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>1399</td><td>XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN</td><td></td><td>50</td><td>-0.23</td><td>-0.79</td><td>0.812</td><td>0.945</td><td>1.000</td><td>3717</td><td>tags=42%, list=32%, signal=62%</td></tr><tr><td class='lessen'>1400</td><td>CHANG_CYCLING_GENES</td><td></td><td>133</td><td>-0.20</td><td>-0.79</td><td>0.907</td><td>0.946</td><td>1.000</td><td>2663</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>1401</td><td>REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS</td><td></td><td>18</td><td>-0.29</td><td>-0.79</td><td>0.768</td><td>0.946</td><td>1.000</td><td>2426</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1402</td><td>KEGG_BASAL_CELL_CARCINOMA</td><td></td><td>21</td><td>-0.28</td><td>-0.79</td><td>0.757</td><td>0.946</td><td>1.000</td><td>1535</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1403</td><td>SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC</td><td></td><td>86</td><td>-0.21</td><td>-0.79</td><td>0.881</td><td>0.945</td><td>1.000</td><td>1822</td><td>tags=20%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1404</td><td>BIOCARTA_P38MAPK_PATHWAY</td><td></td><td>34</td><td>-0.25</td><td>-0.79</td><td>0.784</td><td>0.945</td><td>1.000</td><td>1841</td><td>tags=24%, list=16%, signal=28%</td></tr><tr><td class='lessen'>1405</td><td>ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP</td><td></td><td>75</td><td>-0.21</td><td>-0.79</td><td>0.855</td><td>0.944</td><td>1.000</td><td>3319</td><td>tags=35%, list=29%, signal=48%</td></tr><tr><td class='lessen'>1406</td><td>REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION</td><td></td><td>28</td><td>-0.27</td><td>-0.79</td><td>0.774</td><td>0.944</td><td>1.000</td><td>2971</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>1407</td><td>VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN</td><td></td><td>50</td><td>-0.23</td><td>-0.79</td><td>0.839</td><td>0.945</td><td>1.000</td><td>1606</td><td>tags=18%, list=14%, signal=21%</td></tr><tr><td class='lessen'>1408</td><td>IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR</td><td></td><td>125</td><td>-0.20</td><td>-0.79</td><td>0.919</td><td>0.944</td><td>1.000</td><td>758</td><td>tags=10%, list=7%, signal=11%</td></tr><tr><td class='lessen'>1409</td><td>REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY</td><td></td><td>41</td><td>-0.24</td><td>-0.79</td><td>0.836</td><td>0.945</td><td>1.000</td><td>2541</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1410</td><td>KEGG_RNA_DEGRADATION</td><td></td><td>54</td><td>-0.23</td><td>-0.79</td><td>0.861</td><td>0.945</td><td>1.000</td><td>1390</td><td>tags=13%, list=12%, signal=15%</td></tr><tr><td class='lessen'>1411</td><td>PID_PTP1B_PATHWAY</td><td></td><td>38</td><td>-0.24</td><td>-0.79</td><td>0.834</td><td>0.945</td><td>1.000</td><td>1826</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1412</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN</td><td></td><td>58</td><td>-0.22</td><td>-0.79</td><td>0.837</td><td>0.947</td><td>1.000</td><td>3751</td><td>tags=36%, list=32%, signal=53%</td></tr><tr><td class='lessen'>1413</td><td>REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS</td><td></td><td>54</td><td>-0.23</td><td>-0.79</td><td>0.825</td><td>0.947</td><td>1.000</td><td>1643</td><td>tags=15%, list=14%, signal=17%</td></tr><tr><td class='lessen'>1414</td><td>XU_GH1_AUTOCRINE_TARGETS_DN</td><td></td><td>98</td><td>-0.20</td><td>-0.78</td><td>0.899</td><td>0.949</td><td>1.000</td><td>2522</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>1415</td><td>CHUNG_BLISTER_CYTOTOXICITY_UP</td><td></td><td>115</td><td>-0.20</td><td>-0.78</td><td>0.920</td><td>0.949</td><td>1.000</td><td>2354</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1416</td><td>VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP</td><td></td><td>81</td><td>-0.21</td><td>-0.78</td><td>0.895</td><td>0.948</td><td>1.000</td><td>1816</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>1417</td><td>BIOCARTA_TID_PATHWAY</td><td></td><td>17</td><td>-0.29</td><td>-0.78</td><td>0.777</td><td>0.948</td><td>1.000</td><td>1644</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>1418</td><td>YANG_BREAST_CANCER_ESR1_UP</td><td></td><td>17</td><td>-0.29</td><td>-0.78</td><td>0.787</td><td>0.949</td><td>1.000</td><td>2311</td><td>tags=29%, list=20%, signal=37%</td></tr><tr><td class='lessen'>1419</td><td>WANG_METHYLATED_IN_BREAST_CANCER</td><td></td><td>27</td><td>-0.26</td><td>-0.78</td><td>0.786</td><td>0.950</td><td>1.000</td><td>2696</td><td>tags=33%, list=23%, signal=43%</td></tr><tr><td class='lessen'>1420</td><td>BOYLAN_MULTIPLE_MYELOMA_C_UP</td><td></td><td>37</td><td>-0.24</td><td>-0.78</td><td>0.818</td><td>0.950</td><td>1.000</td><td>1720</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>1421</td><td>REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE</td><td></td><td>62</td><td>-0.22</td><td>-0.78</td><td>0.875</td><td>0.950</td><td>1.000</td><td>1887</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1422</td><td>LAU_APOPTOSIS_CDKN2A_UP</td><td></td><td>50</td><td>-0.23</td><td>-0.78</td><td>0.837</td><td>0.951</td><td>1.000</td><td>2836</td><td>tags=32%, list=24%, signal=42%</td></tr><tr><td class='lessen'>1423</td><td>PID_IL8_CXCR2_PATHWAY</td><td></td><td>27</td><td>-0.26</td><td>-0.78</td><td>0.804</td><td>0.953</td><td>1.000</td><td>957</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>1424</td><td>BENPORATH_ES_CORE_NINE_CORRELATED</td><td></td><td>77</td><td>-0.21</td><td>-0.78</td><td>0.899</td><td>0.953</td><td>1.000</td><td>2446</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>1425</td><td>KEGG_DNA_REPLICATION</td><td></td><td>35</td><td>-0.24</td><td>-0.78</td><td>0.821</td><td>0.952</td><td>1.000</td><td>1842</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1426</td><td>JI_RESPONSE_TO_FSH_DN</td><td></td><td>48</td><td>-0.22</td><td>-0.77</td><td>0.853</td><td>0.955</td><td>1.000</td><td>3126</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>1427</td><td>ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP</td><td></td><td>135</td><td>-0.19</td><td>-0.77</td><td>0.948</td><td>0.955</td><td>1.000</td><td>1315</td><td>tags=12%, list=11%, signal=13%</td></tr><tr><td class='lessen'>1428</td><td>REACTOME_IL_2_SIGNALING</td><td></td><td>35</td><td>-0.24</td><td>-0.77</td><td>0.835</td><td>0.955</td><td>1.000</td><td>2429</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1429</td><td>NATSUME_RESPONSE_TO_INTERFERON_BETA_UP</td><td></td><td>54</td><td>-0.22</td><td>-0.77</td><td>0.884</td><td>0.955</td><td>1.000</td><td>2442</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1430</td><td>MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP</td><td></td><td>15</td><td>-0.29</td><td>-0.77</td><td>0.759</td><td>0.955</td><td>1.000</td><td>1702</td><td>tags=20%, list=15%, signal=23%</td></tr><tr><td class='lessen'>1431</td><td>MCCABE_HOXC6_TARGETS_CANCER_DN</td><td></td><td>17</td><td>-0.28</td><td>-0.77</td><td>0.777</td><td>0.955</td><td>1.000</td><td>2046</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>1432</td><td>LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN</td><td></td><td>25</td><td>-0.26</td><td>-0.77</td><td>0.817</td><td>0.955</td><td>1.000</td><td>2801</td><td>tags=40%, list=24%, signal=53%</td></tr><tr><td class='lessen'>1433</td><td>KEGG_VIRAL_MYOCARDITIS</td><td></td><td>52</td><td>-0.22</td><td>-0.77</td><td>0.874</td><td>0.955</td><td>1.000</td><td>1063</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>1434</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>257</td><td>-0.18</td><td>-0.77</td><td>0.990</td><td>0.954</td><td>1.000</td><td>1629</td><td>tags=14%, list=14%, signal=15%</td></tr><tr><td class='lessen'>1435</td><td>CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN</td><td></td><td>175</td><td>-0.18</td><td>-0.77</td><td>0.963</td><td>0.953</td><td>1.000</td><td>2983</td><td>tags=25%, list=26%, signal=33%</td></tr><tr><td class='lessen'>1436</td><td>KEGG_HOMOLOGOUS_RECOMBINATION</td><td></td><td>25</td><td>-0.26</td><td>-0.77</td><td>0.815</td><td>0.953</td><td>1.000</td><td>1926</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>1437</td><td>BROWNE_HCMV_INFECTION_2HR_DN</td><td></td><td>36</td><td>-0.24</td><td>-0.77</td><td>0.828</td><td>0.953</td><td>1.000</td><td>3242</td><td>tags=42%, list=28%, signal=58%</td></tr><tr><td class='lessen'>1438</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_DN</td><td></td><td>29</td><td>-0.25</td><td>-0.77</td><td>0.834</td><td>0.952</td><td>1.000</td><td>3744</td><td>tags=38%, list=32%, signal=56%</td></tr><tr><td class='lessen'>1439</td><td>SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1</td><td></td><td>216</td><td>-0.18</td><td>-0.77</td><td>0.985</td><td>0.952</td><td>1.000</td><td>2172</td><td>tags=18%, list=19%, signal=21%</td></tr><tr><td class='lessen'>1440</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_UP</td><td></td><td>44</td><td>-0.23</td><td>-0.77</td><td>0.852</td><td>0.952</td><td>1.000</td><td>1837</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>1441</td><td>YAMASHITA_LIVER_CANCER_STEM_CELL_UP</td><td></td><td>26</td><td>-0.26</td><td>-0.77</td><td>0.816</td><td>0.951</td><td>1.000</td><td>1560</td><td>tags=23%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1442</td><td>LU_TUMOR_VASCULATURE_UP</td><td></td><td>15</td><td>-0.30</td><td>-0.77</td><td>0.784</td><td>0.953</td><td>1.000</td><td>949</td><td>tags=20%, list=8%, signal=22%</td></tr><tr><td class='lessen'>1443</td><td>WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP</td><td></td><td>17</td><td>-0.29</td><td>-0.77</td><td>0.795</td><td>0.954</td><td>1.000</td><td>3616</td><td>tags=53%, list=31%, signal=77%</td></tr><tr><td class='lessen'>1444</td><td>REACTOME_G1_S_TRANSITION</td><td></td><td>103</td><td>-0.20</td><td>-0.77</td><td>0.921</td><td>0.954</td><td>1.000</td><td>1842</td><td>tags=16%, list=16%, signal=18%</td></tr><tr><td class='lessen'>1445</td><td>PID_P38_MK2_PATHWAY</td><td></td><td>18</td><td>-0.28</td><td>-0.77</td><td>0.798</td><td>0.954</td><td>1.000</td><td>2202</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>1446</td><td>VALK_AML_CLUSTER_5</td><td></td><td>22</td><td>-0.27</td><td>-0.77</td><td>0.798</td><td>0.953</td><td>1.000</td><td>1765</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>1447</td><td>BILANGES_SERUM_SENSITIVE_GENES</td><td></td><td>53</td><td>-0.22</td><td>-0.77</td><td>0.862</td><td>0.953</td><td>1.000</td><td>1714</td><td>tags=15%, list=15%, signal=18%</td></tr><tr><td class='lessen'>1448</td><td>KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY</td><td></td><td>60</td><td>-0.21</td><td>-0.76</td><td>0.893</td><td>0.954</td><td>1.000</td><td>2439</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>1449</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>41</td><td>-0.23</td><td>-0.76</td><td>0.843</td><td>0.954</td><td>1.000</td><td>1739</td><td>tags=15%, list=15%, signal=17%</td></tr><tr><td class='lessen'>1450</td><td>CHENG_RESPONSE_TO_NICKEL_ACETATE</td><td></td><td>36</td><td>-0.23</td><td>-0.76</td><td>0.839</td><td>0.954</td><td>1.000</td><td>1080</td><td>tags=11%, list=9%, signal=12%</td></tr><tr><td class='lessen'>1451</td><td>BIOCARTA_RAC1_PATHWAY</td><td></td><td>19</td><td>-0.28</td><td>-0.76</td><td>0.803</td><td>0.953</td><td>1.000</td><td>2641</td><td>tags=26%, list=23%, signal=34%</td></tr><tr><td class='lessen'>1452</td><td>REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS</td><td></td><td>30</td><td>-0.25</td><td>-0.76</td><td>0.834</td><td>0.953</td><td>1.000</td><td>937</td><td>tags=13%, list=8%, signal=14%</td></tr><tr><td class='lessen'>1453</td><td>REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE</td><td></td><td>72</td><td>-0.21</td><td>-0.76</td><td>0.906</td><td>0.952</td><td>1.000</td><td>2871</td><td>tags=29%, list=25%, signal=39%</td></tr><tr><td class='lessen'>1454</td><td>ST_GRANULE_CELL_SURVIVAL_PATHWAY</td><td></td><td>19</td><td>-0.28</td><td>-0.76</td><td>0.798</td><td>0.952</td><td>1.000</td><td>175</td><td>tags=11%, list=2%, signal=11%</td></tr><tr><td class='lessen'>1455</td><td>SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES</td><td></td><td>21</td><td>-0.27</td><td>-0.76</td><td>0.815</td><td>0.951</td><td>1.000</td><td>3126</td><td>tags=24%, list=27%, signal=33%</td></tr><tr><td class='lessen'>1456</td><td>HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS</td><td></td><td>48</td><td>-0.22</td><td>-0.76</td><td>0.868</td><td>0.951</td><td>1.000</td><td>3488</td><td>tags=33%, list=30%, signal=48%</td></tr><tr><td class='lessen'>1457</td><td>DELASERNA_MYOD_TARGETS_DN</td><td></td><td>36</td><td>-0.24</td><td>-0.76</td><td>0.879</td><td>0.952</td><td>1.000</td><td>1066</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>1458</td><td>PID_RAC1_REG_PATHWAY</td><td></td><td>27</td><td>-0.26</td><td>-0.76</td><td>0.820</td><td>0.953</td><td>1.000</td><td>1867</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>1459</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_4</td><td></td><td>46</td><td>-0.23</td><td>-0.76</td><td>0.876</td><td>0.953</td><td>1.000</td><td>2850</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>1460</td><td>LASTOWSKA_COAMPLIFIED_WITH_MYCN</td><td></td><td>25</td><td>-0.26</td><td>-0.76</td><td>0.840</td><td>0.952</td><td>1.000</td><td>2658</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1461</td><td>ELVIDGE_HIF1A_TARGETS_UP</td><td></td><td>59</td><td>-0.21</td><td>-0.76</td><td>0.906</td><td>0.953</td><td>1.000</td><td>2359</td><td>tags=22%, list=20%, signal=28%</td></tr><tr><td class='lessen'>1462</td><td>WATANABE_COLON_CANCER_MSI_VS_MSS_DN</td><td></td><td>40</td><td>-0.23</td><td>-0.76</td><td>0.861</td><td>0.953</td><td>1.000</td><td>2232</td><td>tags=18%, list=19%, signal=22%</td></tr><tr><td class='lessen'>1463</td><td>PETRETTO_HEART_MASS_QTL_CIS_UP</td><td></td><td>21</td><td>-0.27</td><td>-0.76</td><td>0.808</td><td>0.953</td><td>1.000</td><td>3100</td><td>tags=33%, list=27%, signal=45%</td></tr><tr><td class='lessen'>1464</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td><td></td><td>17</td><td>-0.28</td><td>-0.75</td><td>0.814</td><td>0.955</td><td>1.000</td><td>30</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>1465</td><td>BOYLAN_MULTIPLE_MYELOMA_D_DN</td><td></td><td>59</td><td>-0.21</td><td>-0.75</td><td>0.913</td><td>0.954</td><td>1.000</td><td>3326</td><td>tags=39%, list=29%, signal=54%</td></tr><tr><td class='lessen'>1466</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>220</td><td>-0.17</td><td>-0.75</td><td>0.988</td><td>0.956</td><td>1.000</td><td>1892</td><td>tags=15%, list=16%, signal=18%</td></tr><tr><td class='lessen'>1467</td><td>PID_ER_NONGENOMIC_PATHWAY</td><td></td><td>28</td><td>-0.25</td><td>-0.75</td><td>0.850</td><td>0.957</td><td>1.000</td><td>1401</td><td>tags=14%, list=12%, signal=16%</td></tr><tr><td class='lessen'>1468</td><td>HOFMANN_CELL_LYMPHOMA_DN</td><td></td><td>30</td><td>-0.25</td><td>-0.75</td><td>0.842</td><td>0.959</td><td>1.000</td><td>1968</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1469</td><td>KOHOUTEK_CCNT1_TARGETS</td><td></td><td>28</td><td>-0.25</td><td>-0.75</td><td>0.819</td><td>0.960</td><td>1.000</td><td>3392</td><td>tags=36%, list=29%, signal=50%</td></tr><tr><td class='lessen'>1470</td><td>PAL_PRMT5_TARGETS_DN</td><td></td><td>15</td><td>-0.28</td><td>-0.75</td><td>0.834</td><td>0.962</td><td>1.000</td><td>3308</td><td>tags=33%, list=29%, signal=47%</td></tr><tr><td class='lessen'>1471</td><td>FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP</td><td></td><td>38</td><td>-0.23</td><td>-0.75</td><td>0.872</td><td>0.961</td><td>1.000</td><td>1262</td><td>tags=18%, list=11%, signal=21%</td></tr><tr><td class='lessen'>1472</td><td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td><td></td><td>93</td><td>-0.20</td><td>-0.75</td><td>0.960</td><td>0.960</td><td>1.000</td><td>2347</td><td>tags=20%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1473</td><td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td><td></td><td>27</td><td>-0.25</td><td>-0.75</td><td>0.855</td><td>0.960</td><td>1.000</td><td>3232</td><td>tags=41%, list=28%, signal=56%</td></tr><tr><td class='lessen'>1474</td><td>KRIGE_AMINO_ACID_DEPRIVATION</td><td></td><td>26</td><td>-0.25</td><td>-0.74</td><td>0.849</td><td>0.961</td><td>1.000</td><td>657</td><td>tags=8%, list=6%, signal=8%</td></tr><tr><td class='lessen'>1475</td><td>AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G</td><td></td><td>71</td><td>-0.20</td><td>-0.74</td><td>0.932</td><td>0.962</td><td>1.000</td><td>3224</td><td>tags=27%, list=28%, signal=37%</td></tr><tr><td class='lessen'>1476</td><td>REACTOME_PEROXISOMAL_LIPID_METABOLISM</td><td></td><td>18</td><td>-0.27</td><td>-0.74</td><td>0.814</td><td>0.961</td><td>1.000</td><td>1975</td><td>tags=28%, list=17%, signal=33%</td></tr><tr><td class='lessen'>1477</td><td>REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1</td><td></td><td>60</td><td>-0.21</td><td>-0.74</td><td>0.918</td><td>0.960</td><td>1.000</td><td>1647</td><td>tags=17%, list=14%, signal=19%</td></tr><tr><td class='lessen'>1478</td><td>LAMB_CCND1_TARGETS</td><td></td><td>15</td><td>-0.28</td><td>-0.74</td><td>0.825</td><td>0.961</td><td>1.000</td><td>1916</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>1479</td><td>PID_INTEGRIN2_PATHWAY</td><td></td><td>16</td><td>-0.28</td><td>-0.74</td><td>0.814</td><td>0.960</td><td>1.000</td><td>2677</td><td>tags=44%, list=23%, signal=57%</td></tr><tr><td class='lessen'>1480</td><td>REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING</td><td></td><td>62</td><td>-0.21</td><td>-0.74</td><td>0.930</td><td>0.960</td><td>1.000</td><td>1887</td><td>tags=19%, list=16%, signal=23%</td></tr><tr><td class='lessen'>1481</td><td>REACTOME_SIGNALING_BY_FGFR1_MUTANTS</td><td></td><td>21</td><td>-0.27</td><td>-0.74</td><td>0.864</td><td>0.960</td><td>1.000</td><td>2426</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1482</td><td>MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3</td><td></td><td>38</td><td>-0.22</td><td>-0.74</td><td>0.887</td><td>0.960</td><td>1.000</td><td>1659</td><td>tags=16%, list=14%, signal=18%</td></tr><tr><td class='lessen'>1483</td><td>AMIT_EGF_RESPONSE_480_MCF10A</td><td></td><td>26</td><td>-0.25</td><td>-0.74</td><td>0.854</td><td>0.959</td><td>1.000</td><td>2108</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>1484</td><td>IRITANI_MAD1_TARGETS_DN</td><td></td><td>44</td><td>-0.22</td><td>-0.74</td><td>0.894</td><td>0.959</td><td>1.000</td><td>2456</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>1485</td><td>PID_AURORA_A_PATHWAY</td><td></td><td>28</td><td>-0.24</td><td>-0.74</td><td>0.862</td><td>0.961</td><td>1.000</td><td>2497</td><td>tags=29%, list=22%, signal=36%</td></tr><tr><td class='lessen'>1486</td><td>KEGG_PYRIMIDINE_METABOLISM</td><td></td><td>87</td><td>-0.19</td><td>-0.74</td><td>0.967</td><td>0.961</td><td>1.000</td><td>3085</td><td>tags=25%, list=27%, signal=34%</td></tr><tr><td class='lessen'>1487</td><td>BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN</td><td></td><td>38</td><td>-0.23</td><td>-0.74</td><td>0.871</td><td>0.961</td><td>1.000</td><td>1231</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>1488</td><td>KEGG_AMINOACYL_TRNA_BIOSYNTHESIS</td><td></td><td>41</td><td>-0.23</td><td>-0.74</td><td>0.893</td><td>0.961</td><td>1.000</td><td>2010</td><td>tags=17%, list=17%, signal=21%</td></tr><tr><td class='lessen'>1489</td><td>TOMLINS_PROSTATE_CANCER_UP</td><td></td><td>35</td><td>-0.23</td><td>-0.73</td><td>0.894</td><td>0.962</td><td>1.000</td><td>546</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>1490</td><td>BIOCARTA_SPPA_PATHWAY</td><td></td><td>18</td><td>-0.26</td><td>-0.73</td><td>0.867</td><td>0.961</td><td>1.000</td><td>1690</td><td>tags=28%, list=15%, signal=32%</td></tr><tr><td class='lessen'>1491</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP</td><td></td><td>47</td><td>-0.21</td><td>-0.73</td><td>0.908</td><td>0.961</td><td>1.000</td><td>3183</td><td>tags=38%, list=27%, signal=53%</td></tr><tr><td class='lessen'>1492</td><td>KEGG_RNA_POLYMERASE</td><td></td><td>29</td><td>-0.24</td><td>-0.73</td><td>0.869</td><td>0.960</td><td>1.000</td><td>18</td><td>tags=3%, list=0%, signal=3%</td></tr><tr><td class='lessen'>1493</td><td>PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP</td><td></td><td>71</td><td>-0.20</td><td>-0.73</td><td>0.942</td><td>0.960</td><td>1.000</td><td>2306</td><td>tags=21%, list=20%, signal=26%</td></tr><tr><td class='lessen'>1494</td><td>REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION</td><td></td><td>23</td><td>-0.25</td><td>-0.73</td><td>0.838</td><td>0.960</td><td>1.000</td><td>2622</td><td>tags=22%, list=23%, signal=28%</td></tr><tr><td class='lessen'>1495</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_DN</td><td></td><td>102</td><td>-0.19</td><td>-0.73</td><td>0.965</td><td>0.960</td><td>1.000</td><td>2587</td><td>tags=22%, list=22%, signal=28%</td></tr><tr><td class='lessen'>1496</td><td>FOSTER_KDM1A_TARGETS_UP</td><td></td><td>117</td><td>-0.18</td><td>-0.73</td><td>0.971</td><td>0.962</td><td>1.000</td><td>1998</td><td>tags=16%, list=17%, signal=19%</td></tr><tr><td class='lessen'>1497</td><td>HOEGERKORP_CD44_TARGETS_TEMPORAL_DN</td><td></td><td>16</td><td>-0.27</td><td>-0.73</td><td>0.818</td><td>0.963</td><td>1.000</td><td>2680</td><td>tags=31%, list=23%, signal=41%</td></tr><tr><td class='lessen'>1498</td><td>INGRAM_SHH_TARGETS_DN</td><td></td><td>34</td><td>-0.23</td><td>-0.73</td><td>0.867</td><td>0.962</td><td>1.000</td><td>2381</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1499</td><td>GU_PDEF_TARGETS_UP</td><td></td><td>41</td><td>-0.22</td><td>-0.73</td><td>0.901</td><td>0.963</td><td>1.000</td><td>1543</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1500</td><td>KEGG_O_GLYCAN_BIOSYNTHESIS</td><td></td><td>16</td><td>-0.28</td><td>-0.73</td><td>0.833</td><td>0.963</td><td>1.000</td><td>2168</td><td>tags=25%, list=19%, signal=31%</td></tr><tr><td class='lessen'>1501</td><td>REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX</td><td></td><td>49</td><td>-0.21</td><td>-0.72</td><td>0.926</td><td>0.963</td><td>1.000</td><td>3358</td><td>tags=43%, list=29%, signal=60%</td></tr><tr><td class='lessen'>1502</td><td>HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP</td><td></td><td>15</td><td>-0.28</td><td>-0.72</td><td>0.840</td><td>0.966</td><td>1.000</td><td>3596</td><td>tags=40%, list=31%, signal=58%</td></tr><tr><td class='lessen'>1503</td><td>KAMIKUBO_MYELOID_CEBPA_NETWORK</td><td></td><td>17</td><td>-0.27</td><td>-0.72</td><td>0.841</td><td>0.967</td><td>1.000</td><td>1016</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>1504</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_1_UP</td><td></td><td>61</td><td>-0.20</td><td>-0.72</td><td>0.937</td><td>0.966</td><td>1.000</td><td>409</td><td>tags=8%, list=4%, signal=8%</td></tr><tr><td class='lessen'>1505</td><td>LEE_LIVER_CANCER_CIPROFIBRATE_DN</td><td></td><td>21</td><td>-0.26</td><td>-0.72</td><td>0.889</td><td>0.966</td><td>1.000</td><td>737</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>1506</td><td>WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP</td><td></td><td>75</td><td>-0.19</td><td>-0.72</td><td>0.955</td><td>0.966</td><td>1.000</td><td>2331</td><td>tags=19%, list=20%, signal=23%</td></tr><tr><td class='lessen'>1507</td><td>CHEN_HOXA5_TARGETS_9HR_DN</td><td></td><td>31</td><td>-0.23</td><td>-0.72</td><td>0.886</td><td>0.965</td><td>1.000</td><td>2474</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>1508</td><td>ZHENG_IL22_SIGNALING_DN</td><td></td><td>19</td><td>-0.26</td><td>-0.72</td><td>0.868</td><td>0.966</td><td>1.000</td><td>2343</td><td>tags=26%, list=20%, signal=33%</td></tr><tr><td class='lessen'>1509</td><td>REACTOME_ORC1_REMOVAL_FROM_CHROMATIN</td><td></td><td>63</td><td>-0.20</td><td>-0.72</td><td>0.941</td><td>0.966</td><td>1.000</td><td>1702</td><td>tags=16%, list=15%, signal=19%</td></tr><tr><td class='lessen'>1510</td><td>BIOCARTA_IL10_PATHWAY</td><td></td><td>17</td><td>-0.27</td><td>-0.72</td><td>0.839</td><td>0.965</td><td>1.000</td><td>1537</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>1511</td><td>REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS</td><td></td><td>22</td><td>-0.24</td><td>-0.71</td><td>0.870</td><td>0.966</td><td>1.000</td><td>1285</td><td>tags=14%, list=11%, signal=15%</td></tr><tr><td class='lessen'>1512</td><td>MOOTHA_FFA_OXYDATION</td><td></td><td>21</td><td>-0.25</td><td>-0.71</td><td>0.881</td><td>0.966</td><td>1.000</td><td>2397</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>1513</td><td>PID_EPHA_FWDPATHWAY</td><td></td><td>22</td><td>-0.24</td><td>-0.71</td><td>0.872</td><td>0.967</td><td>1.000</td><td>2360</td><td>tags=27%, list=20%, signal=34%</td></tr><tr><td class='lessen'>1514</td><td>DORN_ADENOVIRUS_INFECTION_24HR_DN</td><td></td><td>34</td><td>-0.22</td><td>-0.71</td><td>0.925</td><td>0.968</td><td>1.000</td><td>983</td><td>tags=12%, list=8%, signal=13%</td></tr><tr><td class='lessen'>1515</td><td>AUNG_GASTRIC_CANCER</td><td></td><td>33</td><td>-0.22</td><td>-0.71</td><td>0.926</td><td>0.970</td><td>1.000</td><td>1828</td><td>tags=24%, list=16%, signal=29%</td></tr><tr><td class='lessen'>1516</td><td>CHANGOLKAR_H2AFY_TARGETS_UP</td><td></td><td>30</td><td>-0.22</td><td>-0.71</td><td>0.915</td><td>0.970</td><td>1.000</td><td>983</td><td>tags=13%, list=8%, signal=15%</td></tr><tr><td class='lessen'>1517</td><td>OZEN_MIR125B1_TARGETS</td><td></td><td>22</td><td>-0.24</td><td>-0.70</td><td>0.898</td><td>0.971</td><td>1.000</td><td>2165</td><td>tags=27%, list=19%, signal=33%</td></tr><tr><td class='lessen'>1518</td><td>KEGG_BASAL_TRANSCRIPTION_FACTORS</td><td></td><td>30</td><td>-0.23</td><td>-0.70</td><td>0.917</td><td>0.970</td><td>1.000</td><td>3351</td><td>tags=43%, list=29%, signal=61%</td></tr><tr><td class='lessen'>1519</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_UP</td><td></td><td>49</td><td>-0.20</td><td>-0.70</td><td>0.950</td><td>0.975</td><td>1.000</td><td>2185</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1520</td><td>NAKAMURA_ADIPOGENESIS_LATE_DN</td><td></td><td>23</td><td>-0.24</td><td>-0.69</td><td>0.902</td><td>0.978</td><td>1.000</td><td>665</td><td>tags=9%, list=6%, signal=9%</td></tr><tr><td class='lessen'>1521</td><td>KANG_IMMORTALIZED_BY_TERT_DN</td><td></td><td>46</td><td>-0.20</td><td>-0.69</td><td>0.933</td><td>0.978</td><td>1.000</td><td>3100</td><td>tags=30%, list=27%, signal=41%</td></tr><tr><td class='lessen'>1522</td><td>MIKKELSEN_NPC_LCP_WITH_H3K4ME3</td><td></td><td>26</td><td>-0.23</td><td>-0.69</td><td>0.912</td><td>0.979</td><td>1.000</td><td>3182</td><td>tags=42%, list=27%, signal=58%</td></tr><tr><td class='lessen'>1523</td><td>REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C</td><td></td><td>53</td><td>-0.20</td><td>-0.69</td><td>0.966</td><td>0.979</td><td>1.000</td><td>2871</td><td>tags=28%, list=25%, signal=37%</td></tr><tr><td class='lessen'>1524</td><td>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</td><td></td><td>15</td><td>-0.27</td><td>-0.69</td><td>0.888</td><td>0.979</td><td>1.000</td><td>723</td><td>tags=13%, list=6%, signal=14%</td></tr><tr><td class='lessen'>1525</td><td>REACTOME_PYRIMIDINE_METABOLISM</td><td></td><td>17</td><td>-0.26</td><td>-0.69</td><td>0.902</td><td>0.979</td><td>1.000</td><td>805</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>1526</td><td>XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP</td><td></td><td>15</td><td>-0.26</td><td>-0.68</td><td>0.893</td><td>0.981</td><td>1.000</td><td>110</td><td>tags=7%, list=1%, signal=7%</td></tr><tr><td class='lessen'>1527</td><td>STONER_ESOPHAGEAL_CARCINOGENESIS_UP</td><td></td><td>30</td><td>-0.22</td><td>-0.68</td><td>0.934</td><td>0.981</td><td>1.000</td><td>3054</td><td>tags=37%, list=26%, signal=50%</td></tr><tr><td class='lessen'>1528</td><td>CHANDRAN_METASTASIS_TOP50_UP</td><td></td><td>35</td><td>-0.22</td><td>-0.68</td><td>0.928</td><td>0.980</td><td>1.000</td><td>2912</td><td>tags=31%, list=25%, signal=42%</td></tr><tr><td class='lessen'>1529</td><td>BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN</td><td></td><td>28</td><td>-0.22</td><td>-0.68</td><td>0.932</td><td>0.981</td><td>1.000</td><td>2426</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>1530</td><td>COWLING_MYCN_TARGETS</td><td></td><td>19</td><td>-0.24</td><td>-0.68</td><td>0.892</td><td>0.981</td><td>1.000</td><td>3703</td><td>tags=42%, list=32%, signal=62%</td></tr><tr><td class='lessen'>1531</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_DN</td><td></td><td>17</td><td>-0.25</td><td>-0.68</td><td>0.888</td><td>0.980</td><td>1.000</td><td>2614</td><td>tags=29%, list=23%, signal=38%</td></tr><tr><td class='lessen'>1532</td><td>REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS</td><td></td><td>20</td><td>-0.24</td><td>-0.68</td><td>0.930</td><td>0.980</td><td>1.000</td><td>1265</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>1533</td><td>ROSS_ACUTE_MYELOID_LEUKEMIA_CBF</td><td></td><td>59</td><td>-0.19</td><td>-0.67</td><td>0.989</td><td>0.981</td><td>1.000</td><td>2156</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1534</td><td>MURAKAMI_UV_RESPONSE_6HR_UP</td><td></td><td>30</td><td>-0.22</td><td>-0.67</td><td>0.949</td><td>0.981</td><td>1.000</td><td>3144</td><td>tags=33%, list=27%, signal=46%</td></tr><tr><td class='lessen'>1535</td><td>HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN</td><td></td><td>32</td><td>-0.22</td><td>-0.67</td><td>0.942</td><td>0.981</td><td>1.000</td><td>2929</td><td>tags=31%, list=25%, signal=42%</td></tr><tr><td class='lessen'>1536</td><td>AKL_HTLV1_INFECTION_DN</td><td></td><td>50</td><td>-0.20</td><td>-0.67</td><td>0.972</td><td>0.980</td><td>1.000</td><td>1928</td><td>tags=18%, list=17%, signal=22%</td></tr><tr><td class='lessen'>1537</td><td>REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION</td><td></td><td>21</td><td>-0.23</td><td>-0.67</td><td>0.929</td><td>0.982</td><td>1.000</td><td>1995</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>1538</td><td>KEGG_TIGHT_JUNCTION</td><td></td><td>82</td><td>-0.17</td><td>-0.67</td><td>0.988</td><td>0.981</td><td>1.000</td><td>1822</td><td>tags=15%, list=16%, signal=17%</td></tr><tr><td class='lessen'>1539</td><td>HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP</td><td></td><td>27</td><td>-0.22</td><td>-0.67</td><td>0.946</td><td>0.982</td><td>1.000</td><td>1444</td><td>tags=19%, list=12%, signal=21%</td></tr><tr><td class='lessen'>1540</td><td>SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN</td><td></td><td>29</td><td>-0.22</td><td>-0.67</td><td>0.948</td><td>0.982</td><td>1.000</td><td>2296</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>1541</td><td>ST_GAQ_PATHWAY</td><td></td><td>22</td><td>-0.23</td><td>-0.66</td><td>0.921</td><td>0.981</td><td>1.000</td><td>2705</td><td>tags=27%, list=23%, signal=36%</td></tr><tr><td class='lessen'>1542</td><td>REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND</td><td></td><td>15</td><td>-0.26</td><td>-0.66</td><td>0.915</td><td>0.981</td><td>1.000</td><td>3251</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>1543</td><td>NOJIMA_SFRP2_TARGETS_UP</td><td></td><td>25</td><td>-0.23</td><td>-0.66</td><td>0.924</td><td>0.983</td><td>1.000</td><td>2497</td><td>tags=28%, list=22%, signal=36%</td></tr><tr><td class='lessen'>1544</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>21</td><td>-0.24</td><td>-0.66</td><td>0.928</td><td>0.984</td><td>1.000</td><td>3685</td><td>tags=52%, list=32%, signal=77%</td></tr><tr><td class='lessen'>1545</td><td>ZAMORA_NOS2_TARGETS_UP</td><td></td><td>59</td><td>-0.18</td><td>-0.65</td><td>0.981</td><td>0.987</td><td>1.000</td><td>3338</td><td>tags=32%, list=29%, signal=45%</td></tr><tr><td class='lessen'>1546</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>65</td><td>-0.18</td><td>-0.65</td><td>0.981</td><td>0.986</td><td>1.000</td><td>2628</td><td>tags=25%, list=23%, signal=32%</td></tr><tr><td class='lessen'>1547</td><td>REACTOME_ACTIVATION_OF_GENES_BY_ATF4</td><td></td><td>21</td><td>-0.23</td><td>-0.64</td><td>0.934</td><td>0.987</td><td>1.000</td><td>112</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>1548</td><td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td><td></td><td>23</td><td>-0.22</td><td>-0.64</td><td>0.914</td><td>0.987</td><td>1.000</td><td>1513</td><td>tags=17%, list=13%, signal=20%</td></tr><tr><td class='lessen'>1549</td><td>YANG_BREAST_CANCER_ESR1_BULK_DN</td><td></td><td>19</td><td>-0.23</td><td>-0.64</td><td>0.917</td><td>0.987</td><td>1.000</td><td>1847</td><td>tags=21%, list=16%, signal=25%</td></tr><tr><td class='lessen'>1550</td><td>CHOW_RASSF1_TARGETS_DN</td><td></td><td>27</td><td>-0.21</td><td>-0.64</td><td>0.941</td><td>0.987</td><td>1.000</td><td>2606</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>1551</td><td>HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP</td><td></td><td>56</td><td>-0.18</td><td>-0.64</td><td>0.978</td><td>0.987</td><td>1.000</td><td>2695</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>1552</td><td>PATTERSON_DOCETAXEL_RESISTANCE</td><td></td><td>20</td><td>-0.23</td><td>-0.64</td><td>0.945</td><td>0.986</td><td>1.000</td><td>2265</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>1553</td><td>REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING</td><td></td><td>18</td><td>-0.24</td><td>-0.64</td><td>0.930</td><td>0.986</td><td>1.000</td><td>1265</td><td>tags=17%, list=11%, signal=19%</td></tr><tr><td class='lessen'>1554</td><td>REACTOME_PROTEIN_FOLDING</td><td></td><td>44</td><td>-0.19</td><td>-0.64</td><td>0.983</td><td>0.986</td><td>1.000</td><td>2384</td><td>tags=18%, list=21%, signal=23%</td></tr><tr><td class='lessen'>1555</td><td>FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP</td><td></td><td>18</td><td>-0.23</td><td>-0.63</td><td>0.933</td><td>0.986</td><td>1.000</td><td>2480</td><td>tags=33%, list=21%, signal=42%</td></tr><tr><td class='lessen'>1556</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN</td><td></td><td>25</td><td>-0.21</td><td>-0.63</td><td>0.965</td><td>0.987</td><td>1.000</td><td>2162</td><td>tags=20%, list=19%, signal=25%</td></tr><tr><td class='lessen'>1557</td><td>BIOCARTA_VEGF_PATHWAY</td><td></td><td>25</td><td>-0.21</td><td>-0.63</td><td>0.951</td><td>0.986</td><td>1.000</td><td>2327</td><td>tags=20%, list=20%, signal=25%</td></tr><tr><td class='lessen'>1558</td><td>KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION</td><td></td><td>63</td><td>-0.17</td><td>-0.63</td><td>0.991</td><td>0.986</td><td>1.000</td><td>2628</td><td>tags=24%, list=23%, signal=31%</td></tr><tr><td class='lessen'>1559</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN</td><td></td><td>30</td><td>-0.20</td><td>-0.63</td><td>0.951</td><td>0.986</td><td>1.000</td><td>2351</td><td>tags=23%, list=20%, signal=29%</td></tr><tr><td class='lessen'>1560</td><td>HEDENFALK_BREAST_CANCER_BRACX_DN</td><td></td><td>17</td><td>-0.23</td><td>-0.63</td><td>0.942</td><td>0.985</td><td>1.000</td><td>3205</td><td>tags=35%, list=28%, signal=49%</td></tr><tr><td class='lessen'>1561</td><td>REACTOME_BASIGIN_INTERACTIONS</td><td></td><td>15</td><td>-0.24</td><td>-0.63</td><td>0.934</td><td>0.985</td><td>1.000</td><td>212</td><td>tags=7%, list=2%, signal=7%</td></tr><tr><td class='lessen'>1562</td><td>MA_MYELOID_DIFFERENTIATION_UP</td><td></td><td>34</td><td>-0.20</td><td>-0.63</td><td>0.975</td><td>0.985</td><td>1.000</td><td>2742</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>1563</td><td>YEGNASUBRAMANIAN_PROSTATE_CANCER</td><td></td><td>58</td><td>-0.18</td><td>-0.63</td><td>0.993</td><td>0.984</td><td>1.000</td><td>3114</td><td>tags=24%, list=27%, signal=33%</td></tr><tr><td class='lessen'>1564</td><td>CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN</td><td></td><td>19</td><td>-0.23</td><td>-0.62</td><td>0.957</td><td>0.986</td><td>1.000</td><td>2122</td><td>tags=26%, list=18%, signal=32%</td></tr><tr><td class='lessen'>1565</td><td>RAHMAN_TP53_TARGETS_PHOSPHORYLATED</td><td></td><td>21</td><td>-0.21</td><td>-0.61</td><td>0.956</td><td>0.987</td><td>1.000</td><td>2930</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>1566</td><td>REACTOME_INSULIN_RECEPTOR_RECYCLING</td><td></td><td>15</td><td>-0.23</td><td>-0.60</td><td>0.946</td><td>0.990</td><td>1.000</td><td>3267</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>1567</td><td>REACTOME_IRON_UPTAKE_AND_TRANSPORT</td><td></td><td>23</td><td>-0.21</td><td>-0.60</td><td>0.966</td><td>0.990</td><td>1.000</td><td>1265</td><td>tags=13%, list=11%, signal=15%</td></tr><tr><td class='lessen'>1568</td><td>BIOCARTA_PGC1A_PATHWAY</td><td></td><td>16</td><td>-0.22</td><td>-0.59</td><td>0.957</td><td>0.992</td><td>1.000</td><td>1516</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>1569</td><td>CAMPS_COLON_CANCER_COPY_NUMBER_DN</td><td></td><td>34</td><td>-0.19</td><td>-0.59</td><td>0.986</td><td>0.992</td><td>1.000</td><td>2106</td><td>tags=18%, list=18%, signal=22%</td></tr><tr><td class='lessen'>1570</td><td>SYED_ESTRADIOL_RESPONSE</td><td></td><td>18</td><td>-0.21</td><td>-0.58</td><td>0.961</td><td>0.993</td><td>1.000</td><td>3260</td><td>tags=39%, list=28%, signal=54%</td></tr><tr><td class='lessen'>1571</td><td>SEMENZA_HIF1_TARGETS</td><td></td><td>24</td><td>-0.18</td><td>-0.54</td><td>0.996</td><td>0.999</td><td>1.000</td><td>2329</td><td>tags=17%, list=20%, signal=21%</td></tr><tr><td class='lessen'>1572</td><td>AIYAR_COBRA1_TARGETS_UP</td><td></td><td>26</td><td>-0.18</td><td>-0.53</td><td>0.993</td><td>0.998</td><td>1.000</td><td>3300</td><td>tags=31%, list=28%, signal=43%</td></tr><tr><td class='lessen'>1573</td><td>GROSS_HYPOXIA_VIA_ELK3_ONLY_UP</td><td></td><td>25</td><td>-0.18</td><td>-0.53</td><td>0.988</td><td>0.998</td><td>1.000</td><td>2497</td><td>tags=20%, list=22%, signal=25%</td></tr><tr><td class='lessen'>1574</td><td>FARDIN_HYPOXIA_11</td><td></td><td>30</td><td>-0.17</td><td>-0.52</td><td>0.991</td><td>0.998</td><td>1.000</td><td>3488</td><td>tags=27%, list=30%, signal=38%</td></tr><tr><td class='lessen'>1575</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN</td><td></td><td>46</td><td>-0.15</td><td>-0.52</td><td>1.000</td><td>0.998</td><td>1.000</td><td>1690</td><td>tags=13%, list=15%, signal=15%</td></tr><tr><td class='lessen'>1576</td><td>HU_ANGIOGENESIS_DN</td><td></td><td>32</td><td>-0.16</td><td>-0.51</td><td>0.997</td><td>0.998</td><td>1.000</td><td>115</td><td>tags=3%, list=1%, signal=3%</td></tr><tr><td class='lessen'>1577</td><td>VALK_AML_CLUSTER_9</td><td></td><td>23</td><td>-0.16</td><td>-0.48</td><td>0.995</td><td>0.999</td><td>1.000</td><td>3858</td><td>tags=39%, list=33%, signal=59%</td></tr><tr><td class='lessen'>1578</td><td>WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN</td><td></td><td>26</td><td>-0.14</td><td>-0.42</td><td>1.000</td><td>1.000</td><td>1.000</td><td>2614</td><td>tags=15%, list=23%, signal=20%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_neg_1500329484171.xls'>[plain text format]</a></caption></table></div><br></body></html>